In vitro effects of bioactive extracts of local Italian cultivars: from molecular mechanisms to potential nutraceutical applications for consumers’ well-being by Moccia, Stefania
Stefania Moccia 
UNIVERSITÀ DEGLI STUDI DI SALERNO 
DIPARTIMENTO DI FARMACIA 
Dottorato di Ricerca in Scienze del Farmaco 
Ciclo XXIX 
Anno Accademico 2016-2017 
In vitro effects of bioactive extracts of local Italian 
cultivars: from molecular mechanisms to potential 
nutraceutical applications for consumers’ well-being 
  
 
UNIVERSITÀ DEGLI STUDI DI SALERNO 
Dipartimento di Farmacia 
 
 
Dottorato di Ricerca 
in Scienze del Farmaco 
Ciclo XXIX — Anno accademico 2016/2017 
 
 
 
In vitro effects of bioactive extracts of local 
Italian cultivars: from molecular mechanisms 
to potential nutraceutical applications for 
consumers’ well-being 
 
 
 
 
Dottorando Tutore 
 
Dott. Stefania Moccia Chiar.ma Prof. 
 Rita Patrizia Aquino 
 
 
 
Co-tutore: 
Dott. Gian Luigi Russo 
 
 
 
 
Coordinatore: Chiar.mo Prof. Gianluca Sbardella 
  
 
 
 
  
 
 
 
 
INDEX 
 
 Abbreviation list  
 CHAPTER I: Introduction  
1.1 Biological properties of phytochemicals……………………... 2 
1.1.1 Reduction of cardiovascular diseases risk…………………....... 3 
1.1.2 Protection from neurodegenerative damage………………........ 5 
1.1.3 Chemopreventive effect…………………………………………. 10 
1.2  Chemical structure and classification of phytochemicals…... 15 
1.2.1 Polyphenols………………………………………………........... 15 
1.2.2 Carotenoids……………………………………………………... 19 
1.3 Functional foods, nutraceuticals and well-being..................... 23 
1.3.1 Functional foods………………………………………………... 25 
1.3.2 Nutraceuticals…………………………………………………... 29 
1.3.3 EU legislation, healthy claims and marketing implications......... 31 
1.4 Specific aims of the Doctorate project……………………….. 33 
1.5 References……………………………………………………… 37 
   
 Chapter II: Antioxidant activity of red wine polyphenols in 
human RBCs 
 
2.1 Introduction……………………………………………………. 44 
2.2 Aims of the Chapter…………………………………………… 50 
2.3 Materials and Methods……………………………………….. 51 
2.3.1 Chemicals………………………………………………………. 51 
2.3.2 Preparation of RBCs and plasma……………………………..... 51 
2.3.3 Production of red wine and red wine fractionation…………...... 52 
2.3.4 Determination of polyphenol content and antioxidant activity.... 53 
2.3.5 Determination of plasma chloramines formation…………......... 53 
2.3.6 Hemolysis assay…………………………………..................... 54 
 
 
 
 
2.3.7 Evaluation of antioxidant activity in RBCs…………………...... 54 
2.3.8 Determination of Plasma Membrane Redox System…………… 55 
2.3.9 Measurement of GSH levels…………………………………...... 55 
2.3.10 Reactive oxygen species (ROS) measurement………………...... 56 
2.3.11 Activity of antioxidant enzymes………………………………… 56 
2.3.12 Statistical analysis……………………………………………… 58 
2.4 Results and discussion………………………………………… 59 
2.4.1 Phenolic content and antioxidant activity of red wine…………. 59 
2.4.2 Protection from plasma chloramines formation and RBCs 
hemolysis……………………………………………………....... 60 
2.4.3 Activation of PMRS activity by red wine……………………...... 63 
2.4.4 Red wine interaction with RBCs antioxidant systems………….. 65 
2.4.5 PMRS activity by red wine anthocyanins and polymers……....... 70 
2.5 Conclusions…….………………………………………………. 76 
2.6 References……………………………………………………… 78 
   
 Chapter III: Neuroprotective effects of a polyphenolic 
extract from Sambucus nigra 
 
3.1 Introduction……………………………………………………. 84 
3.2 Aims of the Chapter…………………………………………… 89 
3.3 Materials and Methods………………………………………... 91 
3.3.1 Chemicals……………………………………………………….. 91 
3.3.2 Cell culture and differentiation…………………………………. 92 
3.3.3 Real time PCR…………………………………………………... 93 
3.3.4 Preparation of S. nigra polyphenol extract…………………...... 94 
3.3.5 Polyphenol content and antioxidant activity…………………… 95 
3.3.6 Viability assay (MTT) ………………………………………….. 97 
3.3.7 Caspase assays…………………………………………………. 98 
3.3.8 Haechst assay…………………………………………………... 99 
 
 
 
 
3.3.9 Reactive oxygen species (ROS) measurement………………….. 99 
3.3.10 Statistical analysis……………………………………………… 100 
3.4 Results and discussion………………………………………… 101 
3.4.1 Neuronal differentiation of IMR-32…………………………….. 101 
3.4.2 Phenolic content and antioxidant activity of S. nigra extract…... 103 
3.4.3 Evaluation of the protective effect of S. nigra extract in 
neuronal differentiation of IMR-32……………………………... 104 
3.4.4 Protection of S. nigra extract from neuronal cell death………... 106 
3.4.5 Protection of S. nigra extract from oxidative stress……………. 112 
3.5 Conclusions…………………………………………………….. 114 
3.6 References…………………………………………………….... 115 
   
 Chapter IV: Antiproliferative effect of carotenoids from 
Cucurbita moschata 
 
4.1 Introduction……………………………………………………. 120 
4.2 Aims of the Chapter…………………………………………… 131 
4.3 Materials and Methods………………………………………... 132 
4.3.1 Chemicals……………………………………………………….. 132 
4.3.2 Sample preparation……………………………………………... 132 
4.3.3 Preparation and analysis of nanoemulsions  from the 
carotenoid extract………………………………………………. 133 
4.3.4 Cell culture……………………………………………………... 135 
4.3.5 CyQuant viability assay………………………………………… 135 
4.3.6 CytoID Autophagy assay……………………………………….. 136 
4.3.7 SDS-PAGE and immunoblotting……………………………….. 137 
4.3.8 Chemiluminescence assay……………………………………… 138 
4.3.9 Statistical analysis……………………………………………… 138 
4.4 Results and Discussion………………………………………... 139 
 
 
 
 
4.4.1 Pumpkin S-CO2 extract composition…………………………… 139 
4.4.2 Nanoemulsions preparation and characherization…………….. 140 
4.4.3 Antiproliferative effect of CEN on Caco-2 and SAOs cell lines... 143 
4.4.4 Activation of autophagy by carotenoid extract…………………. 147 
4.4.5 CEN activates “not protective” autophagy…………………….. 151 
4.4.6 Biochemical regulation of autophagy by carotenoid extract…… 156 
4.5 Conclusions…………………………………………………….. 161 
4.6 References……………………………………………………… 162 
   
 Chapter V: Conclusions  
5.1 Conclusions…………………………………………………….. 168 
5.2 References……………………………………………………… 177 
   
 
  
 
 
 
 
 
 
 
 
 
i 
 
Abbreviations list  
AChEIs: Cholinesterase inhibitors  
ABTS: 2,2'-azinobis (3-etilbenzotiazolin-6-sulfonate) 
AD: Alzheimer  
AFC: 7-Amino-4-trifluoromethyl coumarin 
AFR: Ascorbyl Free Radical 
APL: Acute Promyelocytic Leukemia 
AMPK: Adenosine 5′-Monophosphate–activated Protein Kinase 
APP: Amyloid precursor protein  
ATP: Adenosine Triphosphate 
ATRA: All-trans retinoic acid 
ASC: Ascorbate 
BBB: Blood brain barrier  
BSA: Bovine Serum Albumin 
CAT: Catalase  
CEN: Carotenoid extract nanoemulsion 
CGA: Chlorogenic acids  
CNS: Central nervous system  
CVD: Cardiovascular diseases 
 
 
ii 
 
DHA: Dehydroascorbate  
DMSO: Dimethyl sulfoxide 
DPPH: 1,1-diphenyl-2-picrilidrazilic  
EFSA: European Food and Safety Authority  
EGCG: Epigallocatechin-3-gallate  
EGFR: Epidermal growth factor receptor  
FIC: Ferricyanide 
FOC: Ferrocyanide  
FOSHU: Foods for Specific Health Use  
FRAP: Ferric Reducing Antioxidant Power 
FUFOSE: Functional Food Science in Europe  
GAE: Gallic acid equivalent  
G6PD: Glucose-6-Phosphate Dehydrogenase  
GPx: Glutathione Peroxidase  
GR: Glutathione Reductase  
GSH: Glutathione  
GSSG: Oxidized glutathione  
IGFR: Insulin like growth factor receptor  
ISPA-CNR: Istituto di Scienze delle Produzioni Alimentari, Consiglio 
Nazionale delle Ricerche 
 
 
iii 
 
LC3: Microtubule-associated protein Light Chain 3 
LDL: Low-Density Lipoprotein  
MAPK: Mitogen-activated protein kinase  
MDA: Malondialdehyde  
mTOR: Mammalian target of rapamycin 
MUFA: Monounsaturated fatty acid 
ND: Neurodegenerative diseases  
NFB: Nuclear factor  
NO: Nitric Oxide 
NREA: Research and education nutraceutical 
OxLDL: Oxidized LDL  
PASSCLAIM: Process for the Assessment of Scientific Support for Claims 
on Foods 
RT-PCR: Real-time PCR  
PD: Parkinson’s disease 
PI3K: Phosphoinositide 3-kinase 
PMRS: Plasma Membrane Redox System 
PSA: Prostate antigen specific 
PUFA: Polyunsaturated fatty acid 
RBCs: Red Blood Cells 
 
 
iv 
 
ROS: Reactive Oxygen Species  
RW: Red wine 
RWP: Red wine polymers 
SnPE: Sambucus nigra polyphenolic extract  
SOD: Superoxide Dismutase  
ULK1: UNC-51-Like Kinase 1 
 
 
 
 
 
 
 
 
 
 
Chapter I 
 
Introduction 
 
  
 
 
Chapter I: Introduction 
2 
 
1.1 Biological properties of phytochemicals 
 
Several hundred scientific studies focus on the beneficial effects for human 
health, of bioactive compounds, collectively called phytochemicals and 
usually present in the diet. These molecules are widely present in plant derived 
foods and beverages (fruits, vegetables and beverages, such as tea, wine, beer) 
and include a very heterogeneous group of natural substances, like vitamins 
(carotenoids) and polyphenols, phytoalexins, indoles and sulfur rich 
compounds [1, 2].  
Phytochemicals are secondary metabolites that plants produce to protect 
themselves from other organisms and they regulate enzymes involved in cell 
metabolism and in mechanisms of defense against foreign agents such as 
radiations, viruses and parasites. Due to the variety of their physiological roles 
in plant tissues, phytochemicals have been associated to pleiotropic effects in 
animal cells [3, 4]. In fact, their physiological role on human body could be 
exerted by activating the detoxifying defense mechanisms, interacting with the 
metabolic pathway, by modulating the signaling cascades implicated in the 
cell growth, proliferation, differentiation and death [5] [6]. In particular, 
several signaling pathways are affected by phytochemicals, such as insulin like 
growth factor receptor (IGFR), Ras/Raf signaling, mitogen-activated protein 
kinase (MAPK/ERK), phosphoinositide 3-kinase (PI3K), epidermal growth 
factor receptor (EGFR) and nuclear factor (NF-B) [7]. Their beneficial 
properties on human health have been considered mainly in relation to their 
anti-inflammatory and antioxidant activity, since the inflammation and 
oxidative stress are the critical conditions in many human degenerative 
diseases such as cardiovascular disease (CVD), neurodegenerative disorders, 
aging and cancer, as reported by several epidemiological studies [8, 9].  
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1.1.1 Reduction of cardiovascular diseases risk 
Atherosclerosis is the most common cause of CVD, characterized by the 
inflammation of the vessel wall and the damage of the endothelium, caused by 
the infiltration and accumulation of low-density lipoproteins (LDL), forming 
oxidized LDL (oxLDL) [10]. The accumulation of several cell types, including 
living and dead foam cells, endothelial cells and smooth muscle cells, is 
involved in this inflammatory process and produces different multifocal 
lesions and the formation atherosclerotic plaque. Among phytochemicals, 
polyphenols have been largely considered as agents able to promote health, 
including amelioration of CVD, where an increased intake of polyphenol-
derived preparations have been shown to improve markers of cardiovascular 
risk (hypertension, endothelial dysfunction, arterial stiffness, dyslipidemia, 
inflammation, oxidative status and hyperglycemia) (Figure 1.1) [9]. 
 
 
Figure 1.1. Cardioprotective effects of polyphenols and molecular 
mechanisms by which polyphenolic compounds may counteract endothelial 
dysfunction [11]. 
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Several meta-analysis have shown that preparation based on cocoa and tea 
polyphenols improve blood pressure and endothelial functions (Figure 1.1). In 
particular, the increase of nitric oxide (NO) levels and NO-synthase activity, 
has been reported in dietary intervention studies where flavanol-enriched 
cocoa drinks were administered to volunteers. Furthermore, other studies have 
been carried out to evaluate the possible role of polyphenols in coffee, such as 
chlorogenic acids (CGA), on the blood pressure. As an example, dark roast 
coffee intake reduces the systolic blood pressure in overweight subjects. In a 
different meta-analysis, the reduction of blood pressure by soy isoflavones is 
measured in hypertensive subjects, but not in normotensive ones. Moreover, 
the consumption of a meal based on virgin olive oil with high content of 
phenolic compounds improves the endothelium-dependent microvascular 
vasodilation and decreases the oxidative stress during the first 4 h from the 
assumption in hypercholesterolemic subjects [9]. 
Other studies focus on the role of red wine polyphenols in the CVD protection 
[12]. In particular, the consumption of wine, especially red wine, could be 
linked to the so-called "French paradox", which refers to the apparent 
contradiction existing between the low incidence of CVD in the French 
consumers despite the high consumption of saturated fats [13]. To this regard, 
several studies have reported a correlation between moderate wine 
consumption and a reduced risk of CVD, such as reduction of blood pressure, 
serum glucose, hypertension, LDL, hyperglycemia and progression of 
atherosclerosis, probably related to the presence of bioactive compounds in 
this beverage [14]. In fact, it has been shown that a moderate consumption of 
red wine (15–30 g/day of ethanol, about 130–250 ml of wine/day) provides an 
appropriate amount of bioactive compounds (a glass of red wine contains 
approximately 200 mg of polyphenols) able to induce beneficial effects on 
human health [14]. An intervention study was conducted in healthy volunteers 
who received beverages such as red wine, white wine, beer and whiskey and 
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has shown beneficial effects of red wine on endothelial function after 1-4 h 
after ingestion, probably due to its higher content of total polyphenols respect 
to other beverages [15, 16]. The reduction of platelet aggregation, which 
increases the risk of coronary thrombosis and myocardial infarction, and the 
reduction of the oxidative stress have been related to the assumption of grape 
and wine polyphenols, showing a positive effect on blood lipids and 
inflammation [12].  
Among polyphenols, anthocyanins could play an important role in the CVD 
protection, by modulating the endothelial dysfunction and reducing platelet 
aggregability [17]. In fact, several anthocyanin-purified extracts from red 
wine, blueberry, bilberry and elderberry have shown the reduction of the 
inflammatory process, the endothelial dysfunction and vasoconstriction, 
through the NO production, reduction of blood pressure, oxLDL and serum 
malondialdehyde (MDA) [18]. 
 
1.1.2 Protection from neurodegenerative damage 
Neurodegeneration is a progressive functional alteration of neuronal systems, 
resulting in a state of dementia which is considered one of the most common 
psychiatric disorders of the elderly. It is an age-related irreversible condition, 
resulting in a progressive decline of cognitive functions (Figure 1.2) [19]. 
Neurodegenerative diseases (ND), such as Alzheimer's disease (AD), 
Parkinson's disease (PD) and multiple sclerosis (MS) induced a deterioration 
of neurons or the myelin sheath, resulting in a reduction of sensory 
transmission and movements [20]. The two pathological hallmarks of AD are 
senile plaques and neurofibrillary tangles (Figure 1.2) [21]. Senile plaques are 
made of insoluble Amyloid-β (Aβ) peptides that result from sequential 
cleavage of the amyloid precursor protein (APP) by β-cleaving amyloid 
precursor protein enzyme (BACE) and γ-secretase. Neurofibrillary tangles are 
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made of aggregates of hyper-phosphorylated tau protein that becomes 
dysfunctional causing the microtubules collapse and blocking 
neurotransmitters and neuronal signaling [22]. Once these abnormal proteins, 
Aβ and hyperphosphorylated tau, accumulated in the brain, induce the 
apoptotic pathway in neuronal cells promoting the progression of the 
pathological process in an exponential way.  
 
 
Figure 1.2. Pathological hallmarks of Alzheimer's disease 
(http://www.brightfocus.org/). 
 
Another key event in AD pathophysiology is the neuroinflammation of Central 
Nervous System (CNS). The neuronal injury is induced by an uncontrolled 
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activation of microglial cells, the primary immune cells in the CNS, which 
could lead to an excessive production of various factors such as NO, pro-
inflammatory cytokines (IL-1β, TNF-α), reactive oxygen species (ROS) and 
glutamate [23]. Therefore, the inflammatory response, resulting in oxidative 
stress, induces neuronal damage and death. Current drugs for the 
neurodegeneration therapy are cholinesterase inhibitors (AChEIs), employed 
in the mild stages of disease. The AChEIs maintain the cerebral availability of 
acetylcholine, the neurotransmitter involved in the cognitive functions, such as 
memory [24]. However, these are only "symptomatic" drugs, aimed to reduce 
the clinical symptoms of the disease, but they are not able to cure or prevent 
ND occurrence and the progressive decline of cognitive functions. The 
research is now directed towards the identification of new pharmacological 
strategies for the treatment of neurodegenerative ageing-related disorders. 
The mechanisms involved in microglia and neuroinflammation or oxidative 
stress represent the promising targets of future ND treatment. Recently, a great 
number of natural plant extracts have been tested for their therapeutic 
properties in neuroprotection [4] [25-27]. Data present in literature highlight 
the role of polyphenols as promising sources in the prevention or treatment of 
neurodegenerative conditions, reporting how polyphenols could slow the 
disease progression and interfere with some mechanisms involved in the 
development of neurodegenerative processes.  
In vivo studies have described the improvement of several aspects of memory 
and learning after assumption of dietary polyphenols. In particular, 
epidemiological data demonstrate that the assumption of green and black tea, 
rich in polyphenols, protects the brain from aging and reduces the dementia, 
which occurs in AD and PD [26]. In parallel, considering the potential 
properties of the single bioactive compounds present in these beverages and 
other foods, several preclinical studies have been carried out in order to 
evaluate the neuroprotective effects of curcumin, resveratrol and 
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epigallocatechin-3-gallate (EGCG), highlighting their antioxidant, anti-
inflammatory, anti-amyloidogenic and anti-apoptotic activities [19]. More in 
details, the potential therapeutic utility of polyphenols in dementia has been 
associated with different mechanisms, such as the ability to interfere with 
cellular signaling, proliferation, apoptosis, redox balance and differentiation, 
all events which are involved in the progression of the disease [28] (Figure 
1.3) [4]. 
 
 
Figure 1.3. Potential biological processes targeted by polyphenols in 
neurodegenerative diseases [4]. 
 
In such a contest, the well-described anti-inflammatory activity of polyphenols 
have suggested their potential use against neuroinflammation-associated AD. 
In particular, they could modulate the expression of pro-inflammatory genes, 
such as cyclooxygenase, lipoxygenase, NO synthases and several important 
cytokines, mainly acting through NF-κB and MAPK [29]. In addition, the 
antioxidant activity of polyphenols could result in neuroprotection, since the 
oxidative stress plays an important role in pathogenesis of neurodegeneration 
[4] [30]. Furthermore, the potential neuroprotective activity of polyphenols is 
also related to a decrease of damage induced by neurotoxic agents, through the 
reduction of amyloid plaque formation, involved in AD etiology (Figure 1.3).  
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In fact, some in vitro studies have reported the neuroprotective effect of 
quercetin, curcumin, EGCG and resveratrol, resulting in a reduction of Aβ 
fibrils formation [31]. Another proposed mechanism to explain the 
neuroprotective potential effect of polyphenols is the chelating activity of 
metal ions, which accumulate in specific brain regions, inducing the oxidative 
stress. These compounds form complexes with transition divalent metal ions 
(Fe
2+,
 Cu
2+
 and Zn
2+
) and prevent the formation of iron induced free radicals 
by Fenton chemistry [32]. Despite these encouraging data, important 
limitations must be considered, such as the low bioavailability of polyphenols 
relative to their bio-transformation and conjugation occurring during the 
uptake in the gastrointestinal tract, liver and finally in the peripheral tissue 
cells. In fact, after oral intake, in the small intestine and liver, polyphenols are 
substrates for phase I enzymes (hydrolysis and oxidase) and Phase II 
(conjugation and detoxification) and are conjugated to methyl and sulfate 
groups and glucuronic acid [33]. Further transformations occur in the colon by 
the intestinal microflora enzymes with the formation of phenolic acids which 
undergo further metabolism in the liver. These chemical changes induce 
modifications in polyphenol structures and may result in the alteration of their 
biological effects. For these reasons, new formulation strategies are need in 
order to modify their bioavailability, allowing an improvement of their 
vehiculation in order to cross the blood brain barrier (BBB). The BBB is a 
highly selective semipermeable membrane barrier, formed by endothelial cells 
connected by tight junctions, which separate the circulating blood from the 
brain extracellular fluid in the CNS. The BBB limits the passage of 
macromolecules and small polar molecules from the circulation to the brain 
tissue [34]. The crossing capacity depends on the lipophilic nature of 
molecules and on the interactions with specific efflux transporters expressed in 
the BBB, such as P-glycoprotein. To investigate the trans-membrane transport 
across the BBB of polyphenols and their metabolites, specific in vitro models 
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have been selected, through cell cultures, highlighting that the metabolites 
have a better transport efficiency compared to native flavonoids [35]. For 
example, in vivo studies have found the accumulation of flavonoids in the 
brain hippocampus and at the level of the cerebral cortex, after the 
supplementation of blueberries in older animals [36]. These results have 
provided the first indication that polyphenols can cross the BBB, highlighting 
their potential function as neuromodulatory agents. 
 
1.1.3 Chemopreventive effect 
Phytochemicals also attracted scientists’ interests since the demonstration that 
their biological targets in mammalian cells were the same involved in 
inflammatory processes and oncogenic transformation, such as the alterations 
of cell cycle control, apoptosis evasion, angiogenesis and metastases [3]. The 
transformation from normal to malignant cells involves the somatic mutations, 
induced by chemical or physical carcinogenic agents, with the activation of 
proto-oncogenes and inactivation of tumor suppressor genes, resulting in 
malignant phenotypic changes. After this irreversible initiation phase, which 
lasts a few days, the promotion phase occurs. The final stages of carcinogenic 
process is the progression (1-5 years) of tumor growth and the metastasis 
formation (Figure 1.4) [1, 2, 37]. A large number of epidemiological studies 
have suggested that a daily intake of phytochemicals, including vitamins, 
carotenoids and polyphenols, could reduce the incidence of several types of 
cancers [38]. These compounds act interfering with one or more stages of the 
carcinogenesis process, as potential chemopreventive agents. A complete 
definition of chemoprevention was given by Dr. Sporn and includes the use of 
natural or pharmacological agents to suppress, arrest or reverse 
carcinogenesis at its early stages (Figure 1.4) [2]. 
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Figure 1.4. Carcinogenesis phases: initiation, promotion, progression, and 
metastasis [37]. 
 
Chemoprevention includes three areas: 1. primary prevention in healthy 
subjects with high risk, for example in smoking population or positive 
biomarkers for specific cancer; 2. cancer prevention in subjects with a 
premalignant lesions, which may progress to invasive cancer; 3. prevention of 
secondary forms of cancers in patients who have already developed a primary 
cancer [6]. The final goal of all these different aspects of chemoprevention is 
the attainment of clinical evidences for cancer reduction. Chemopreventive 
agents can be divided into two main groups: cancer-blocking and cancer-
suppressing agents (Figure 1.4) [39].  
The ability of cancer-blocking agents to interact with the initiation step can 
occurs through the detoxification of carcinogenic substances, modifying their 
uptake and metabolism, scavenging ROS, enhancing DNA repair. The cancer-
suppressing agents block the cancer promotion and progression after the 
formation of pre-neoplastic cells and interact with cell cycle regulation, signal 
transduction, transcriptional regulation, and apoptosis [1, 39]. 
Growing evidences suggest that not only individual genetic background are 
implicated in cancer development, but also a heathy life style and correct diet 
[40]. The concept of "chemoprevention" was associated to the use of natural 
substances, able to interfere with the development or the progression of 
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neoplastic processes [6]. These compounds include vitamins, carotenoids, 
flavonoids and organosulfur compounds (Table 1.1). 
 
Table 1.1. Examples of dietary chemopreventive compounds [39]. 
 
 
For example, several studies have demonstrated that natural molecules, such 
as genistein, rutin, silymarin, EGCG, are potential negative modulators of 
inflammatory processes and oncogenic transformation by inhibiting 
proliferation, inducing apoptosis, cell cycle arrest and downregulating the 
signals transduction pathways regulated by PI3K, NF-B (Table 1.1) [41].  
Currently, one of the major challenge is to demonstrate, by means of 
randomized controlled trial study design, that the positive effects of 
phytochemicals reported in vitro and in preclinical models are confirmed in 
human subjects [6]. Significant differences among these models are related to 
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the metabolic processes that these substances undergo after oral 
administration, moreover their low bioavailability could reduce the amount 
circulating in the bloodstream and their effectiveness. It should be considered 
that concentrations applied in in vitro studies (usually tens of micromolars) are 
not reachable in vivo after vegetable and fruit assumption (usually below 1 
M), relating to the scarce bioavailability and bio-transformation of these 
molecules after oral intake. In fact, despite the encouraging results and the 
abundance of in vitro studies which clarify the molecular mechanisms 
triggered by phytochemicals to inhibit cell growth and induce apoptosis in 
cancer cells, only few of them enter clinical trials. Phase I clinical trials have 
been completed only for few of these compounds and Table 1.2 reports meta-
analysis, cohort studies and case-control studies of different phytochemicals. 
However, there are important examples of large clinical trials which failed, 
such as the -Carotene and Retinol Efficacy Trial (CARET) aimed to test the 
combination of 30 mg -carotene and 25,000 IU retinyl palmitate (vitamin A) 
daily in 18314 men and women at high risk of developing lung cancer. This 
study was stopped 21 months early because of clear evidence of no benefits 
and of possible harm. In fact, there were 28% more lung cancers and 17% 
more deaths in the active intervention group [42]. 
One generally accepted property of natural compounds refer to their functional 
pleiotropic effect. In fact, they interfere with multiple intracellular targets, 
affecting different cell signaling processes usually modified in cancer cells, 
with limited toxicity on normal cells. 
Targeting simultaneously multiple pathways may help to kill cancer cells and 
slow drug resistance onset. 
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Table 1.2. Reduced risk of cancer by phytochemicals associated with different 
scientific approaches [6].
 
+++meta-analysis studies, ++cohort studies, +case-control 
studies, *animals or in vitro studies. 
 
Thus considering the pleiotropy of phytochemicals, they could be employed in 
association with classical chemotherapeutic drugs. In this case, through the 
synergism with cytotoxic drugs, a double positive effect can be expected, 
increasing their efficacy and lowering the toxic side effects on normal cells 
and also the combined treatment can delay resistance onset [1, 3]. Therefore, 
the association of several molecules might be effective in cancer prevention 
respect to single compounds, supporting the concept of “combined 
chemoprevention”, i.e. the synergistic effect of low doses of chemopreventive 
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agents with different mechanisms of action, resulting in increased efficacy and 
low toxicity [3]. 
 
1.2 Chemical structure and classification of phytochemicals 
Phytochemicals are secondary metabolites of plants, essential for the basic 
functions, such as growth, reproduction, defense against pathogens and 
protection from UV radiation [43]. Polyphenolic and carotenoid compounds 
represent two of the major classes whose structure and classification will be 
further described in the next paragraphs since they have been employed in the 
present project. 
 
1.2.1 Polyphenols 
It has been estimated that more than 8000 polyphenolic compounds in 
vegetable kingdom have been isolated and described [44]. Polyphenols are 
widespread constituents of foods (fruits, vegetables, cereals, olive, legumes, 
chocolate, etc.) and beverages (tea, coffee, beer, wine, etc.), partially 
responsible for their overall organoleptic properties. They have a common 
chemical structure, with the aromatic ring and associated one or more 
hydroxyl groups and they are classified into (Figure 1.5) [45]: 
 Phenolic acids, which are divided into benzoic acid (hydroxybenzoic 
acid, gallic acid) and cinnamic acid (coumaric acid, ferulic acid, caffeic 
acid) derivatives; 
 Flavonoids, which have two aromatic rings and an oxygenated 
heterocycle, and can be divided into 6 subclasses depending on the 
type of heterocycle: flavonols, flavones, isoflavones, flavanones, 
anthocyanidins and flavanols (monomeric form: catechins; polymeric 
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form: proanthocyanidins). The flavonols are the most abundant, and 
quercetin is the main representative; 
 Stilbenes, which are formed by an ethylene substituted with two 
benzenes and resveratrol is the most important compound and is found 
mostly in red wine; 
 Lignans, which are constituted by two units of phenylpropane, such as 
pinoresinol. 
 
 
Figure 1.5. Chemical structures of polyphenols [46]. 
 
The biological activity of polyphenols has been largely attributed to their 
chemical structure. In fact, the aromatic ring and highly conjugated system 
with multiple hydroxyl groups are responsible for their intrinsic reactivity. 
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Due to the ability of the aromatic system to delocalize an unpaired electron, 
these molecules can easily donate hydrogen of the phenolic group to a radical, 
neutralizing free radicals. In fact, they are powerful reducing agents in vitro, 
able to neutralize free radicals by donating an electron or hydrogen atom to a 
wide range of reactive oxygen, nitrogen and chlorine species, including O2
•-
, 
OH•, peroxyl radicals RO2
•, hypochlorous acid (HOCl). These redox properties 
of polyphenols are responsible for their reducing properties, acting as 
"quencher" of free radicals to end the chain of oxidative reactions, including 
the propagation stage of the lipid autoxidation chain reactions. They also act as 
"scavenger" of radicals, activating antioxidants enzymes and chelating free 
ions of transition metals, through the directly inhibition of Fe
3+
 reduction, 
resulting in the reduction of OH
•
 production by Fenton reaction [47]. Figure 
1.6 reports the tempted mesomeric structures of quercetin which contribute to 
stabilize the aroxyl radical [48]. 
 
 
Figure 1.6. Mesomeric structures of aroxyl radical generated from quercetin 
[48]. 
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Among polyphenols, particular relevance lies with anthocyanins, a flavonoid 
group, predominant in tea, honey, wines, fruits, vegetables, nuts, olive oil, 
cocoa and cereals. The anthocyanins are constituted by a molecule of benzene 
with a pyran (heterocyclic ring containing oxygen) connected with a phenyl 
group which can be linked to various substituents. This structure, called cation 
flavilio, is the base component of all anthocyanins (Figure 1.7). They are 
derived from the respective aglycones (anthocyanidins), from which they 
differentiate by the addition of a glycosidic group, such as glucose, rhamnose, 
xylose, galactose, arabinose and fructose.  
 
 
Figure 1.7. Basic structure of the anthocyanin [49]. 
 
The antioxidant activity of anthocyanins closely depend on their basic 
structure, such as the ring orientation, hydroxyl groups and conjugated double 
bonds, presence of acyl groups, number of sugar residues [50].  
As reported above, polyphenols are extensively metabolized either in tissues, 
after absorption through the gut barrier, or, the non-absorbed fraction and the 
fraction re-excreted in the bile, by the colonic microflora (Figure 1.8). 
Polyphenols are conjugated to form O-glucuronides, sulphate esters and O-
methyl ether and all circulating polyphenols are glucuronidated and/or 
sulphated, and no free aglycones are found in plasma [51]. 
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Figure 1.8. Routes of dietary polyphenols in human body [51]. 
 
1.2.2 Carotenoids 
The second important class investigated in the present project is represented 
by carotenoids. Their name originates from carotene, a substance yellow-
orange found for the first once in 1831 in the root of Daucus carota. They are 
pigments widespread in nature, with colour from yellow to orange, red to 
violet, responsible for the coloration of plants, fruits, flowers, roots, but also 
found in algae, bacteria, molds, yeasts, invertebrates, fish and birds [52]. They 
are lipid-soluble compounds, widely used in food, pharmaceutical and 
cosmetic industries. There are over 600 carotenoids occurring in nature and 
their basic structure is characterized by a long system of conjugated double 
bonds with p-electrons delocalized over the length of the polyene chain. 
Carotenoids are C40 tetraterpenoid pigments, belonging to isoprenoid 
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polyenes and the chemical structures of some carotenoids are reported in 
Figure 1.9. 
 
 
Figure 1.9. Chemical structure of few among the most represented 
carotenoids in nature [52]. 
 
The presence of numerous conjugated double bonds and cyclic end groups in 
their chemical structure allow the formation of some stereoisomers around the 
C=C bonds, such as geometric (E-Z), showing different chemical and physical 
properties, even if the isomeric form trans gives a more stable conformation 
than cis isomeric form in nature [53]. Addition of polar groups (epoxy, 
hydroxyl and keto) changes the polarity of carotenoids and influences their 
biological activity. In relation to the functional groups, they are divided in 
[54]:  
 Xanthophylls, which contain oxygen as functional group and include 
lutein and zeaxanthin, neoxanthin and fucoxanthin; 
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 Carotenes, which contain only hydrocarbon chain without other 
functional groups, such as α-carotene, β-carotene and lycopene.  
Due to the numerous conjugated double bonds and cyclic end groups, 
carotenoids present a variety of stereoisomers with different chemical and 
physical properties. The presence of the conjugated double bonds allow 
carotenoids to delocalize unpaired electrons, resulting excellent reducing 
agents, able to scavenge and neutralize free radicals, as largely demonstrated 
by in vitro and in vivo tests [55]. This property is related to the capacity to 
physically quench singlet oxygen and terminate reactive free radicals. For their 
reducing properties, carotenoids have been associated with potential protective 
effects against degenerative diseases, including atherosclerosis, cataracts, 
macular degeneration, MS and CVD [55]. 
From a functional point of view, they can divided into: 
 Vitamin A precursors, such as β-carotene; 
  Pigments with partial vitamin A activity such as cryptoxanthin, β-
apo-8′-carotenoic acid ethyl ester;  
 Not vitamin A precursors and not pigment, such as violaxanthin and 
neoxanthin;  
 Pigment without activity of vitamin A precursors, such as lutein, 
zeaxanthin and canthaxanthin [53]. 
Regarding pro-vitamin A activity, part of carotenoids taken by enterocytes is 
converted into retinoid via two different mechanisms. In particular, β-carotene 
is the only carotenoid that can yield 2 molecules of retinaldehyde upon its 
symmetrical cleavage by the enzyme β-carotene-15,15′-oxygenase (CMOI or 
BCMO1 or BCO1) (Figure 1.10). β-Carotene is transformed into 
retinaldehyde, which is converted to retinol by a reductase dependent on 
NAD(P)H (Figure 1.10) [56]. However, β-carotene can also be cleaved 
asymmetrically by the enzyme β-carotene-9′,10′-oxygenase (CMOII or 
BCDO2 or BCO2), to generate apocarotenals, which can be converted to one 
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molecule of retinaldehyde. Retinaldehyde formed upon the cleavage of 
provitamin A can be oxidized by the action of enzymes belonging to the 
retinaldehyde dehydrogenase family (RALDH or ALDH 1 family) to generate 
all-trans retinoic acid (ATRA), the biologically active form of vitamin A [56]. 
 
 
Figure 1.10.-Carotene as source of retinoids [56]. 
 
The bioavailability of carotenoids after oral intake is influenced by several 
factors relating to the molecular linkage, the amount of carotenoids consumed 
in a meal, the matrix which incorporate them, the effectors of absorption and 
bioconversion, the genetic factors and the interactions with biological 
molecules. Their feature of lipid molecules allows their absorption by 
incorporation into mixed micelles. Recent studies have showed an increase of 
absorption of carotenoids when they are ingested with dietary lipids [57]. 
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1.3 Functional foods, nutraceuticals and well-being 
 
As schematically summarized in the Figure 1.11, the potential applications of 
food-derived bioactive compounds and/or extracts span from the 
pharmaceutical to the nutraceutical sectors. In both cases, it is possible to 
identify strengths and weaknesses due, for example, to the general low 
bioavailability and high pleiotropy of these compounds. The present thesis will 
explore the possibility that the biological properties of the polyphenolic and 
carotenoid extracts under investigation may find applicative outcomes in the 
areas of pharmacology and/or nutraceuticals/functional foods. The latter field 
will be shortly introduced in the following paragraphs. 
 
 
Figure 1.11. Cartoon showing the possible applicative outcomes of food-
derived natural compounds. 
 
The concept of “food as medicine” as a way to improve health and wellness 
was originally proposed by two medieval Persian practitioners, Avicenna and 
Rhazes, who developed the scientific guidelines about the use of natural 
products for the treatment of diseases and health problems [58]. Perhaps, this 
anecdotal episode represents the ancient origin of Nutritional Sciences with 
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the attempt to focus on dietary recommendations and foods to consume and 
others to avoid. Subsequently, as declared in 1947 by World Health 
Organization "Health is a state of physical, mental and social well-being and 
not merely the absence of disease", showing a pioneering perspective of 
nutrition respect to the last three decades, characterized by the many advances 
in medicine and drug discovery. The sanitary revolution of 19
th
 century led to 
the development of a public health system, which provided the adequate 
treatment and drugs for most of diseases. In particular, the discovery of new 
synthetic drugs and a correct pharmacological approach to the main illnesses 
of the population, ensured better living conditions, resulting in a longer 
average lifespan [59].  
The 20
th
 century has been characterized by industrialized society, with 
changing dietary patterns and lifestyles due to a frenetic and stressful life, 
which resulted in an increase of diseases such as diabetes, CVD and obesity. 
For this reason, in recent years, the mission of Nutritional Science has been 
devoted to reduce malnutrition and diet-related diseases (obesity, diabetes, 
some forms of cancer) with cause an exponential growing of the health care 
costs. In partial contradiction to these considerations, at least in the Western 
world, the average life span is constantly extending, making the need for on 
improving of the quality of life especially during aging. This represents an 
additional pressure to the consumption of healthy foods. The lengthening of 
life expectancy and the emerging concept that therapeutic treatments can be 
supported by changes of lifestyle have contributed to focus the attention of the 
scientific community on the role of nutrition in maintaining of a health state on 
a specific category of foods, namely, functional foods [60]. 
Currently, the food and pharmaceutical industries are constantly looking for 
new products able to promote dietary patterns which include foods containing 
bioactive compounds, such as fruits and vegetables. In fact, many 
epidemiological studies have shown that a regular consumption of fruits and 
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vegetables is associated with a lower risk of coronary heart disease, obesity, 
diabetes and other age-related chronic and degenerative pathologies, like PD 
and AD [61] [62] [63, 64]. For these reasons, the consumers’ demand changed 
dramatically over the years, resulting in a great attention to specific category 
of healthy promoting dietary products, namely functional foods and 
nutraceuticals [65].  
 
1.3.1 Functional foods 
The term “functional food” was first used in 1984 in Japan as a result of a 
study on the relationships between nutrition, sensory satisfaction, fortification 
and modulation of physiological systems in order to define those food 
products fortified with special constituents that possess advantageous 
physiological effects [66]. In 1991, the concept of Foods for Specific Health 
Use (FOSHU) was born in order to create a formal food category, in which a 
product must prove scientific evidences of its effectiveness. Functional foods 
should improve the general conditions of the body and decrease the risk of 
specific diseases [67]. For this reason, food products can be considered 
“functional” if, in addition to their nutritional provision, contain one or more 
components that positively influence one or more body functions, in order to 
promote a state of well-being and health, or to reduce the risk of degenerative 
disease. Based on these definitions, the terminology “physiologically 
functional foods” or simply “functional foods” is used to indicate an enhancer 
of physiological functions able to maintain and prolong health status, due to 
the presence of bioactive molecules [58]. The concept of “functional” 
indicates the third function of a food, related to the maintenance of a physical 
and mental well-being, in addition to the primary function of food, providing 
nutrition and caloric intake, and the secondary function of preference (taste) 
and sensory pleasure [68]. A new definition of “functional food” has been 
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provided recently by [69] as “natural or processed food that contains known 
or unknown biologically active compounds, which, in defined, provides a 
clinically proven and documented health benefit for the prevention, 
management, or treatment of chronic disease.” Whereby, the idea of 
functional food aims to connect the function of ordinary food in maintaining a 
suitable nutrition status to pharmaceutical area reducing the risk of diseases. 
The category of functional foods generally includes conventional foods, 
consumed within the usual diet which can be classified as natural, if they 
naturally contain specific bioactive components or processed, if addition of 
beneficial effects have been reached by addition of beneficial components or 
removal of toxic ones, respectively. A functional food may also undergo 
chemical modifications aimed to improve the bioavailability of its bioactive 
compounds [69]. Basing on this definition, the category of “functional foods” 
includes fortified, enriched, altered and enhanced foods, as showed in Table 
1.3 [67]. Examples are fortified foods with vitamins and/or minerals, fortified 
beverages with calcium, enriched products, such as margarine with 
phytosterols, muffins with beta-glucan, yogurt with probiotics, margarines 
enriched with cholesterol-lowering phytosterols, cereals fortified with soluble 
fibres [65]. 
The functional ingredients are bioactive compounds, which taken in small 
quantities, may act synergistically to improve health well-being. They can be 
macronutrients, such as carbohydrates (soluble and insoluble fibers, 
prebiotics), monounsaturated (MUFA) and polyunsaturated (PUFA) lipids, 
peptides (caseinophosphopeptides (CPP), calmodulin-binding peptides), or 
micronutrients, such as vitamins (ascorbic acid and tocopherol) and natural 
phytochemical, such as polyphenols and carotenoids [69]. Examples of 
functional ingredients in specific foods, their sources and potential benefits are 
reported in Table 1.4. 
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Table 1.3. Examples of functional foods [70]. 
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Table 1.4. Examples of functional ingredients of food, their sources and 
potential benefits [71]. 
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1.3.2 Nutraceuticals 
Parallel to the role of functional foods, the global landscape has seen the 
advent of the new concept of "nutraceutical", term coined in 1989 by Stephen 
De Felice, founder and president of the Foundation for Innovation in 
Medicine, fusing the words "nutrition" and "pharmaceutical" [72]. It refers to 
health promoting bioactive compounds found in some foods, extracted, refined 
and finally sold as purified preparations, or added to other foods [9]. 
Nutraceuticals can be realized in form of pills, capsules, powders, as 
formulations that contain single or mixed compounds, but they can be also 
incorporated into foods or foods supplement as functional ingredients. 
Chemically nutraceuticals can be classified as isoprenoid derivatives 
(terpenoids, carotenoids, saponins, tocotrienols, tocopherols, terpenes), 
phenolic compounds (tannins, lignans, anthocyanins, isoflavones, flavonones, 
flavanoids), carbohydrate derivatives (oligosaccharides, not-starch 
polysaccharides), fatty acid and structural lipids, PUFA, conjugated linoleic 
acid (CLA), MUFA, sphingolipids, lecithins, amino acid derivatives (allyl-S 
compounds, capsaicinoids, isothiocyanates, indoles, folate, choline), microbes 
(probiotics, prebiotics) and minerals [73]. They play a crucial role in 
maintaining optimal immune response and they exert antioxidant, 
antibacterial, anti-inflammatory, anti-diabetic, antifungal, antiproliferative, 
hepato-protector, hypolipidemic and analgesic effects [74]. Examples of 
nutraceutical grouped by mechanism of action are reported in Table 1.5. 
By definition, nutraceuticals may possess or not nutritional properties, but 
should provide clinical health benefits by means of their pharmaceutical 
activities. They are not synthetic drugs and represent the interface between 
food and medication (Figure 1.12) [75]. 
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Table 1.5. Examples of nutraceutical grouped by mechanism of action [73]. 
 
 
 
Despite this definition, some important points relating to the differences 
between drugs and nutraceuticals, should be considered. In fact, a key feature 
of nutraceuticals compared to drugs regards the observation that the formers 
should not necessarily consist of a single active component, since the 
beneficial effects can be the result of synergistic actions of their specific 
components or classes of molecules. 
 
  
Figure 1.12. The concept of nutraceutical agents [65]. 
 
For drugs, we can tolerate the presence of side effects, while nutraceuticals 
must be safe, with minimal side effects compared to conventional drugs. 
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However, should be paid attention to the complexity of nutraceutical 
composition, whereby incorrect use could be toxic [66]. 
Pharmaceutical compounds and nutraceuticals may be able to treat and prevent 
pathological conditions, but only the formers foresee governmental sanctions, 
must prove to be safe and effective for human use, because of clinical trials. 
The lack of regulation leads to an incorrect approach to the nutraceutical 
products by the consumers who tend to use them without the required attention 
for the only reason that they are natural [66]. 
 
1.3.3 EU legislation, healthy claims and marketing implications 
Nutraceutical products are widely available and minimally monitored since 
companies are not obligated to back claims about the function and 
effectiveness of their product. Despite this, Stephen DeFelice proposed in 
2002 a first law on research and education Nutraceutical (NREA), focused to 
the creation of a Nutraceutical Commission (NUCOM) for the approval of 
nutraceuticals and also development of programs specifically addressed to 
encourage clinical research [76]. On the opposite, functional foods are 
subjected to a more detailed regulation than nutraceuticals [77]. In fact, in 
Japan, to be approved as FOSHU by the Minister of Health, Labor and 
Welfare these products must meet three specific criteria: assessment of the real 
efficacy in clinical trials; assessment of safety; determination of active 
functional ingredients [69]. Once approved, the FOSHU label contains: 
declared health claim, the food daily amount recommended, nutritional 
information, guidelines to healthy life and other information [69]. 
In EU government, the rules on nutrition and health claims have been 
established by Regulation (EC) No 1924/2006, and was applied starting from 
July, 1
st
 2007. This regulation is the legal framework used by food business 
operators when they want to highlight the particular beneficial effects of their 
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products, in relation to health and nutrition, on the product label or in their 
advertising. According to the Regulation, there are nutritional claims, such as 
"low fat", "high fiber", and health claims, such as "Vitamin D is needed for the 
normal growth and development of bone in children". These rules try to ensure 
that any claims made on a food labelling, presentation or advertising in the 
European Union is clear, accurate and based on scientific evidence. The main 
rules are the following: 
 Regulation 1924/2006 on nutrition and health claims made on foods;  
 Commission Regulation No 353/2008 establishing implementing rules 
for applications for authorization of health claims; 
 Commission Regulation No 1169/2009 amending Regulation (EC) No 
353/2008 establishing implementing rules for applications for 
authorization of health claims. 
In particular, to define the health claims the European Union set up a 
European Commission Concerted Action coordinated by the International Life 
Sciences Institute (ILSI) Europe that establishes the Functional Food Science 
in Europe (FUFOSE). The aim was to develop and establish a science-based 
approach that supports the declaration of beneficial effect on an identified 
physiological function in the body, or to improve an individual state of health 
and well-being and/or reduce the risk of disease. The FUFOSE project looked 
at six areas of science and health: growth, development and differentiation, 
substrate metabolism, defense against ROS, functional foods and the 
cardiovascular system, gastrointestinal physiology and function, and the 
effects of foods on behavior and psychological performance. The final 
document was published in the British Journal of Nutrition [78]. The report 
indicates that functional foods should be in the form of normal foods and they 
must demonstrate their effects in amounts that can be normally consumed in 
the diet.  
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The new European Regulation on nutrition and health claims had come into 
force in January 2007. This followed a concerted action project supported by 
the European Commission titled “Process for the Assessment of Scientific 
Support for Claims on Foods” (PASSCLAIM) aiming to resolve some of the 
ongoing issues of validation, scientific substantiation of claims and 
communication to the consumer. The project started and will build upon the 
principle that "enhanced function" and "reduced risk of disease" claims should 
be based on designed clinical studies using appropriately identified, 
characterized and validated biomarkers. PASSCLAIM aims to establish 
common criteria to assess the scientific substantiation of health-claims, 
providing the framework to prepare scientific dossiers supporting claims [79]. 
The PASSCLAIM Consensus Document will assist those making claims and it 
will also improve the credibility of claims for consumers. This integrated 
strategy will generate more consumer confidence in the science base related to 
claims on foods and will better address the concerns of consumers [79]. 
The European Food and Safety Authority (EFSA) analyzes the evidence for 
the health claim. EFSA is responsible to verify the scientific substantiation of 
the submitted claims, some of which are currently in use, others are proposed 
by applicants who submit claims with the aim to authorize the 
commercialization of their products in EU. The EFSA opinions serve as basis 
for the European Commission and Member States, which will then decide 
whether to authorize the claims. 
 
1.4 Specific aims of the Doctorate project 
The main aim of the present Doctorate project is to evaluate the effects of 
bioactive extracts prepared from local Italian cultivars using pre-clinical 
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models resembling chronical and degenerative diseases, as summarized in 
Figure 1.13. 
The initial goal is the identification of bioactive components with functional 
effects by a screening of Italian varieties of fruits and vegetables by the 
following steps. 
-Preparation of bioactive extracts from selected food matrices; 
-Identification of the most appropriate experimental models to assess the 
beneficial outcomes of food extracts, in details: 
 Human Red Blood Cells (RBCs) and plasma, to evaluate the 
antioxidant response; 
 Cell lines mimicking a neurodegenerative damage, to evaluate the 
protection from aging-related dysfunctions; 
 Malignant cell lines to evaluate the chemopreventive effects of 
bioactive extracts. 
The biological and biochemical characterization of bioactive extracts are 
relating to the following activities: 
 Protection from oxidative stress; 
 Protection from neurodegenerative damage; 
 Protection from malignant transformation. 
Among the typical Italian products/cultivars under investigation, two of them 
will be selected as rich sources of polyphenols and carotenoids, e.g. red wine 
obtained from local grapes and Neapolitan pumpkin. 
Campania Region preserves old and treasured grape varieties, which are the 
basis of oenology with a strong typicality. The region is one of the oldest 
settlement areas of vines and is characterized by the presence of centenarians 
Gyves in many vineyards, including Hellenica vitis, Vitis apiana, the Vinum 
album phalanginum and Aminea gemina, the progenitors of Aglianico, Fiano, 
Falanghina and Greco. The real "dominus" of the Campania vineyard is the 
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Aglianico, an ancient vine, which has long been known in the international 
scene, giving rise to wines of excellent quality, such as Taurasi of Avellino, 
first DOCG among the southern Italian DOCG and Mastroberardino Aglianico 
(http://www.agricoltura.regione.campania.it). 
 
 
Figure 1.13. Scheme summarizing the main aims of the project. 
 
Another typical product linked to the traditional cultivation of Campania 
Region is pumpkin, variety “Long Neapolitan Pumpkin” also known as 
pumpkin “full” of Naples. This cucurbitaceae, species Cucurbita moschata, is  
widely used in South Italy and enjoys a good reputation in Italy and abroad. 
Long Neapolitan Pumpkin in 2006 has been included in the list of traditional 
food products of the Campania Region. The Long Neapolitan Pumpkin is the 
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subject of a genetic stabilization program sponsored by Agriculture and 
Productive Activities of the Campania Region which was prompted by the 
recovery of semen found in the garden of a convent in the town of Visciano 
(Na) and it made landfall as early as the field cultivation on an experimental 
basis. The leaves are kidney-shaped, with 5-6 just mentioned lobes, dark green 
with lighter streaks, with strong presence of cirrus clouds. The flowers are 
carried axils of leaves and have a corolla bright yellow; male ones appear first 
and are characterized by a long stalk; female ones have a short stalk that holds 
the ovary from which will originate the result in fertilization took place. The 
fruit is a peponide, curved and swollen on both ends. It can be 60-70 cm long 
(exceptionally 100) with a diameter of 15-20 cm; its weight is, on average, of 
about 20-25 Kg. The skin is smooth, thin, light green or dark green. It is 
completely filled with orange-red flesh, firm, sweet and musky flavor. The 
internal cavity contains numerous seeds of white color, gray-brown, oval, 
flattened, slightly wrinkled and with the marginal rim clearly detected. 
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2.1 Introduction 
The protective role of red wine polyphenols against oxidative stress in RBCs 
has been reported in several in vivo and in vitro studies [1]. As mentioned in 
Chapter I, many epidemiological studies indicated that a moderate and regular 
consumption of red wine decreases cardiovascular and cerebrovascular 
ischemic events, through the ability to increase the antioxidant plasmatic 
potential, by improving endothelium dependent vasodilation [2] and inhibiting 
platelet aggregation [3] [4]. In addition, a regular intake of red wine inhibits 
lipoproteins oxidation, macrophage cholesterol accumulation and foam-cell 
formation [5]. These properties can be partially explained considering the 
presence of phenolic components in red wine, able to interact with 
physiological targets, through different mechanisms. For example, it has been 
reported that a daily intake of resveratrol protects Cu-oxLDL against 
peroxynitrite, copper, or 2-amidinopropane dihydrochloride-induced oxidation 
[6]. A recent review discusses the role of resveratrol in reducing organ damage 
following ischemia. Such effect is functionally related to a decreased 
formation of ROS and pro-inflammatory cytokines, as well as the mediation of 
a variety of intracellular signaling pathways, including NOS, nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase, MAPK and estrogen 
receptor-related pathways [7]. Furthermore, the red wine cardioprotective 
properties have been also referred to the presence of other phenolic 
compounds, such as anthocyanins. They are water soluble compounds, 
abundantly present in red wines and responsible for their red color. The main 
anthocyanins of a typical Italian red wine are malvidin-3-O-glucoside, 
cyanidin-3-O-glucoside, peonidin-3-O-glucoside and delphinidin-3-O-
glucoside [8]. The presence of anthocyanins in red wines has been related to 
their ability to interact with endothelial functions, promoting vascular 
homeostasis through the release of NO and controlling platelet aggregation, as 
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reported above [9]. In addition, red wine anthocyanins exert antioxidant 
effects against H2O2-generated hemolysis of normal and catalase-inactive 
human RBCs [10]. Their antioxidant activity is closely connected to hydroxyl 
groups and to conjugated double bond system, even if it is assumed that their 
biological effects cannot be explained solely on the based on these features 
[9]. The inhibition of lipid peroxidation by red wine anthocyanin derivatives is 
also mediated by their interaction with lipid bilayer membrane [11]. One 
attractive hypothesis considers the possibility that phenolic groups of red wine 
components are oxidized by polyphenol oxidase to produce extremely reactive 
intermediates which, in turns, trigger the cellular antioxidant defenses [12]. 
For this reason, the role of antioxidant compounds, which modulate the 
cellular redox state has been considered [13]. In fact, in subjects receiving a 
diet low in antioxidants, a reduction in the activity of antioxidant enzymes, 
including catalase (CAT), glutathione peroxidase (GPx) and glutathione 
reductase (GR), is measured in RBCs [14].  
RBCs represent an ideal in vitro experimental model for the evaluation of the 
antioxidant defence mechanisms. In fact, they are constantly exposed to 
oxidative stress, due to their role of oxygen carriers and the high concentration 
of redox active haemoglobin with iron molecules [15]. These processes can 
catalyse free radicals reactions and produce ROS, responsible for oxidative 
stress when they are not removed by the endogenous defence systems [16]. 
ROS are a large family of highly reactive species, such as hydrogen peroxide, 
organic peroxide, superoxide anion and hydroxyl radical, that are formed 
through enzymatic and non-enzymatic reactions, through metabolic processes, 
or by exogenous sources such as food components, drugs, ultraviolet light and 
ionizing radiations. When present at not physiological concentrations, they can 
induce cell damage directly or through the formation of intermediates involved 
in different signalling pathways inducing the damage of RBCs [12]. In fact, 
elevated concentrations of ROS are involved in the damage of RBCs of sickle 
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cell anemia and -thalassemia [17]. Furthermore, due to the absence of nuclei 
and mitochondria, oxidant molecules cause deformation of RBCs membrane 
and osmotic fragility, being the structural integrity particularly sensitive to 
changes of reactive oxygen content [16]. In particular, regarding their 
endogenous defences, RBCs are provided with several antioxidant enzymes, 
such as superoxide dismutase (SOD), CAT, GR, and GPx [18, 19] (Figure 
2.1). An important role in maintaining cellular redox state is played by 
reduced glutathione (GSH), a peptide with cysteine residue containing a 
reactive thiol group. From the oxidation of GSH is produced the disulfide form 
(GSSG), which is converted back to GSH by the enzyme GR [20] (Figure 
2.1). GSH is involved in cell detoxification processes, acting as antioxidant 
and scavenging free radicals. Indeed, a suitable ratio of GSH and GSSG is 
relevant for cell vitality and allows to maintain intracellular redox potential 
[21]. 
 
 
Figure 2.1. Schematic activity of RBCs antioxidant enzymes [22].  
 
Furthermore, the surface of RBCs displays a cross-membrane electrons 
transport complex, named Plasma Membrane Redox System (PMRS) (Figure 
2.2). PMRS has been suggested to play a vital role in reducing oxidative stress 
and this property has been hypothesized to control the rate of aging, lifespan, 
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and many pathological conditions associated with increased oxidative stress 
[23]. PMRS is not yet completely biochemically and functionally 
characterized and includes key enzymes differently expressed in various cell 
types, including membrane-associated oxidoreductase enzymes, such as 
NAD(P)H-dependent redox enzymes, cytochrome b5 reductase (b5R), a 
member of the cytochrome b561 family, and NAD(P)H-quinone 
oxidoreductase 1 (NQO1). The electron shuttles are coenzyme Q and 
cytochrome c and electrons donors, including NAD(P)H [24]. This enzymatic 
complex transfers electrons across the cell membrane from intracellular 
electron donors, such as NADH or ascorbate (ASC), GSH, to extracellular 
acceptors, like ascorbyl free radical (AFR), neutralizing free radical and 
maintaining the extracellular concentration of plasma antioxidant molecules, 
such as ASC and tocopherol [25] (Figure 2.2). 
It is largely accepted that one of the main function of PMRS is the recovery of 
ASC, preventing its oxidation to AFR, which forms dehydroascorbate (DHA), 
a highly unstable compound [26]. More recently, ASC has been recognized as 
the most relevant intracellular electron donor in mammalian cells, with several 
mechanisms to maintain the intracellular ASC concentration in the millimolar 
range [26].  
 
 
Figure 2.2. Schematic diagram of PMRS in the maintenance of intracellular 
and extracellular redox state. 
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Human RBCs are peculiar since they keep intracellular ASC concentrations 
equivalent to those present in plasma (40–80 M) by a rapid and efficient 
uptake of extracellular DHA and reduce it to ASC [26]. The general 
mechanism implies the oxidation of extracellular ASC to AFR, which in the 
absence of the enzymatic reduction to ASC, can reacts with another AFR and 
forms one ASC and one DHA unit. DHA is highly unstable and it can undergo 
a double fate: rapid cellular uptake through the glucose transporter, GLUT-1 
[27] and reduction to ASC, or hydrolysis to 2,3-diketogulonate, with 
irreversible loss of ASC (Figure 2.3). Once inside the RBCs, DHA is rapidly 
reduced, enzymatically or not enzymatically by GSH and reactions catalyzed 
by glutaredoxin and thioredoxin reductase to ASC, which becomes available 
for PMRS activity. 
 
 
Figure 2.3. Reactions of ascorbic acid [28].  
 
The synergistic action of the PMRS and DHA reductase provides a recovery 
mechanism of ASC between the intra- and extracellular compartments. The 
ASC is able to regenerate the α-tocopherol and prevent the oxidative damage 
to cellular proteins from peroxyl radicals ROO
•
, which is firstly oxidized in 
plasma [29]. 
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The importance of the PMRS is also highlighted by its key role in maintaining 
balanced NAD(P)/NAD(P)H ratio, essential for the normal energy metabolism 
and cell survival [30]. PMRS transports electrons from cytosolic NAD(P)H to 
extracellular electron acceptors, with the involvement at least two components, 
NADH-cytochrome b5 oxidoreductase and DT-diaphorase. It is also supported 
by NADPH oxidase, an enzyme complex on the plasma membrane, whose 
connection with the PMRS is still unclear [31]. 
It should be emphasized that the exact function of PMRS has not been fully 
understood, even if this complex is involved in many activities, such as: 1. 
maintenance of the redox state of sulfhydryl residues in membrane proteins; 2. 
neutralization of the oxidative molecules outside the cells; 3. recycle of the 
tocopherol; 4. reduction of lipid hydroperoxides; 5. maintenance of the 
extracellular concentration of ASC [29]. 
The induction of oxidative damage that occurs during aging is a condition 
characterized by a decrease of the antioxidant systems efficiency [32] [33]. 
However, it has been shown that PMRS activity reduces the oxidative damage 
during aging [34] [35]. Exogenous antioxidants, such as polyphenols, can 
modulate PMRS activity, improving the protection from the oxidative stress 
[29] [36]. The ability of polyphenols to provide electrons to this system is 
supported by the hypothesis that these molecules can cross the cell membranes 
[36]. In fact, the presence of caffeic acid, taxifolin, and ferulic acid has been 
evidenced into RBCs, even if only their metabolites, such as d-(3,4-dihydroxy-
phenyl)--valerolactone, show increased accumulation [37]. Probably, the 
uptake of these metabolites takes place via GLUT-1 transporter since their 
partitioning into RBCs is significantly inhibited by the presence of glucose 
[37]. Once inside the cells, polyphenols can donate electrons to extracellular 
electron acceptors through PMRS [29]. 
Other evidence also supports the hypothesis that red wine polyphenols, such as 
quercetin and resveratrol, can be incorporate into RBCs and activate PMRS 
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[29]. Therefore, considering the protective role of red wine polyphenols in 
CVD risk, it is reasonable to investigate the role of red wine polyphenols to 
protect human RBCs from oxidative stress through a potential activation of 
PMRS. 
 
2.2 Aims of the Chapter 
The aim of this Chapter has been the evaluation of the ability of red wine 
polyphenols to improve the antioxidant activity of RBCs, through a 
mechanism that involves the modulation of PMRS activity.  
In particular, the specific aims of the present study have been: 
-To evaluate the red wine ability to increase PMRS activity; 
-To verify if red wine polyphenols are able to modulate RBCs antioxidant 
systems, such as GSH and GSH-dependent enzymes; 
-To evaluate if red wine interfere with intracellular ROS in RBCs; 
-To investigate the red wine components responsible for the antioxidant 
effects in RBCs. 
Overall, in this Chapter, we investigated, at molecular level, if and how red 
wine components could potentiate antioxidant defenses in human RBCs. 
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2.3  Materials and Methods 
 
2.3.1 Chemicals 
Phosphate buffer saline (PBS) tablets (Life Technologies); 
Polyvinylpolypyrrolidone (PVPP); Gallic acid; Ferrous sulfate (FeSO4); 1,1-
diphenyl-2-picrilidrazilic (DPPH
•
) (Sigma-Aldrich); 5,5’-dithiobis(2-
nitrobenzoic) acid (Nbs2); HCl; Ethanol; HOCl; Ascorbic acid; Ascorbate 
oxidase (AO); Xylenol orange (XO); Ammonium iron(II) sulfate hexahydrate; 
2,6-di-tert-butyl-4-methylphenol; Potassium ferricyanide (K3Fe(CN)6); 
Sodium acetate (NaOAc); Citric acid; Ferric chloride (FeCl3); 
Bathophenanthrolinedisulfonic acid disodium salt hydrate; Glucose; 
Iodoacetamide (IAC); N-acetyl-l-cysteine (NAC); Trichloroacetic acid (TCA); 
Phtaldialdehyde; Glutathione (GSH); Folin-Ciocalteau’s reagent (FCR) 
(Sigma-Aldrich); 2,4,6-Tris (2-pyridyl)-triazine (TPTZ) (Sigma-Aldrich); 
Phtaldialdehyde; Sodium hypochlorite (NaOCl); Ethylenediaminetetraacetic 
acid (EDTA); Potassium metabisulfite (Carlo Erba); Dichloroﬂuorescein-
diacetate (DCFDA); Nicotinamide adenine dinucleotide phosphate reduced 
(NADPH); Phenylmethylsulfonyl fluoride (PMSF); Flavin adenine 
dinucleotide (FAD); 3,5-Di-tert-butyl-4-hydroxytoluene (BHT); Oxidized 
glutathione (GSSG); Glutathione reductase (GR); Magnesium chloride 
(MgCl2); Tris (hydroxymethyl) aminomethane hydrochloride (Tris-HCl); 
Pyrogallol; Glucose-6-phosphate (G6P). All other chemicals used were of 
research highest purity grade. 
 
2.3.2 Preparation of RBCs and plasma  
Human blood samples were obtained from healthy donors, not smoking males 
and females of an average age of 41.2 (23–64). All subjects gave their 
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informed consents for this study, which are in custody of Blood Donation 
Centre at the Division of Onco-Hematology of “San Giuseppe Moscati” 
hospital in Avellino. Blood samples were collected in EDTA treated tubes and 
than prepared through consecutive centrifugations and washing in PBS to 
remove plasma, platelets, and buffy coat. The plasma were employed by the 
chloramine assay, while RBCs were washed for three times in PBS at 1800xg 
for 10 min and used for hemolysis, PMRS, GSH and ROS measurement, and 
determination of antioxidant enzymes activity. 
 
2.3.3 Production of red wine and red wine fractionation 
A selected red wine (RW), “Aglianico” (VCR 13 2011) vinified in 2010 from 
Vitis vinifera cultivars, grown in the vineyard of the Mastroberardino’s cellar, 
located in the area surrounding the city of Avellino (Italy), were obtained by a 
microvinification process, which allows controlled and reproducible 
conditions. Grapes were destemmed and crushed; then they must be treated 
with potassium metabisulfite (100 mg/l of must) and 2g/hl Lafazym CL were 
added (Polsinelli, Frosinone, Italy). Subsequently, the must was transferred in 
stainless steel tanks (100 l) for fermentation that took place at 22-23 °C with 
20g/hl of Saccharomyces cerevisiae strain D254 (Lallemand Inc., Castel 
d’Azzano, Italy) and the cap was immersed twice a day by pumping over. 
Maceration of the pomace lasted 10 days then they must be pressed to obtain 
the final wine. After 24 h, wines were racked from gross lees, added with 100 
mg/l of potassium metabisulfite and bottled. No malolactic fermentation 
occurred. The wine was analyzed at bottling time. After opening, wine 
samples were divided in aliquots, stored in the dark at room temperature and 
used once for all experiments. In some cases, to avoid volatile components, 
aliquots of wines were lyophilized and resuspended in the same volume of 
0.01 N HCl. In order to separate RW components, two preparations were 
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obtained by consecutive extractions with ethyl acetate: the aqueous phase, rich 
in total anthocyanins, monomers and polymers (Fraction A) and the organic 
phase, containing not-anthocyanin molecules and including flavanols, phenolic 
acids and catechins (Fraction B) [10]. After preparation, the two fractions 
were dried and dissolved in 0.01 N HCl. Polyphenols-stripped RW (Fraction 
C) was prepared using a column of PVPP, which was previously activated by 
several washings with 12% ethanol v/v and centrifugations [38]. To separate 
the high molecular weight components of RW, indicated as polymers (RWP), 
RW was dialyzed against 0.01 N HCl using a membrane of 3000 kDa cut-off 
and left under stirring for 72 h. When necessary, aliquots of RWP were dried 
and suspended in 0.01N HCl.  
 
2.3.4 Determination of polyphenol content and antioxidant activity 
Total polyphenols content was measured by Folin-Ciocalteu’s assay [39] and 
the results were expressed as g/ml gallic acid equivalent (GAE), a 
polyphenol abundant in RW. The anthocyanin content was estimated using a 
pH shift method [40] and the results were expressed as micromolar of 
malvidin-3-glucoside (M3GE), the main anthocyanin present in RW. The 
antioxidant activity in vitro was determined by FRAP (Ferric Reducing 
Antioxidant Power) [41] and DPPH radical scavenging (free radical 2,2-
diphenyl-1-picrylhydrazyl) [42] assays and the results were expressed as 
millimolar of a solution of pure FeSO4 and % quenching, respectively.  
 
2.3.5 Determination of plasma chloramines formation 
Chloramines concentration was measured using Nbs (5-thio-2-nitrobenzoic 
acid), prepared from Nbs2 with NaOH before dilution into PBS [43]. Samples 
  
 Chapter II: Antioxidant activity of red wine polyphenols in human RBCs 
 
54 
 
of plasma were incubated with the maximal volume of RW allowed by the 
assay (corresponding to 9.13 g/ml GAE) for 10 min at 37 °C or with 50 M 
quercetin, as positive control. After incubation, samples were treated with 1 
mM HOCl for 15 min at 4 °C. Subsequently, Nbs was added to samples for 5 
min at room temperature. The amount of Nbs remaining after plasma 
incubation was inversely related to chloramines formation and was measured 
spectrophotometrically at 412 nm, using the molar extinction coefficient of 
8160 M
-1
 cm
-1
. 
 
2.3.6 Hemolysis assay 
RBCs (8x10
5
 RBCs/l) were diluted to 0.6 ml with PBS and were incubated 
with RW (73 g/ml GAE) for 45 min at 37 °C [44]. Samples were centrifuged 
at 1800xg for 2 min and were washed for three times with PBS, and incubated 
with 300 M HOCl for 15 min at 37 °C. After centrifugation at 1800xg for 2 
min, the absorbance of supernatants was measured at 540 nm and results were 
expressed as percentage of hemolysis, which was calculated by the ratio 
between the absorbance values of samples and the value of total hemolysis, 
obtained by osmotic shock using distilled water (100% hemolysis). 
 
2.3.7 Evaluation of antioxidant activity in RBCs 
RBCs (8x10
5
 RBCs/l) were incubated with RW (73 g/ml GAE) for 10 min 
at 37 °C. Samples were centrifuged at 1800xg for 2 min and were washed for 
three times with PBS, and hemolyzed with 0.3 ml of cold water. After 
centrifugation at 11000xg for 5 min, the supernatants were treated for three 
times with the same volume of absolute ethyl acetate. The organic phases were 
collected, were dried and incubated with a methanolic solution of DPPH (100 
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mM) for 30 min at room temperature. The samples were centrifuged at 
11000xg for 5 min and the absorbance of supernatants was measured at 517 
nm. The results were expressed as percentage of quenching. 
 
2.3.8 Determination of Plasma Membrane Redox System  
PMRS activity was determined following different RBC treatments. RBCs 
(8x10
5
 RBCs/l) were diluted to 0.6 ml with PBS and incubated at 37 °C with 
different concentrations of: 1. RW (7.3, 18.25, 36.5, 73, 109.5, 182.5 g/ml 
GAE) for 10 min; 2. same volume (20 l) of Fraction A (48 g/ml GAE), 
Fraction B (8.3 g/ml GAE), and Fraction C (0.3g/ml GAE); 3. RW and 
RWP (20 l corresponding to 73 and 27 g/ml GAE, respectively) for 1-10 
min; 4. 200 M catechin, 20 M quercetin, 7.3 M resveratrol, and 290 M 
gallic acid (final concentrations); 5. preincubated with 10 mM IAC, or 40 mM 
NAC at 37 °C for 1 h. In all cases, after treatment and washing with PBS, 
RBCs were incubated with a mixture containing PBS, 5 mM glucose and 1 
mM K3Fe(CN)6 at 37 °C for 30 min. Samples were centrifuged at 1800xg for 2 
min and the supernatants were collected for PMRS assay [29]. Briefly, the 
supernatants (25 l) were incubated for 5 min with a mixture containing 750 
mM NaOAc, pH 6.5; 500 mM citric acid; 0.41 mM FeCl3; 0.775 mM 
bathophenanthroline disulfonic acid disodium salt hydrate. Absorbance was 
measured at 540 nm and results were expressed as picomoles ferrocyanide/10
6
 
RBCs/min.  
 
2.3.9 Measurement of GSH levels 
RBCs (8x10
5
 RBCs/l) were diluted to 0.6 ml with PBS and incubated with 
RW (73 g/ml GAE) for 10 min at 37 °C. Samples were centrifuged at 1800xg 
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for 2 min and were washed for three times with PBS, and solubilized with 
TCA solution (5% v/v final concentration in 0.1 M HCl and 10 mM EDTA). 
For measurement of GSH [45] 0.5mg/ml phtaldialdehyde in PBS plus 10 mM 
EDTA were added to the samples, which was centrifuged at 11000xg, before 
measuring the fluorescence of supernatants at 340 nm (excitation wavelength) 
and 460 nm (emission wavelength). The micromolar concentration of GSH 
was calculated from a standard curve of pure GSH. 
 
2.3.10 Reactive oxygen species (ROS) measurement  
RBCs (8x10
5
 RBCs/l) were preincubated for 30 min with 20M DCFDA, a 
non-fluorescent compound able to cross the cell membrane. DCFDA is 
hydrolyzed to dichlorofluorescein, which reacts with the intracellular peroxide 
and gives rise to 2’,7’-dichlorofluorescin (DCF), detected 
spectrofluorimetrically. After incubation, RBCs were centrifuged, washed 
with PBS and treated for 1 or 10 min with RW (73 g/ml GAE). ROS 
production was measured fluorometrically with excitation and emission 
settings at 495 and 530 nm, respectively [44]. 
 
2.3.11 Activity of antioxidant enzymes 
RBCs (8x10
5
 RBCs/l) were diluted to 0.6 ml with PBS and were treated at 
different times with RW (73 g/ml GAE). After incubation, samples were 
centrifuged at 1800xg for 2 min, washed for three times with PBS and were 
lysed with 5 mM phosphate buffer, pH 8.0 containing PMSF. After 
centrifugation at 11000xg for 5 min, supernatant was used for enzymatic 
assays. 
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 Activity of glutathione reductase 
GR activity was measured according to Lopez et al. [46]. The oxidation of 
NADPH to NADP
+
 during the reaction of GSSG  reduction, was measured at 
340 nm. After 5 min of incubation at 37 °C with 5.1 M FAD 0.16 mM 
NADPH 0.49 mM EDTA, the reaction was started with the addition of 1.95 
mM GSSG. The absorbance was measured after 30 min and the specific 
enzymatic activity was expressed as nmol/min/ml RBCs. 
 Activity of glutathione peroxidase 
GPx activity was measured according to Lopez et al. [46]. After 5 min of 
incubation at 37 °C with 0.38 mM GSH, 0.38 mM NADPH, 1.25 mM EDTA, 
1.37 U/ml GR, the reaction was started with the addition of 78 mM BHT. The 
absorbance was measured after 30 min and the specific enzymatic activity was 
expressed as nmol/min/ml RBCs. 
 Activity of glucose-6-phosphate dehydrogenase  
G6PD activity was measured according to Sirati-Sabet et al. [47], assaying the 
production of NADPH at 340 nm. After 5 min of incubation at 37 °C with 0.3 
mM NADP, 10 mM MgCl2 in 100 mM Tris-HCl, pH 8.0, the reaction was 
started with the addition of 1 mM G6P. The absorbance was measured after 30 
min and the enzymatic activity expressed as nmol/min/ml RBCs. 
 Activity of superoxide dismutase  
SOD activity was measured as previously reported by Li [48]. Samples, 
treated with RW as reported above, were incubated for 5 min at 37 °C with 
0.05 M Tris-HCl, pH 7.4; 1 mM EDTA; subsequently, the reaction was started 
with the addition of 50 mM pyrogallol at 37 °C. The absorbance was measured 
after 20min and the specific enzymatic activity expressed as U/ml RBCs. 
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2.3.12 Statistical analysis 
Data are presented as mean values±standard error (SE) or values±standard 
deviation (SD) and the significance was measured by the use of Student’s test 
of at least five determinations. 
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2.4 Results and discussion 
 
2.4.1 Phenolic content and antioxidant activity of red wine 
The total phenolic and anthocyanin contents of RW, determined as reported in 
“Materials and Methods” section, were of 2190±0.05 g/ml GAE and 
109.7±0.8 M M3GE, respectively (Table 2.1). The antioxidant activity of 
RW, measured using FRAP assay, was of 6.62±0.38 mM Fe
2+
equivalent 
(Table 2.1). Results reported in Table 2.1 show that RW had phenolic content 
and antioxidant activity in the range of those previously measured in other 
wines [49]. In order to evaluate the activity of RW costituents, we separated 
RW components by different separation methods: a fraction containing total 
anthocyanins (monomers and polymers) (Fraction A), a fraction deprived of 
anthocyanins (Fraction B), a fraction deprived above 97% of polyphenols 
(Fraction C).  
 
Table 2.1. Phenolic, anthocyanin contents and antioxidant activity of total RW 
and fractions A, B, C and RWP. 
Samples 
Total phenolic 
content
a
 
Anthocyanin 
content 
b
 
FRAP
c
 
RW 2190 ± 0.05 109.7 ± 0.81 6.62 ± 0.38 
Fraction A 1430 ± 0.07 63.0 ± 1.56 4.38 ± 0.59 
Fraction B 250 ± 0.01 8.4 ± 1.90 0.75 ± 0.05 
Fraction C 10 ± 0.05 0.01 ± 0.02 0.02 ± 0.01 
RWP 810 ± 0.03 -- -- 
Results are expressed as g/ml GAEa; M malvidin-3-glucoside equivalent 
(M3GE)
b
; mM Fe
2+
 equivalent
c
. All data are the means ± SD of at least five 
independent determinations. 
 
As expected, Fraction A showed higher antioxidant power compared to 
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Fraction B and C, accordingly with the highest content of total phenols and 
anthocyanins (Table 2.1), while the absence of polyphenols of Fraction C 
showed the lower antioxidant activity. We also separated, through dialysis, the 
high molecular weight compounds of RW, RWP, and measured the phenolic 
content by Folin-Ciocalteu’s assay (Table 2.1). 
 
2.4.2 Protection from plasma chloramines formation and RBCs 
hemolysis 
Based on the data reported in Table 2.1, we tested the ability of RW to 
improve the physiological antioxidant defenses. During the respiratory burst, 
activated macrophages and neutrophils trigger metabolic enzymatic events, 
including the activation of the enzyme myeloperoxidase, which catalyzes the 
reaction between H2O2 and Cl
-
, resulting in the formation of the oxidizing 
HClO. This species is a potent antibacterial, antimicrobial and has highly 
reactive oxidant action, for which, an excessive production is responsible for 
the tissue damage. The thiol groups (-SH) of cysteine, methionine and the 
amino groups of the plasma proteins are the major targets of HClO. In 
particular, the free amino groups of the lysine residues react with HClO and 
form chloramines (RNHCl), very reactive oxidative agents [50] (Figure 2.4).  
 
 
Figure 2.4. Reaction of chloramine formation [50]. 
 
  
 Chapter II: Antioxidant activity of red wine polyphenols in human RBCs 
 
61 
 
We tested the ability of RW to protect against HOCl-induced plasma 
oxidation, measuring the reduction of N-chloramines formation in human 
plasma. The assay is an indirect measure of the concentration of chloramines, 
which is inversely proportional to the concentration of Nbs. After adding 
HClO to induce the formation of chloramines, it was added Nbs which 
interacts with the free amino groups of lysines plasma. The presence of many 
free groups which react with NBS corresponds to the lower chloramines 
formation. The plasma samples were preincubated with RW (9.13 g/ml 
GAE) before the oxidative damage induced by HClO, as reported in 
“Materials and Methods” section. After incubation with RW, we observed a 
significant increase of Nbs concentration respect to HOCl-treated samples 
(Figure 2.5), which corresponded to a reduction of chloramines formation. As 
positive control of the assay, we used quercetin, a flavonoid present in RW 
and possing a strong antioxidant activity. 
 
 
Figure 2.5. Determination of chloramines in plasma after treatment with RW 
(9.13 g/ml GAE). Chloramines were measured as reported in “Materials and 
Methods” and expressed as M Nbs remaining. Quercetin (50 M) was used 
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as positive control. Data are means of samples from 10 subjects (n=10) in 
duplicate ± SE. Symbols indicate significance: *p<0.05 respect to untreated 
(CTRL); #p<0.05 vs CTRL+HOCl-treatment. 
 
In order to evaluate the ability of RW to improve the physiological antioxidant 
defenses, we also verified the protection against hemolysis, treating RBCs 
with 300 M HOCl, which induced a rapid hemolysis [51]. We detected an 
hemolysis of 8.6% that was significantly reduced to 5.4% by RW (73 g/ml 
GAE) treatment (about 40% reduction), as showed in Figure 2.6. 
 
 
Figure 2.6. Reduction of hemolysis induced by HOCl after treatment with RW 
(73 g/ml GAE). The oxidative stress was induced by adding 300 M HOCl 
for 15 min at 37 °C. Percent of hemolysis was calculated as reported in 
“Materials and Methods”. Data are means of samples from 10 subjects in 
duplicate±SE. Symbols indicate significance: *p<0.05 respect to untreated 
(CTRL); #p<0.05 vs CTRL+HOCl-treatment. 
 
These experiments confirmed the protective effect of RW in RBCs against the 
formation of plasma chloramines and hemolysis induced experimentally by 
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HOCl. Therefore, we hypothesized that RW improved the antioxidant 
intracellular redox state, enhancing the physiological antioxidant defenses. To 
confirm this, we measured the total RBCs antioxidant activity by DPPH 
quenching assay and we observed that the treatment with RW (73 g/ml GAE) 
increased (up to 3-fold) the intracellular antioxidant activity compared to 
untreated RBCs (Table 2.2). 
 
Table 2.2. Antioxidant capacity of RW into RBCs. 
Samples DPPH 
CTRL 12.8 ± 13.2 
RW 39.6 ± 10.3 
 
Results are expressed as quenching (%). All data are the 
means ± SD of four independent determinations. 
 
2.4.3 Activation of PMRS activity by red wine 
We evaluated the RW capability to interfere with PMRS activity, one of the 
major player in regulating RBCs antioxidant defences. The assay is based on 
the ability of ferricyanide (FIC), an oxidant molecule impermeable to plasma 
membrane, to accept electrons. The reduction of FIC to ferrocyanide (FOC), 
which occurs at the plasma membrane, was assessed spectrophotometrically 
and was related to the RW ability to donor electrons to the PMRS, increasing 
its activity. Therefore, we firstly performed a dose-response experiment (7.3-
182.5 g/ml GAE) to select the concentration of RW to be employed in the 
assays. We chose a concentration of 73 g/ml GAE, which induced an 
increase of about 2-fold in PMRS activity (Figure 2.7).  
To exclude the involvement of volatile compounds in increasing PMRS 
activity, samples were dried and suspended in the same volume of 0.01N HCl, 
before assaying the PMRS activity. No significant changes were observed, 
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confirming that the presence of all volatile components in wine did not 
interfere with PMRS activity (data not shown). We also studied the role of 
GSH, an important regulator of PMRS and RBCs antioxidant defenses, which 
plays a crucial role in reduction of DHA to ascorbate [26], as reported in the 
“Introduction” section. For this reason, we evaluated the role of RW 
polyphenols on GSH metabolism, using two GSH modulators, IAC, an 
alkylating agent that binds covalently the thiol group of cysteine inducing a 
depletion of GSH [52], and NAC, a synthetic precursor of intracellular 
cysteine and de novo synthesis of GSH [53] and we measured PMRS activity. 
 
 
Figure 2.7. Dose-response of RW on PMRS activity in RBCs. PMRS activity 
was evaluated as reported in “Materials and Methods” and expressed in 
terms of pmol ferrocyanide/10
6
 RBCs/min. Data represent means of samples 
from 5 donors in duplicate ± SE (n=5). Symbols indicate significance: 
*p<0.05 respect to untreated (CTRL). 
 
The results in Figure 2.8 confirmed the role of GSH in regulating PMRS, 
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since the incubation of RBCs with IAC (10 mM) determined a dramatic 
decrease of PMRS activity. This inhibitory effect was overcome by treatment 
with RW, suggesting a role GSH-like of RW polyphenols. The treatment with 
NAC increased PMRS activity, but at the tested concentration (40 mM), the 
molecule was less efficient (Figure 2.8). In fact, in the presence of NAC, 
PMRS activity increased by 1.58-fold. When we combined NAC plus RW, the 
increase of PMRS activity was comparable to that induced by RW single 
treatment. 
 
 
Figure 2.8. Effects of IAC and NAC on PMRS activity. PMRS activity was 
described as reported in “Materials and Methods” and expressed in terms of 
pmol ferrocyanide/10
6
 RBCs/min. Data are means of samples from 10 donors 
in duplicate ± SE (n=10). Symbols indicate significance: *p <0.05 respect to 
untreated (CTRL); #p<0.05 vs IAC and NAC single treatments. 
 
2.4.4 Red wine interaction with RBCs antioxidant systems 
In the attempt to investigate the molecular mechanism triggered by RW and 
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mediated by PMRS, we reasoned that GSH levels could play a key role being 
among the most important non-enzymatic erythrocytic antioxidants. For this 
reason, we measured GSH concentration by a spectrofluorimetric method, 
after 10 min of incubation with RW (73 g/ml GAE). As showed in Figure 
2.9, GSH increased significantly compared to untreated control, as the result 
of RW treatment.  
 
 
Figure 2.9. Effect of RW (73 g/ml GAE) on GSH concentration in RBCs. 
GSH micromolar concentration was measured spectrofluorimetrically at 
340±20nm of excitation and 460±20nm of emission and calculated using a 
standard curve of GSH as reported in “Materials and Methods”. Data are 
means of samples from seven donors in duplicate±SE. Symbols indicate 
significance: *p<0.05 respect to untreated (CTRL). 
 
Based on this evidence, we hypothesized that the activation of PMRS by RW 
polyphenols (Figure 2.7) was related to the GSH increase (Figure 2.9). 
Therefore, we investigated the possible mechanism triggered by RW to 
activate PMRS via an increase of GSH intracellular concentration. For this 
reason, we measured ROS production following RW treatment to assess if the 
response of GSH was due to an increase in radical molecules. As reported in 
Figure 2.10, the incubation of RBCs with RW for 1 and 10 min increased by 
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10% and 15% of intracellular ROS production, respectively.  
 
Figure 2.10. ROS production in RBCs treated with RW (73 g/ml GAE) at 
different times. ROS were measured using DCFDA/ DCF fluorescent method 
as reported in “Materials and Methods”. Symbols indicate signiﬁcance: 
*p<0.05 respect to untreated (CTRL). Data are means ± SD of at least five 
independent determinations. No significant difference was reported between 
treatment at 1 and 10 min (RW bars). 
 
Therefore, we suggested that this slight but significant pro-oxidant effect by 
RW could be responsible for the induction of an antioxidant response, as a 
RBC defense mechanism. Since the rapid activation of PMRS (Figure 2.7) 
and the observation that RW totally rescued the effect of IAC (Figure 2.8), we 
excluded the possibility of a de novo synthesis of GSH. In fact, L-buthionine 
sulfoximine (BSO), a specific inhibitor of glutamate-cysteine ligase, which is 
the key rate-limiting enzyme in GSH synthesis, did not significantly inhibit the 
activation of PMRS by RW (data not shown). Alternatively, we considered 
that the conversion from GSSG to GSH could be involved in the activation of 
PMRS via increased levels of GSH. To explore this possibility, we measured 
the activity of GR, the enzyme responsible for the conversion of GSSG to 
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GSH (Figure 2.1). As reported in Figure 2.11, RW increased GR activity 
significantly in the range 1-10 min compared to the untreated control with a 
peak at 2 min corresponding to 29% increase compared to 1 min. We also 
showed that the enzymatic activity of GPx, the complementary enzyme in the 
cycle of GSH (Figure 2.1) did not increase at the time of incubation tested 
(data not shown). 
 
 
Figure 2.11. GR activity of RBCs after incubation with RW (73 g/ml GAE). 
GR activity was expressed as nmol/min/ml RBCs. Symbols indicate 
signiﬁcance with **p<0.005 respect to untreated (CTRL); #p<0.05 
significance between 1 and 2 min of incubation with RW. Data are means ± 
SD of at least seven independent determinations. 
 
We also hypothesized the involvement of G6PD, an enzyme involved in 
maintaining the normal levels of NADPH, cofactor of the enzyme GR (Figure 
2.1). G6PD enzyme is required to produce NADPH in the pentose phosphate 
pathway and protects RBCs from oxidative stress. Figure 2.12 shows a 
significant increase of G6PD activity at 2, 5 and 10 min of treatment with RW. 
The increase of G6PD activity peaked at 2 min with 47% increased respect to 
1 min.  
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Figure 2.12. G6PD activity of RBCs after incubation with RW (73 g/ml 
GAE). G6PD activity was expressed as nmol/min/ml RBCs. Symbols indicate 
signiﬁcance with *p<0.05 respect to untreated (CTRL); #p<0.05 significance 
between 1 and 2 min of incubation with RW. Data are means ± SD of at least 
seven independent determinations. 
 
Finally, we detected the increase of SOD activity, an important antioxidant 
enzyme, which catalyzes the dismutation of the superoxide radical into 
molecular oxygen or hydrogen peroxide (Figure 2.1). In Figure 2.13 a kinetic 
of SOD activity after treatment with RW is reported. The only significant 
difference compared to untreated control was detected after 10 min of 
incubation (38% of increase). 
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Figure 2.13. SOD activity of RBCs after incubation with RW (73 g/ml GAE). 
SOD activity was expressed as U/ml RBCs. Symbols indicate signiﬁcance with 
*p<0.05 respect to untreated (CTRL). Data are means ± SD of at least seven 
independent determinations. 
 
2.4.5 PMRS activity by red wine anthocyanins and polymers 
To investigate the RW components potentially responsible for the activation of 
PMRS, we tested the capacity of individual antioxidant molecules, such as 
quercetin, resveratrol, gallic acid and catechin to activate PMRS. These 
molecules were selected since they are among the most representative in RW 
and were applied in the range of concentrations usually found in an Aglianico 
wine [54-56]. Figure 2.14 shows that single molecules had not a significant 
effect on PMRS activity respect to RW mixture. In one case (resveratrol), even 
at a concentration 3-fold higher than that normally present in RW, no effect on 
PMRS activity was detected (data not shown). 
We also calculated by FRASC method the concentration of ASC, one of the 
major non-phenolic antioxidant, whose value was about 280 M, in good 
agreement with other values reported in literature [57]. Since human RBCs do 
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not express sodium-dependent vitamin C transporters (SVCTs), they cannot 
take up ASC; therefore, it was useless to test its ability to directly activate 
PMRS. Instead, we assayed DHA as a positive control and, as expected, we 
found that DHA was able to activate PMRS (data not shown). Previous 
evidence suggested that phenols also present in RW, such as quercetin and 
resveratrol, are effectively incorporated into RBCs and activate PMRS [23]. 
However, the concentrations applied were far from those present in RW. 
 
 
Figure 2.14. Effects of antioxidant compounds present in RW on PMRS 
activity. RBCs were incubated for 10 min with 20 l of RW (73 g/ml GAE) or 
single compounds (200 M catechin, 20 M quercetin, 7.3 M resveratrol, 
290 M gallic acid). PMRS activity was described as reported in “Materials 
and Methods” and expressed in terms of pmol ferrocyanide/106 RBCs/min. 
Data are means of samples from 5 donors duplicate±SE. 
 
Based on these results, we investigated the possibility that other classes of 
polyphenols could be involved in the activation of PMRS. Therefore, we 
applied a separation method, based on ethyl acetate extraction, which allowed 
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us to obtain a fraction enriched in total anthocyanins (Fraction A) and a 
fraction without anthocyanins and rich in flavonols, phenolic acids, and 
catechins (Fraction B) [8, 10] (Table 2.1). A third fraction deprived of 
polyphenols (Fraction C) was also prepared by mixing RW with a column of 
PVPP [38]. The total polyphenol content of the RW was determined before 
and after the phenolic compounds were stripped and >97% of phenols were 
removed by this procedure (Table 2.1). 
We tested the PMRS activity of these fractions normalizing to the original 
volume of RW used at the beginning of the separation procedure. As reported 
in Figure 2.15, Fraction A (48 g/ml GAE) increased PMRS activity of 3-fold 
respect to untreated samples, while Fraction B (8.3 g/ml GAE) did not induce 
a significant increase of PMRS. We confirmed that RW polyphenols were able 
to modulate PMRS activity and the anthocyanins components were 
responsible for the increase of PMRS, since the Fraction C (0.33 g/ml GAE), 
deprived of polyphenols, was completely inactive (Figure 2.15).  
Figure 2.15 shows that more than 95% of the PMRS modulating effect of RW 
was associated with Fraction A, containing monomeric and polymeric 
anthocyanins. A residual activity, although not significant, was associated to 
the fraction without anthocyanins (Fraction B) indirectly confirming the data 
reported in Figure 2.14, which refer to the inability of well-known bioactive 
and antioxidant compounds, such as phenolic acids, flavonoids, catechins, and 
stilbenes, to activate PMRS at the concentrations normally present in RW. 
These molecules are been bona fide present in Fraction B. A corollary of data 
shown in Figure 2.15 regards the observation that the activity of RW is 
specifically associated to polyphenols, not to other compounds present in the 
tested sample, since stripping of polyphenols from RW (Fraction C) abolished 
its ability to activate PMRS. 
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Figure 2.15. Effects on PMRS activity of RW components. RBCs were 
incubated for 10 min with 20 l of RW (73 g/ml GAE), Fraction A (47.6 
g/ml GAE), Fraction B (8.33 g/ml GAE) and Fraction C (0.3 g/ml GAE). 
PMRS activity was described as reported in the section ‘‘Materials and 
Methods’’ and expressed in terms of pmol ferrocyanide/106 RBCs/min. Data 
are means of samples from 5 donors duplicate±SE. Symbols indicate 
significance: *p<0.05 respect to untreated (CTRL); #p<0.05 and +p<0.05 vs 
fractions B and C, respectively. 
 
We further investigated the contribution of bioactive RW components, after 
separating in two groups: high molecular weight (RWP) and monomers by 
dialysis, as reported in “Materials and Methods” section. After dialysis, RWP 
were dried and suspended in 0.01N HCl and used for the assay normalizing to 
the original volume of RW used at the beginning of the separation procedure. 
Figure 2.16 shows a kinetic of PMRS activity after treatment with RW and 
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RWP (73 and 27 g/ml GAE, respectively) for the indicated times. In 
particular, RW and RWP increased PMRS activity significantly starting from 
1 min of incubation and the activation persisted up to 10 min. The differences 
in PMRS activity among the two groups, e.g. RW versus RWP were not 
significant. 
 
 
Figure 2.16. Kinetic of PMRS activity in RBCs after incubation with RW and 
RWP (73 g/ml GAE for RW, 27 g/ml GAE for RWP). PMRS activity was 
expressed in terms of pmol ferrocyanide/10
6
RBCs/min. Symbols indicate 
signiﬁcance with *p<0.05 respect to untreated (CTRL). Data are means ± SD 
of at least four independent determinations. 
 
We also tested the ability of RWP to increase GSH intracellular concentration. 
As showed in Figure 2.10, GSH increased significantly of 27% and 25% 
compared to untreated control, as the result of RW and RWP treatment, 
respectively. No significant difference was measured between RW and RWP, 
confirming the contribution of these molecules to biological activity of RW. 
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Figure 2.17. GSH levels after incubation with RW and RWP (73 g/ml GAE 
for RW, 27 g/ml GAE for RWP).GSH levels were expressed in terms of M 
GSH as reported in “Materials and Methods”. Symbols indicate signiﬁcance 
with *p<0.05 respect to untreated (CTRL). Data are means ± SD of at least 
four independent determinations. 
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2.5 Conclusions 
In the present Chapter, we demonstrated that RW possesses pleiotropic 
functions able to protect human RBCs against oxidative stress and/or capable 
to potentiate their antioxidant defenses acting extra- and intracellularly on 
multiple mechanisms (Figure 2.18). The data reported demonstrate, for the 
first time to our knowledge, that the protective antioxidant effect exerted by 
RW on human RBCs is mediated by PMRS. In particular, we suggested that 
the increase of ROS by RW induces an adaptive response in RBCs, which 
results in an increase of their antioxidant defenses protecting them from 
oxidative stress (Figure 2.18). In fact, we showed that RW activates GR 
(Figure 2.11), the enzyme responsible for the conversion of GSSG to GSH, 
suggesting that compounds present in RW contribute to increase the level of 
GSH, directly or indirectly. In support of this view, the rapid activation of 
PMRS and the observation that RW totally rescued the effect of IAC (Figure 
2.8) make unlikely that the de novo synthesis of GSH can play an important 
role. In addition, RW is capable of increasing the intracellular concentration of 
GSH even more efficiently than NAC, since the combined treatment, NAC 
plus RW, does not significantly enhance the effect of RW mono-treatment 
(Figure 2.8). 
Among the several red wine components, the anthocyanin fraction appears the 
most likely responsible for stimulating the PMRS enzymatic activity. Future 
work will be devoted to the purification and characterization of specific 
compounds present in RW and/or in the anthocyanin-enriched fraction, with 
high molecular weight, and able to interfere with specific PMRS components. 
We cannot exclude a synergistic effect of bioactive compounds present in RW, 
which may explain its capacity to increase the PMRS activity and the 
protection from oxidative stress. However, further studies are going in order to 
measure the concentration of RW polyphenols into RBCs, not excluding 
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possible interactions at the membrane bilayer by RWP.  
 
 
Figure 2.18. Proposed mechanism triggered by RW components to enhance 
antioxidant defences in RBCs mediated by PMRS. 
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3.1 Introduction 
Several studies report the potential role of polyphenols in the prevention of the 
occurrence of degenerative diseases [1]. In fact, a growing body of evidence 
suggests that the intake of polyphenols may contribute to counteract the 
neuronal injuries, involved in neurodegeneration [2]. This term refers to a 
pathological condition characterized by dysfunction and death of neurons in 
the brain and spinal cord [3]. The exact aetiology of this pathogenic process is 
not defined; however, both environmental and genetic risk factors seem to 
play a fundamental role. The neuronal deterioration is due to a fatal and 
inevitable damage of brain function, with cognitive deficits, dementia, motor 
abnormalities and behavioural and psychological disorders. 
Neurodegeneration underlies various diseases such as PD, AD, Huntington's, 
Amyotrophic Lateral Sclerosis [4]. In particular, AD is the most common type 
of dementia, characterized by the progressive neuronal dysfunction occurring 
in adulthood or old age. The memory deficits and the progressive loss of brain 
function, typical of AD, are due to the degeneration of a population of 
neurons, called cholinergic, which release acetylcholine, the neurotransmitter 
involved in complex functions such as memory and reasoning [5]. This disease 
was studied for the first time by Alois Alzheimer, a german neurologist, who 
in 1907 described the symptoms and neuropathological aspects of the disease: 
the presence of neurofibrillary tangles and senile plaques (Figure 3.1), that 
progress from the brain stem to the inner parts of the temporal lobes [6]. These 
two neuropathological markers are derived from the accumulation of aberrant 
cellular proteins, resulting in the deposition of insoluble material, which 
interferes with neuronal function and synaptic plasticity [7].  
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Figure 3.1. Neurofibrillary tangles and senile plaque (provided by 
Alzheimer’s association: https://www.alz.org/braintour/early_stage.asp). 
 
The neurofibrillary tangles derive from several isoforms of 
hyperphosphorylated tau protein, which is generally associated with 
microtubules and exerts two basic functions, supporting the neuron structure 
and regulating the transport of nutrients. The tau protein hyperphosphorylation 
decreases its ability to bind to microtubules, resulting in aggregates, formed by 
paired helical filaments, which induce the collapse of microtubules and the 
reduction of axonal transport [8]. Since the efficiency of this transport is 
necessary for maintaining neuronal connections, the degeneration of neuronal 
network, involved in progression of AD, is promoted by tau 
hyperphosphorylation and senile plaques. In detail, the central part of a senile 
plaque is a fibrous structure, called amyloid body, whose main protein is a 4 
kDa peptide, called A protein purified and sequenced in 1984 by George 
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Glenner, and derived from the proteolytic cleavage of APP [9]. The APP 
protein is the substrate of three different proteolytic activities, α, β and γ-
secretase, in relation to the release of several secreted forms of APP [10]. The 
activity of α-secretase induces the proteolytic cut between the Lys16 and 
Leu17, situated inside the portion of the Aβ peptide, thus preventing its 
formation. For this reason, the APP degradation promoted by α-secretase 
activity is related to a not-amyloidogenic process (Figure 3.2). Instead, the β-
secretase enzyme induces the amyloidogenic pathway, cutting APP to the 
terminal amino portion of A peptide and generating a soluble form of shorter 
APP, APPsβ and a fragment of C99 residues, which becomes the substrate of 
γ-secretase, releasing the A peptide (Figure 3.2) [11]. 
 
 
Figure 3.2. Not amyloidogenic and amyloidogenic process [12]. 
 
During the last two decades, most researches support the “amyloid 
hypothesis”, that considers the deposition of A peptide the initial event 
responsible for the neurodegeneration process (Figure 3.3) [13]. 
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Figure 3.3. Deposition of amyloid plaque, the initial event of 
neurodegeneration [14]. 
 
Normal levels of A peptide are involved in the regulation of excitatory 
neurotransmission in the brain, preventing the hyperactivity of synapses. In 
patients with AD, however, the abnormal amount of oligomers are toxic to 
neurons, causing synaptic dysfunction, inflammation and release of ROS [10]. 
In fact, the presence of A peptide is associated with neuronal inflammation, 
excitotoxicity and oxidative stress [4]. As reported above, the oxidative stress, 
strongly related to neuroinflammation, plays a key role in the AD 
pathogenesis. For example, ROS at elevated concentrations induce the 
formation of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a hydroxyl radical 
obtained by the nucleoside guanine. Several studies have shown that the level 
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of 8-OHdG is elevated in the brain of the elderly, four times higher than in 
young [15]. Furthermore, the damage caused by a massive build-up of free 
radicals implements the apoptotic cell death, the main cause of neuronal loss 
observed in AD [16]. The apoptotic process is based on the activity of specific 
enzymes, caspases, and it has been observed that flavonoids protect against 
neuronal oxidative damage by preventing caspase-3 activation, providing 
evidences in support of their powerful anti-apoptotic action [17]. 
Considering the prominent role of tau proteins and Aβ, they represent 
preferred targets for drug development. However, in many cases, innovative 
drugs against these two proteins fail in clinical trials. The limited effectiveness 
of current therapies against AD highlights the need to intensify research aimed 
to develop new agents able to prevent or retard the disease progression. Thus, 
considering the high complexity and the multiple etiological nature of AD and 
other aging-related ND, novel therapeutic approaches suggest the use of a 
cocktail of naturally antioxidant compounds, such as polyphenols.  
These compounds are potential neuroprotective agents, probably for their 
ability to influence several cellular pathways, such as proliferation, apoptosis, 
redox balance and differentiation [18]. As reported above, polyphenols protect 
from the neuronal damage induced by neurotoxins, reducing the inflammation 
and the oxidative stress, through the regulation of pro-inflammatory genes and 
the modulation of the antioxidant enzymes activity, respectively [19] [20]. 
These effects seem to take place throughout two main mechanisms. In the first 
place, they interact with proteins that lead to the inhibition of apoptosis 
triggered by neurotoxic agents and promote neuronal survival. Secondly, they 
induce beneficial effects on the vascular system leading to changes in blood 
flow cerebrovascular, capable of causing angiogenesis, neurogenesis, and 
changes in neuronal morphology [21].  
Among polyphenols, those from red berries play an important role in the 
protection from degenerating processes related to oxidative stress. In fact, as 
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shown by in vivo studies, the supplementation of highly antioxidant 
polyphenolic extracts, such as blueberries and strawberries, may protect from 
oxidative stress in brain aging [22]. In another study, the effects of daily 
consumption of wild blueberry juice on older adults with early memory 
changes have been investigated, demonstrating an improvement of memory 
and learning, after 12 weeks, with additional positive trends regarding reduced 
depressive symptoms and lowered glucose levels [23]. 
The antioxidant potential of berries is related to the presence of different 
families of compounds: flavonoids, proanthocyanidins, ellagitannins, 
gallotannins, phenolic acids, vitamins A, C and E, folic acid, calcium and 
selenium, α and β-carotene, lutein, phytosterols (β-sitosterol and stigmasterol), 
triterpenic esters [24]. As an example, the anti-oxidative and anti-
inflammatory effect of elderberry extracts, through the inhibition of the 
microglial activation is probably related to the high content of anthocyanins, 
flavonoids and other polyphenols [25]. The major flavonoids in elderberry are 
quercetin and rutin, while the primary anthocyanins are cyanidin-3-O-
sambubioside and cyanidin-3-O-glucoside [26]. Therefore, it is reasonable to 
assume that polyphenols-rich foods and products as nutraceuticals and 
supplementary treatments can potentially be used in the prevention the 
occurrence and in the management of aging-related neurodegeneration. For 
this reason, in this Chapter, we evaluated the potential role of elderberries 
polyphenol extract in the neuroprotection induced by oxidizing agents. 
 
3.2 Aims of the Chapter 
The main aim of this section of the thesis has been the evaluation of the 
potential neuroprotective effect of a polar extract enriched in polyphenols 
obtained from Sambucus nigra berries (Figure 3.4).  
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Figure 3.4. Sambucus nigra berries. 
 
In detail, the specific objectives have been the following: 
-To prepare the polyphenolic extract from S. nigra berries and test its 
antioxidant activity in vitro; 
-To reproduce an in vitro model which resembles the pathological process of 
neurodegeneration using the human cell line IMR-32; 
-To evaluate the potential protective effect of S. nigra polyphenol extract 
against the neurotoxicity induced by specific oxidizing agents, such as 
Apeptide and hydrogen peroxide; 
-To decipher the protective molecular mechanisms triggered by S. nigra 
polyphenol extract against neurodegenerative damage induce in IMR-32 cells. 
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3.3  Materials and Methods 
  
  3.3.1 Chemicals  
Phosphate buffer saline (PBS) tablets (Life Technologies); Minimum Essential 
Medium (MEM) (SAFC Bioscence); Fetal bovine serum (FBS) (HyClone); 
Glutamine (Life Technologies); Penicillin/streptomycin solution (Life 
Technologies); N6,2' Dibutyryladenosine-O-3 ', 5'-cyclic monophosphate 
(dbcAMP) (Sigma); 5-bromodeoxyuridine (BrdU) (Sigma-Aldrich); Dimethyl 
sulfoxide (DMSO); Bromide of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium (MTT); ABTS (2,2'-azinobis (3-etilbenzotiazolin-6-
sulfonate); Methanol; Hydrochloric acid (HCl); Trypsin-EDTA; Trizol reagent 
(Life Technologies); Chloroform; Isopropanol; SuperScriptTM III kit (Life 
Technologies); SYBR Green PCR Master Mix (Applied Biosystems); Folin-
Ciocalteu’s Reagent (FCR) (Sigma-Aldrich); Potassium chloride (KCl); 
Sodium acetate (CH3COONa); Sodium bicarbonate (Na2CO3); Fe(III)-TPTZ 
(2,4,6-tri(2-pyridyl)-s-triazine) (Sigma- Aldrich); Ferric chloride (FeCl3); 2,2'-
azinobis(3-etilbenzotiazolin-6-sulfonate) (Sigma-Aldrich); 1,1-diphenyl-2-
picrilidrazilic (DPPH
•
) (Sigma-Aldrich); 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium); Isopropanol; 4-(2 hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES); Ethylenediaminetetraacetic acid 
(EDTA); 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
(CHAPS); Dithiothreitol (DTT); Methylphenylsulfonylfluoride (PMSF); 
Pepstatin A; Aprotinin; Leupeptin; Bio-Rad Protein reagent (Bio-Rad); Bovine 
serum albumin (BSA); Glycerol; AFC (amino-4-trifluoromethylcoumarin); Z-
DEVD-AFC peptide (carbobenzoxy-Asp-Glu-Val-Asp-7-amino-4-
trifluormethylcoumarin); Ac-IETD AFC-peptide (Ac-Ile-Glu-Thr-Asp-AFC); 
LEHD-AFC peptide (Leu-Hys-Glu-Asp-7-amino-a- trifluormethylcoumarin); 
Hoechst dye (Sigma-Aldrich); Dichloroﬂuorescein-diacetate (DCFDA). All 
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other chemicals used were of research highest purity grade. 
 
            3.3.2 Cell culture and differentiation 
The IMR-32 cell line, derived from human neuroblastoma [27], was employed 
in the present study. For proliferation assays, cells were maintained at low 
confluence in polystyrene Petri plates (Corning, Milan, Italy) treated to ensure 
an optimal adhesion. The culture medium used for their growth was MEM, 
enriched to 10% FBS containing growth factors necessary for the growth of 
cells, 1% glutamine, 1% solution penicillin/streptomycin. The cells were 
maintained in proliferation at a density of 1x10
6
/ml, at a temperature of 37 °C, 
with a percentage of 100% humidity and 5% CO2. In order to reproduce in 
vitro the pathological condition of neurodegenerative process aging-related, 
the IMR-32 cells were induced to differentiate to neuron-like cells. In this cell 
line, the amyloid precursor protein is expressed by 58% in the form APP695, 
APP751 and 38% <4% APP770 [28]. Cells were plated at 40% of confluency 
and differentiation was induced by treating the cells for a week with a mixture 
of N6,2' Dibutyryladenosine-O-3', 5'-cyclic monophosphate (dbcAMP) and 5-
bromodeoxyuridine (BrdU):  
-1 mM dbcAMP an analogue of cyclic-AMP intracellular mediator. The stock 
solution, dissolved in H2O, was stored at -20 °C. Considering the data reported 
in the literature, dbcAMP was used extensively in the differentiation of a 
variety of stem cells or neural progenitor cells into neurons [29]. 
-2.5 M of BrdU, a synthetic analogue of thymidine. The mother 
concentration was dissolved in DMSO. The BrdU is commonly used in the 
detection of proliferating cells in living tissues [30]. The molecule can be 
incorporated in the newly synthesized DNA during the S phase of the cell 
cycle by replacing thymidine. 
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In order to asses the IMR-32 differentiation process, the expected 
morphological changes were observed every 24 h using a microscope by phase 
contrast (inverted microscope AXIOVERT, 200X phase contrast). 
 
            3.3.3 Real time PCR 
The real-time PCR (RT-PCR) is used to quantify the expression of the 
messenger of a given gene by amplification of specific sequences [31]. This 
technique allows to monitor the PCR reaction while it is still in progress and 
the data obtained at the end of the cycles can be used for a relative 
quantification of the amplified fragment. The levels of expression of the -
enolase, also known as neuron-specific enolase (NSE) or enolase 2 (ENO2), 
an highly expressed gene in neurons, were evaluated on days 0 -3 -7 [32]. The 
differentiation was induced with 1 mM dbcAMP and 2.5 M BrdU, as 
reported above. At the end of the stimulation, the cells were collected by 
trypsinization (trypsin-EDTA) and the obtained pellets were lysed using 1 ml 
of Trizol reagent, a mixture of phenol and guanidine isothiocyanate, specific 
for RNA extraction. The addition of chloroform, followed by centrifugation, 
separated the organic phase from the aqueous phase (RNA), which was treated 
with isopropanol to precipitate the RNA. The pellet was washed with 70% 
ethanol and the amount of RNA is determined spectrophotometrically at a 
wavelength of 260 e 280 nm. The RNA was reverse transcribed, using the 
SuperScriptTM III kit, in order to obtain the complementary DNA (cDNA). 
The amplification of the fragment of interest by RT-PCR was carried out using 
the SYBR Green PCR Master Mix, a fluorescent aromatic organic compound 
which during the amplification reaction intercalated into the double-stranded 
DNA that was formed at each cycle. The primers used were: for the NSE gene, 
forward (F) ACTTTGTCAGGGACTATCCTGTG; reverse (R) 
TCCCTACATTGGCTGTGAACT; for GAPDH (glyceraldehyde-3-phosphate 
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dehydrogenase) housekeeping gene, used as reference for normalization: (F) 
CACCAACTGCTTAGCACCCC; (R) TCTTCTGGGTGGCAGTGATG 
(designed using Primer3web). In the step of denaturing the Sybr Green is free 
in the reaction mixture, in the phase of "annealing" is positioned in a non-
specific minor groove of DNA, and finally in the phase of "elongation" and the 
fluorescence due to the presence of SYBR Green within the double-stranded 
amplicon was observed and was directly proportional to the amount of DNA 
present. The gene expression levels were calculated by the method of 2^-Ct 
[33]. 
 
            3.3.4 Preparation of S. nigra polyphenol extract 
The elderberry (Sambucus nigra), belonging to Caprifoliaceae family, is a 
perennial shrub, very vigorous, common in uncultivated areas of Italy, Europe, 
Asia, North Africa and North America. The elderberry plant grows 
ubiquitously, from sea level up to an altitude of 1200 m, mainly near the 
beaches, chestnut and oak. The experimental samples of S. nigra berries, 
provided from University of Basilicata, was carried out in the period of August 
to September. In order to preparate the S. nigra polyphenolic extract (SnPE), 
the berries were weighed (10 g) and homogenized with mortar and pestle [34]. 
Three subsequent extractions were carried out using acidified methanol, (90% 
absolute methanol, 10% 0.01 N HCl) at room temperature. After vigorous 
mixing, the samples were centrifuged at 11000xg (Biofuge Stratos Heraeus 
Instruments) for 10 min before removing the supernatant and frozen at -20 °C. 
For the assays, the methanolic extract was centrifuged at 11000xg for 10 min, 
transferred to microcentrifuge tubes (Eppendorf) and freeze-dried to remove 
the solvent of extraction and the volatile components, and than solubilized 
using 0.01 N HCl to the final concentration of 30 mg/ml (w/v) or H2O to a 
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final concentration of 1 mg/ml (w/v). 
 
            3.3.5 Polyphenol content and antioxidant activity 
The total polyphenol content was determined using the Folin-Ciocalteu’s 
method [35]. The samples were added to an aqueous solution containing 5% 
(v/v) of Folin-Ciocalteau’s reagent (FCR) with 2% (w/v) of Na2CO3. The FCR 
consists of a mixture of fosfotunstic acid and phosphomolybdic acid, which, in 
an alkaline environment, oxidize various substances containing the phenolic 
ring, by interacting with the hydroxyl groups and are reduced to tungsten 
oxides and molybdenum, emitting the blue color. The mixture containing the 
samples was incubated in the dark at room temperature for 2 h, before 
spectroscopically measurement at wavelength of 760 nm of the polyphenolic 
content, expressed as the micromolar concentration of equivalents of quercetin 
(M EqQ).  
The anthocyanin content was determined by pH shift method [36]. The 
samples were parallel incubated with two different solutions: 0.4 M KCl (pH 
1.0) and 0.4 M CH3COONa (pH 4.5). The absorbance of both solutions was 
measured spectrophotometrically to the respective wavelengths of 510 and 700 
nm. The total content of anthocyanins is expressed as micromolar of Cyanidin-
3-O-glucoside equivalent. 
For the evaluation of antioxidant activity, three different in vitro methods were 
employed. 
 FRAP assay 
The FRAP assay is a direct measurement of the reducing power of a solution 
and is based on the reduction of the iron of the complex Fe(III)-TPTZ (2,4,6-
tri(2-pyridyl)-s-triazine) in an acid environment (pH 3.6), by reducing 
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compounds that induce the formation of the Fe(II)-TPTZ. This complex 
exhibits a maximum absorption peak at 593 nm, measurable by 
spectrophotometry. The samples were added to 1 ml of FRAP reagent (20 mM 
FeCl3; TPTZ in 10 mM acetate buffer pH 4.6) and the absorbance was 
determined after 6 min of incubation at 37 °C. To quantify this value, a 
quercetin standard curve, one of the flavonoids largely present in elderberry, 
was determined and reported to the concentration of 1 mg/ml of dry weight. 
 ABTS assay 
The ABTS (2,2'-azinobis (3-etilbenzotiazolin-6-sulfonate) assay is an 
analytical method based on a spectrophotometric measurement to determine 
the antioxidant capacity of the sample. Under normal conditions, the oxidation 
of a colourless solution containing ABTS (2,2'-azinobis (3-etilbenzotiazolin-6-
sulfonate) generates the formation of the radical ABTS
•+
, with a characteristic 
purple colour. The addition of the samples to the ABTS
•+ 
solution (5.5 g/l in an 
aqueous solution pH 3.6 containing 2.4 mM H2O2) may induce the reduction 
of the radical, with decoloration of the reaction mixture, measured 
spectrophotometrically as decrease in absorbance at a certain time at a specific 
wavelength (660 nm). The concentration of ABTS
•+ 
in the reaction medium is 
expressed as a percentage of ABTS
•+ 
remaining (ABTS
•+
/Rem), calculated 
using the following expression: 
%ABTS
•+
Rem = ([ABTS
•+
]0-[ABTS
•+
]t=6min)/[ABTS
•+
]0 x Fd 
T = time required, determined in preliminary experiments, so that the reaction 
reaches the stationary state (6 min); Fd = dilution factor. 
 DPPH assay 
The antioxidant activity of the extract was also determined using the DPPH 
test performed after 30 min by measuring the decrease in absorbance (517 nm) 
of a methanolic solution of the stable radical DPPH
• 
(1,1-diphenyl-2-
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picrilidrazilic). The decrease of absorbance was directly proportional to the 
antioxidants properties of the sample. SnPE, previously diluted 1:10 by HCl, 
was added to a methanolic DPPH solution (100 M). The concentration of 
DPPH
•
 in the reaction medium is expressed as the percentage of DPPH
•
. 
Remaining (% DPPH
•
/Rem), was calculated by the following expression: 
%DPPH
•
Rem = ([DPPH
•
]0-[DPPH
•
]t=30min)/[DPPH
•
]0 x Fd 
T = time required, determined in preliminary experiments, so that the reaction 
reaches the stationary state (30 min); Fd = dilution factor. 
 
            3.3.6 Viability assay (MTT) 
Cell viability was measured by the MTT assay (bromide of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium) [37]. The oxidizing agent 
chromogen (MTT bromide), corresponding to a polycyclic system, contains a 
tetrazole ring which may be easily reduced by the mitochondrial enzyme 
succinate dehydrogenase, which is active only in living cells. The opening of 
tetrazole ring results in the formation of a compound chromogen nitrogen, said 
formazan, which forms insoluble crystals, impermeable to the cells. The cells 
were plated at a concentration of 30,000 cells in a volume of 500 l/well and 
were incubated for 24 h at 37 °C to allow the adhesion to the plate and the cell 
differentiation was induced by dbcAMP and BrdU, as described previously. At 
the end of differentiation, the cells were stimulated with increasing 
concentrations of SnPE (100, 250, 500, 1000 µg/ml, w/v) for 24 h, before 
induction of neurodegeneration obtained adding 20 µM Aβ peptide for 48 h or 
100 µM H2O2 for 18 h. In fact, in order to reproduce in vitro the pathologic 
condition, the damage was induced with two different agents: 1. the oxidizing 
agent H2O2, which is involved in the processes of the plaque formation; 2. the 
A peptide fragment 25-35. To induce the oligomerization, the peptide was 
prepared in PBS (0.5 mM) and incubated at 37 °C for 4 days (see Results 
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section). After incubation with SnPE (µg/ml, w/v) and oxiding agents, MTT 
solution was added to samples and incubated at 37 °C for 3 h. Subsequently, 
the cells were treated with 0.1% isopropanol and 4 mM HCl. The absorbance 
of the solution was determined by spectrophotometric reading at 595 nm. 
 
            3.3.7 Caspase assays 
For the measurement of the enzymatic activity of caspases-3, -8 and -9, the 
IMR-32 cells were plated at a density of 50,000 cells/ml medium. The cells 
were pre-incubated for 24 h with SnPE (500 g/ml, w/v) and subsequently 
with oxiding agent H2O2 (100 µM) for 5 h. After incubation, the cells were 
trypsinized, centrifuged at 11000xg for 5 min and washed in PBS. The pellet 
was resuspended in the following lysis buffer: 10 mM HEPES, pH 7.4; 2 mM 
EDTA; 0.1% CHAPS; 5 mM DTT; 1 mM PMSF; 10 g/ ml pepstatin A; 10 
μml-1 aprotinin; 20 g ml-1 leupeptin. Following the cell lysis, the samples 
were centrifuged at 11000xg for 5 min and kept on ice. The protein 
concentration was determined spectrophotometry according to [38], using the 
reagent "Bio-Rad Protein Assay", before assaying the enzymatic activity. The 
protein concentration of samples, expressed as g protein/l, was obtained by 
interpolation of the absorbance values in a calibration line of BSA, previously 
realized. For testing the enzymatic activity of caspases, cell extracts (10 μg) 
were added with a reaction buffer (100 mM HEPES; 20% v/v glycerol; 0.5 
mM EDTA; 5 mM DTT; pH 7.4) and the substrate were conjugated with the 
fluorochrome AFC (amino-4-trifluoromethyl coumarin). The substrates used 
were the following: for caspase-3, Z-DEVD-AFC peptide (carbobenzoxy-Asp-
Glu-Val-Asp-7-amino-4-trifluormethylcoumarin); for caspase-8, Ac-IETD 
AFC-peptide (Ac-Ile-Glu-Thr-Asp-AFC); for the caspase-9, LEHD-AFC 
peptide (Leu-Hys-Glu-Asp-7-amino-a- trifluormethylcoumarin). Upon 
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proteolytic cleavage of the substrates by the caspases, the free fluorochrome 
AFC was detected spectrophotometrically with excitation 395±20nm and 
emission and 530±20nm. To quantify enzymatic activities, an AFC standard 
curve was determined. Caspase-specific activities were calculated as nmol of 
AFC produced per min per μg proteins at 37 °C at saturating substrate 
concentrations (50 μM; with a Specific activity measured as mean 
fluorescence/time*1000/10744/μg protein). Fold increase in caspase activity 
was determined by direct comparison with the level of the respective controls. 
 
            3.3.8 Haechst assay 
To highlight the presence of the apoptotic bodies, the Hoechst dye, that binds 
to nucleic acids, highly akin to the bases adenine and thymine, was used. The 
IMR-32 cells were plated at a density of 30,000 cells/500 l medium. 
Following the treatment with SnPE (500 g/ml, w/v), the cells were incubated 
with 100 µM H2O2 for 5 h. Hoechst dye was added to a final concentration of 
1 g/ml and incubated in the dark for 10 min. After incubation, cells were 
observed at the fluorescence microscope (Zeiss Axiovert 200), counted in 
three different fields and expressed as percentage of apoptotic bodies 
compared to not apoptotic cells. 
 
            3.3.9 Reactive oxygen species (ROS) measurement 
To detect intracellular ROS production, we used a spectrofluorimetric method 
[39]. ROS production was assayed using DCFDA a not fluorescent compound 
that freely permeates the cells. DCFDA is hydrolyzed to dichlorofluorescein, 
which reacts with the intracellular peroxide and gives rise to DCF, detected 
spectrofluorimetrically. Cells were plated at a density of 60,000 cells/ml 
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medium and pre-incubated for 24 h with SnPE (500-1000 g/ml, w/v). 
Subsequently, 20 µM Aβ peptide (25-35 fragment) was added for 7 h, before 
the incubation of cells with of 20 μM DCFDA for 30 min. To determine the 
intracellular ROS, samples were spectofluorimetrically read with an excitation 
and emission setting of 495 and 530 nm, respectively. 
            3.3.10 Statistical analysis 
Data are presented as mean values ±s tandard error (SE) and the significance 
was measured by the use of Student’s test of at least five determinations. 
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3.4 Results and discussion 
 
            3.4.1 Neuronal differentiation of IMR-32 
To study the neurodegenerative disorders, we used an appropriate in vitro 
model that resembles a neuronal phenotype. The differentiation process 
involves several changes that occur during cell development and induce 
specialization; in particular, the differentiation of a neuroblastoma cell line 
involves many morphological and biochemical changes, including the axonal 
extensions. Therefore, when we induced the differentiation of the IMR-32 
cells with dbcAMP and BrdU, they showed a neuronal phenotype, through the 
expression of neuronal specific proteins. For this reason, the differentiated 
IMR-32 cells represented an adequate model for the study of the potential 
protective effect of SnPE from cytotoxicity induced by Aβ peptide and 
hydrgen peroxide in aging-related neurodegenerative conditions, as confirmed 
by other studies [40] [41]. 
As reported previously, the differentiation was induced treating the cells for 
one week with 1 mM dbcAMP and 2.5 µM BrdU. Examining the different 
stages of the process, several morphological changes were observed by the 
phase contrast microscope. As shown in Figure 3.5, after 7 days of treatment, 
the small cell processes, resembling neuritis, were highlighted and indicated 
by the yellow arrows. 
 
 
Figure 3.5. Differentiation of the IMR-32 cells. The morphological changes 
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and the presence of cellular extensions in IMR-32 cells treated with 1 mM 
dbcAMP and 2.5 μM BrdU after 3 and 7 days (inverted microscope 
AXIOVERT, 200X phase contrast) are indicated by the yellow arrows. 
 
During the differentiation process, we measured by RT-PCR the mRNA level 
of the NSE gene, highly expressed in neurons, after 3 and 7 days of treatment 
with differentiating agents [32]. As shown in Figure 3.6, the increased levels 
of NSE indicated that, after a week of stimulation, the IMR-32 cells were 
differentiated and therefore ready to be used for the stimulation with oxidizing 
agents.  
 
 
Figure 3.6. Level of mRNA expression of NSE of the IMR-32 cells at day 0 and 
after 3 and 7 days of treatment with 1 mM dbcAMP and 2.5 μM BrdU. The 
bars in the graphs indicate the SE; symbols indicate significance: *p<0.05 
and **p<0.01 vs Day 0. 
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            3.4.2 Phenolic content and antioxidant activity of S. nigra extract 
Considering the promising role of red berries in the protection from oxidative 
damage during the brain aging reported by several in vivo studies (Introduction 
section), we evaluated the polyphenol content and antioxidant activity of S. 
nigra, whose neuroprotective role has not yet been studied, comparing to those 
of other more common berries including blackberries, Rubus procerus, whose 
neuroprotective effect was already studied in literature [42].  
As reported in Table 3.1, the polyphenol content of SnPE, measured by Folin-
Ciocalteu’s assay, was of 72.14±2.93 M EqQ, higher compared to R. 
procerus (data not shown). We also measured the total anthocyanin content by 
pH shift method, which was of 52.19±5.72 M Cyanidin-3-O-glucoside 
equivalent, as showed in Table 3.1. In order to evaluate the antioxidant 
properties of SnPE, three different in vitro assays were performed, FRAP, 
ABTS and DPPH assys (Table 3.1). The antioxidant activity was higher in 
SnPE respect to R. procerus (data not shown), probably related to its higher 
polyphenols content. These data have provided a first indication on the 
potential protective role of SnPE in neurodegeneration respect to other berries.  
 
Table 3.1. Phenolic, anthocyanin contents and in vitro antioxidant activity of 
SnPE. 
Sample 
Total 
phenolic 
content
(a)
 
Anthocyanin 
content
(b)
 
FRAP assay
(c)
 
ABTS 
assay
(d)
 
DPPH 
assay
(e)
 
SnPE 72.14±2.93 52.19±5.72 293.66±8.99 29.66±0.48 8.87±0.27 
Results are expressed as M EqQ(a); M Cyanidin 3-O-glucoside 
equivalent
(b)
; M EqQ (c); quenching (%)(d); quenching (%)(e). All data are the 
means ± statistic error (SE) of at least five independent determinations. 
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            3.4.3 Evaluation of the protective effect of S. nigra extract in neuronal 
differentiation of IMR-32  
The potential neuroprotective effect of SnPE to reduce the toxicity induced by 
neurotoxic molecules was evaluated. The differentiated IMR-32 cells were 
pre-treated with increasing concentrations of extract (µg/ml w/v) for 24 h as 
reported in “Materials and Methods”. To reproduce in vitro the pathological 
condition, the neurotoxic damage was induced by treating the cells with two 
agents, Aβ peptide, involved in the formation of amyloid plaque, or H2O2, 
which plays a role in the neurodegenerative process. In particular, the 
oxidative stress is the primary event involved in the cellular injury which 
induces neuropathology conditions [43]. However, it is not only the primary 
cause, but it is also implicated in phathology mechanism that occurs after the 
deposition of amyloid plaque. In particular, a current hypothesis considers the 
possibility that proteins involved in protofibril formation are responsible for 
the oxidative stress, confirming the production of H2O2 induced by Aβ peptide 
[43]. Therefore, after the incubation with SnPE, the cells were treated with 20 
µM Aβ peptide for 48 h or 100 µM H2O2 for 18 h. As report in Figure 3.7, the 
mono-treatment with SnPE did not affect cell viability, determined by MTT 
assay, compared to untreated control, showing the absence of toxicity by 
SnPE. Furthermore, the pre-incubation with SnPE significantly protected 
against toxicity induced by Aβ in a dose dependent manner (Figure 3.7, A). 
Similarly, while the treatment with H2O2 induced a significant reduction in 
cell viability (67%), the pre-treatment with SnPE rescued the cytotoxicity of 
H2O2 of about 30% (Figure 3.7, B). These data demonstrated that SnPE was 
able to significantly reduce the citotoxicity induced by both Aβ peptide and 
H2O2, probably interfering with the deposition of the plaque and the oxidative 
stress.  
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Figure 3.7. Neuroprotective effect of SnPE against toxicity induced by Aβ 
peptide (A) and H2O2 (B). The differentiated IMR-32 cells were pre-incubated 
for 24 h with SnPE at the indicated concentrations (μg/ml, w/v). Subsequently, 
20 μM Aβ peptide (25-35 fragment) was added for 48 h in A and 100 M H2O2 
for 18 h in B. After incubation, the cell viability was determined by MTT 
assay, as described in “Materials and Methods” and the results are expressed 
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as % of cell viability. The bars in the graphs indicate SE; symbols indicate 
significance: #p<0.001 vs untreated, *p<0.05 vs CTRL+Aβ or CTRL+H2O2. 
 
It should also be considered the increased susceptibility to mitochondrial 
dysfunction and inflammatory insults induced by oxidative stress as major 
contributing factors involved in brain aging [44]. Indeed, age-related deficits 
in brain might be due to the injuries by oxidative damage, with a decrease of 
normal antioxidant defense mechanisms. For this reason, the cabability of 
SnPE to reduce the toxicity by H2O2 highlights its potential protective role 
from neurodegenerative mechanisms aging-related.  
 
            3.4.4 Protection of S. nigra extract from neuronal cell death 
We reasoned that the reduction of cell viability induced by the neurotoxic 
molecules could be attributable to the activation of an apoptosic process. In 
fact, as reported in the Introduction section, the neuronal damage by oxidizing 
agents induces the apoptotic process, the main mechanism of death activated 
in AD [16], characterized by chromatin condensation and nuclear 
fragmentation into the apoptotic bodies. In order to verify the ability of SnPE 
to reduce apoptosis, we firstly verified the presence of the apoptotic bodies 
after treatment with 100 µM H2O2 using the nuclear stain Hoechst. The Figure 
3.8 shows that H2O2 induced an increase of about 53% of apoptotic cells 
compared to untreated cells. The pre-treatment with SnPE (500 g/ml, w/v), 
significantly reduced the apoptotic bodies induced by H2O2 by 32%. 
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Figure 3.8. Apoptotic nuclei evidenced by Hoechst staining. Representative 
image from three independent experiments (Inverted microscope AXIOVERT, 
Fluorescence 200X). The numbers indicate the % of apoptotic bodies 
determined as reported in “Materials and Methods”. 
 
To confirm the protection from H2O2-induced apoptosis by SnPE, we 
evaluated additional apoptotic markers, measuring level of activation of the 
caspase-3, -8 and -9. In fact, these enzymes are essential to implement the 
apoptosis, through the proteolitic cleavage after an aspartic acid residue of 
proteins that induce the fragmentation of nuclear material and cell death. In 
particular, the capsases -8 and -9 belong to the "initiators" group of caspases 
which activate, by proteolitic cut, other caspases, called "effectors", such as 
caspase-3. During the execution phase of apoptosis a series of enzymatic 
caspase reactions occurs, leading to cell death cascade [45]. Several authors 
have documented the activities of caspases in the brain of AD patients [46].  
The Figure 3.9 shows how the treatment with H2O2 induced a significantly 
increase in the caspase-3 activity compared to untreated cells, while the 
pretreatment with the SnPE significantly reduced of about 4-fold the activation 
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of caspase-3. These data confirm that SnPE was able to reduce the activaction 
of apoptosis induced by H2O2. 
 
 
Figure 3.9. Protection of SnPE from apoptosis induced by H2O2. The 
differentiated IMR-32 cells were pre-incubated for 24 h with SnPE at 500 
μg/ml (w/v); subsequently, 100 μM H2O2 was added for 5 h. Caspase-3 activity 
was determined by enzymatic assay as described in “Materials and Methods” 
and was expressed as nmol AFC/min/μg total proteins. The bars in the graphs 
indicate SE; symbols indicate significance: #p<0.001 vs untreated; *p<0.05 
vs CTRL+H2O2. 
 
The effector caspase-3 can be activated by two different pathways: the death-
receptor pathway (extrinsic pathway) mediated by death receptors and 
caspase-8 and the mitochondrial pathway triggered by pro-apoptotic protein 
Bcl-2, with a formation of a complex called the "apoptosome", consisting of 
the cytochrome c, caspase 9 and APAF-1 (apoptotic protease activating factor 
1), involving oxidative stress and activation of caspase-9 [47]. Several 
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evidences report that the oxidative damage in the AD brain is possibly related 
to direct oxidizing effects of -amyloid [47], leading to the hypothesis that the 
mitochondrial pathway of apoptosis may be activated in AD. The role of 
mitochondrial dysfunction and oligomerization of A peptide result in high 
susceptibility to oxidative stress and translate into cell death. In AD brain has 
been observed the mitochondrial dysfunction and the stimulation of the 
mitochondrial pathway of apoptosis, by activation of caspase-9 [47]. 
Furthermore, several studies have also reported the involvement of the death 
receptor-mediated pathway in AD brain, suggesting that -amyloid may 
activate the initiator procaspase-8 by cross-linking death receptors such as 
Fas/TNF family, with a sequential activation of both caspase-8 and caspase-3 
[48]. An alternative explanation may suggest a cross-link between the two 
pathways. In fact, according to Figure 3.10, it has been proposed by [49] that 
the mitochondrial pathway is not the only way to trigger apoptosis in AD, 
suggesting that, following stimulation of the mitochondrial pathway, 
activation of caspase-9 may lead to processing of caspase-8 downstream of 
caspase-3. Therefore, it is plausible that -amyloid may initiate the activation 
of both apoptotic pathways, through either cross-linking of death receptors or 
through the generation of oxidative damage.  
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Figure 3.10. Proposed pathway of apoptotic activation by -amyloid in the 
AD brain [49]. 
 
Based on these hypotheses, we investigated if the treatment with SnPE could 
interfere with the two different pathways, measuring the activation levels of 
caspase-8 and -9. As reported in Figure 3.11, the pre-treatment with SnPE 
(500 g/ml, w/v) was able to significantly reduce the activation of both 
apoptotic pathways, inducing the decrease of caspase-8 (Figure 3.11, A) and 
caspase-9 (Figure 3.11, B) activities respect to treatment with H2O2. The 
decrease of caspase activities was of 30% and 22% for caspase-8 and -9, 
respectively. 
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Figure 3.11. Protection of SnPE from apoptosis induced by H2O2. The 
differentiated IMR-32 cells were pre-incubated for 24 h with SnPE at 500 
μg/ml (w/v); subsequently, 100 μM H2O2 was added for 5 h. Caspase-8 (A) 
and -9 (B) activity were determined by enzymatic assay as described in 
“Materials and Methods” and were expressed as nmol AFC/min/μg total 
proteins. The bars in the graphs indicate SE; symbols indicate significance: 
#p<0.001 vs untreated, *p<0.05 vs CTRL+H2O2. 
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3.4.5 Protection of S. nigra extract from oxidative stress 
The brain is overly susceptible to the ROS damages and in particular, the 
oxidative stress has been linked to neuronal cell death, activating intracellular 
signaling pathways. To demonstrate whether the protection of SnPE against 
the toxicity induced by oxidizing agents was related to its antioxidant capacity, 
we measured the levels of intracellular ROS by a fluorimetric assay, as 
reported in “Materials and Methods”. The Figure 3.12 shows that the 
treatment of the IMR-32 differentiated cells with Aβ peptide increases ROS by 
40% compared to untreated control. We observed a significant reduction of 
ROS levels, in a dose-dependent manner, when cells were pre-incubated with 
SnPE at concentrations of 500 and 1000 g/ml (w/v) compared to Aβ 
treatment (Figure 3.12). Furthermore, Figure 3.12 also shows that the mono-
treatment with SnPE increased slightly but significantly the intracellular ROS 
(about 10-20%), suggesting that this limited icrement is enough to induce an 
adaptive cellular response, resulting in an improvement of cellular antioxidant 
defenses and in protection from the oxidative stress induced by oxidizing 
agents. 
We concluded that the potential protective role of SnPE was mediated by the 
reduction of oxidative stress, implicated in aging-related degenerative 
diseases.  
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Figure 3.12. Reduction of intracellular ROS formation induced by A peptide 
after treatment with SnPE. The differentiated IMR-32 cells were pre-incubated 
for 24 h with SnPE at the indicated concentrations (μg/ml, w/v); subsequently, 
20 μM Aβ peptide (25-35 fragment) was added for 7 h. ROS intracellular 
levels were measured as reported in “Materials and Methods” and expressed 
as fluorescence of DCF (% control). The bars in the graphs indicate SE; 
symbols indicate significance: #p<0.001 and ##p<0.05 vs untreated ,*p<0.05 
and **p<0.005 vs CTRL+Aβ. 
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3.5 Conclusions 
The novelty of the present work resides in the demonstration, for the first time 
to our knoeledge, that SnPE exerts potential neuroprotective effects in an in 
vitro experimental model of neurodegeneration. We demostrated that the 
efficacy of SnPE to effectively protect neuronal cells from apoptosis induced 
by Aβ peptide and H2O2, is probably related to its ability to modulate the 
cellular antioxidant response. In fact, the oxidative stress plays an important 
role in neurodegenerative disordes, even if the absolute assumption whether 
this event is the cause or the consequence of the neurodegenerative process is 
still under discussion [43]. Our results suggest that the protective effect of 
SnPE against apoptosis induced by neuritoxic agents, is probably mediated by 
a reduction of oxidative stress, resulting in the decrease of ROS induced by Aβ 
peptide. Considering the in vitro and in vivo data referring to the capability of 
polyphenols to modulate the activity of specific antioxidant enzymes, we 
hypothesized the interaction with cellular antioxidant systems, such as GSH, 
and further studies are currently underway in this direction. Certainly, it will 
be necessary to study the molecular mechanisms triggered by SnPE to 
elucidate the molecular basis of its neuroprotective effects. Therefore, these 
results represent a first indication that SnPE can inspirate future clinical trials 
in order to confirm the preventive and/or therapeutic potential of this natural 
extract against neurodegenerative aging-related diseases and its therapeutic 
application alone or in combination with other neuroprotective compounds. 
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4.1 Introduction 
Studies on the anticancer role of natural compounds rapidly expanded in the 
last decade due to their possible applications in chemoprevention. This term 
refers to the ability of chemically synthesized or naturally occurring agents to 
block, invert or retard one or more mechanisms regulating cancer onset, 
development and progression [1]. Among phytochemicals, carotenoids, such 
as lycopene, -carotene, ATRA and their derivatives, show cancer-preventive 
activity reported in several in vitro and in vivo studies [2, 3]. Lycopene has 
been one of the most studied carotenoids. Epidemiological studies have linked 
the increased assumption of lycopene with a reduction of prostate and breast 
cancer risk. Also in vivo studies have shown that lycopene significantly 
reduces the prostate cancer incidence, through the ability to decrease androgen 
signaling, IGF-I expression, and basal inflammatory signals in a mouse model 
of prostate cancer [4]. However, there is still no clearly proven clinical 
evidences to support the use of lycopene in the prevention or treatment of 
prostate cancer, due to the limited number and quality of published 
randomized clinical trials. In particular, four randomized controlled clinical 
trials analyze the effects of lycopene on the secondary prevention of prostate 
cancer, showing contrasting results. In fact, only one of these studies reports 
that the administration of 4 mg of lycopene for one year reduced the incidence 
of prostate cancer, which was of 10% in the intervention and 30% in the 
control groups (Table 4.1). Other studies shows a significant reduction of 
serum prostate antigen specific (PSA) in patients with prostate hyperplasia 
after lycopene administration (Table 4.1) [4].  
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Table 4.1. Randomized controlled clinical trials analyzing the effects of 
lycopene on the prevention of prostate cancer [4]. 
 
 
 
Furthermore, some randomized controlled clinical trials emphasize the 
possible therapeutic effects of lycopene in prostate cancer, reporting the 
reduction of PSA serum levels and a significant decline in the rate of PSA 
increase from pre-therapy to post-therapy in patient with prostate cancer 
(Table 4.2) [4]. In a recent systematic review about dose-response meta-
analysis of observational studies, the authors conclude that only α-carotene 
and lycopene, not β-carotene, show an inverse association with the risk of 
prostate cancer, although these compounds are not able to reduce the risk in 
advanced forms of this cancer [5]. The other side of the coin is represented by 
an old but still emblematic interventional study, the ATBC (Alpha-Tocopherol 
Beta-Carotene) Cancer Prevention Study, where 29,133 male smokers, ages 
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50-69, were treated daily with -carotene (20 mg/day as all-trans--carotene), 
-tocopherol (50 mg/day as DL--tocopheryl acetate), both -carotene and -
tocopherol, or placebo. 
 
Table 4.2. Randomized controlled clinical trials analyzing the therapeutic 
effects of lycopene in prostate cancer [4]. 
 
 
 
The alarming results obtained after 5-8 years of follow-up, caused the 
immediate end of the trial since -carotene supplementation was associated 
with an increased risk of lung cancer development (Table 4.3) [6, 7]. 
Unexpected results were also obtained from the -Carotene and Retinol 
Efficacy Trial (CARET), where the combination of 30 mg -carotene and 
25,000 IU retinyl palmitate (vitamin A) daily in 18314 men and women at 
high risk of developing lung cancer was tested (Table 4.3). This study was 
terminated 21 months early because of clear evidence of no benefit and of 
possible harm. In fact, a 28% increase of lung cancers was measures with 17% 
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more deaths in the active intervention group [8]. Other long-term large 
randomized intervention trials were designed to test the efficacy of high doses 
of β-carotene (20–30 mg/day) in the prevention of cancer. The Linxian 
(Chinese) Cancer Prevention Study have shown that supplementation with β-
carotene, vitamin E and selenium led to a significant reduction in total 
mortality (9%), especially from total cancer (13%) and stomach cancer in 
particular (21%) (Table 4.3). The positive results of the Chinese study 
probably reflected the correction of a vitamin A deficiency in the study 
population. The Women’s Health Study indicated no statistically significant 
differences in incidence of cancer, although the treatment duration was short (a 
median treatment duration of 2.1 years and a median total follow-up of 4.1 
years) (Table 4.3). 
 
Table 4.3. -carotene supplementation trials [9]. 
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On the opposite, ATRA, derived from carotenoids as described in Chapter I, 
when administered as co-adjuvant in chemotherapy against acute 
promyelocytic leukemia (APL) resulted in absence of cytotoxicity and an 
increase of complete remission 93% to 100% in 5 years [10]. Considering 
these results, future research could focus on the potential application of ATRA 
as adjuvant in therapy of solid tumors. Moving from clinical to pre-clinical 
studies, numerous in vitro and in vivo investigations show the antiproliferative 
activity of carotenoids, e.g., as -carotene, -carotene, -cryptoxanthin, 
lycopene, lutein, zeaxanthin, violaxanthin, neoxanthain, canthaxanthin, 
astaxanthin, fucoxanthin, in different cancer models, such as colon, liver, 
breast, prostate, cervix and leukemia [9]. The in vitro studies on cancer cell 
lines reveal that carotenoids affect cell growth or cell death. In particular, 
carotenoids interfere with different aspects of cancer biology, such as hormone 
and growth factor signalling, regulatory mechanisms of cell cycle progression, 
cell differentiation, apoptosis and autophagy (Figure 4.1). 
 
 
Figure 4.1. Proposed mechanisms by which carotenoids suppress 
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carcinogenesis [9]. 
 Antiproliferative effect 
Dysregulation of cell cycle was one of the major hallmarks of cancer and 
carotenoids inhibit the growth of tumor cells by interfering at different levels 
with this process [11]. In human colon adenocarcinoma cells, -carotene 
induced cell cycle arrest in the G2/M phase by reducing the expression of 
cyclin A, one of the key regulator of the G2/M transition [11]. The 
mechanisms by which lycopene may reduce the risk of prostate cancer also 
involves the arrest of cell cycle progression in G0/G1 phase mediated by the 
decrease of cyclins D1 and E [11]. Moreover, lycopene exerts the anti-
proliferative effect in human colon cancer cells reducing the expression of 
cyclin D1, inhibiting the phosphorylation of pRB protein and increasing the 
expression of p27
KIP
 [11]. The cell cycle arrest induced by fucoxanthin in 
hepatocarcinoma cells is accompanied with an enhanced gap junctional 
intracellular communication linked to the increased expression of gap junction 
proteins, Cx43 and Cx32, and also by decreased activation of c-Jun N-terminal 
kinase (JNK) and extracelluar signal-regulated kinase (ERK) [11].  
Other examples exist in the literature indicating that the antiproliferative effect 
of carotenoids can be the result of differentiating processes. This is the case of 
ATRA which, as reported for the first time in 1980 [12], at micromolar 
concentrations induced granulocytic differentiation in HL-60 cell line, derived 
from a patient with APL. Although preliminary, our research group also 
showed that the radio-sensitizing effects of ATRA on human chronic 
lymphocytic leukemia and osteosarcoma cell lines induces cell differentiation 
[13]. 
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 Activation of apoptosis  
A well-studied process which can help to explain the anticancer effects of 
carotenoids in cancer cell lines is apoptosis. In vitro studies have shown that 
carotenoids, such as -carotene, neoxanthin, fucoxanthin, canthaxanthin and 
lutein, induce apoptosis in different malignant cell lines, such as human 
cervical cancer line, colon adenocarcinoma, mammary carcinoma cells [14]. 
These compounds trigger different mechanisms of caspase cascade activation 
by the interaction with both apoptotic pathways, the extrinsic and 
mitochondrial ones. -Carotene activates caspase-3, the executioner of the 
apoptotic process, necessary for the chromatin condensation and nuclei 
fragmentation [15]. Caspase-3 cascade is activated by carotenoids mainly 
through the interaction with the receptor complex on cell membrane, which 
induces caspase-8 activation, and also through a non-receptor signalling 
pathway, which induces intrinsic pathway through caspase-9 activation [15]. 
The involvement of mitochondrial pathway has been clearly demonstrated by 
-carotene with the alteration of the mitochondrial membrane potential and 
release of cytochrome c from mitochondria in different tumor cells [14]. Other 
carotenoids also induce apoptosis. As an example, in sarcoma 180 xenograft-
bearing mice, fucoxanthin interacts with the ROS-mediated Bcl-xL pathway 
and JAK/STAT (Janus kinase/signal transducer and activator of transcription) 
signaling pathway, through the down-regulation of EGFR, as reported by an in 
vivo study [16]. A different mechanism explaining the apoptosis induction by 
carotenoids refers to conformational changes of some membrane-associated 
“death” receptors, resulting in the activation of caspase 8. It has also been 
suggested that carotenoids could modulate the expression of the pro-apoptotic 
proteins, Bid, Bad, and Bax, in different experimental cell models such as 
leukemia (HL-60) and colon adenocarcinoma cell lines (HT-29) [14]. 
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 Carotenoids and autophagy in cancer cell lines 
Recent studies have reported the involvement of some carotenoids in the 
autophagic processes [17]. The ability to modulate the autophagy has been 
shown by not-retinoid precursors of carotenoids, such as astaxanthin [18] and 
fucoxanthin [19]. In particular, the treatment with flucoxanthin induces 
autophagy-dependent cytotoxic effects in human epithelial cervical cancer, 
HeLa cells, through the inhibition of Akt/mTOR signaling pathway [19]. 
Furthermore, ATRA induces autophagy through the interaction with the 
receptor mannose-6-phosphate cation-independent, a glycoprotein 
constitutively produced by the cells, which plays a key role in endocytosis and 
mediates the transport of proteins bound to the mannose-6-phosphate from the 
trans-Golgi to endosomes. Finally the induction of a cytotoxic autophagy, 
associated to a reduction of the cell viability by ATRA and -radiations 
treatment has been recently reported by [13], showing its radio-sensitizing 
effects on human chronic lymphocytic leukemia (HG3) and osteosarcoma cell 
lines (SAOs). A part from the above cited papers, the role of carotenoids in 
inducing autophagy represents a field only barely studied. Since this topic will 
be experimentally investigated in the present Chapter, it is useful to 
summarize the key events regulating the different forms of autophagy in 
cancer cells. The term autophagy means "eating oneself" and was coined by 
the Nobel Prize Christian de Duve in the '60s. It describes a catabolic process, 
activated by stress conditions aimed to maintain cellular integrity through the 
regeneration of metabolic precursors (amino acids, nucleic acids, fatty acids) 
and the elimination of sub-cellular detritus or damaged organelles 
(mitochondria, endoplasmic reticulum, peroxisomes), or pathogenic organisms 
(viruses, bacteria) by the lysosomal enzymes. This process is essential for 
tissue homeostasis and for regulation of differentiation and development of 
multicellular organisms and can be divided into several steps, governed by 
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about 30 genes (autophagy related gene, ATG), first discovered in yeast and 
then in higher vertebrates [20]. The importance of this process in cell biology 
is confirmed by the assignment of Nobel prize for medicine and physiology in 
2016 to professor Oshumi who studied autophagy in yeast following nutrient 
starvation [21]. The lack of nutrients is a powerful physiological regulator of 
autophagy and this signal converges on the mTOR protein (mammalian target 
of rapamycin), located in a macromolecular complex called mTORC1. 
Therefore, the depletion of energy (a decrease of ATP and an increase of 
AMP) activate AMPK (adenosine 5'-monophosphate-activated protein kinase) 
[22]. This kinase binds and phosphorylates UNC-51 like kinase 1 (ULK1), 
which leads the direct activation of ULK1 by AMPK bypassing mTOR-
inhibition. The ULK1 complex is a crucial factor in the early stages of 
autophagy (Figure 4.2). In fact, ULK1 and Beclin-1 molecular complex 
(Beclin-1 interacting complex), induce the initial stage of autophagy, involved 
in the nucleation of autophagosomes, which are vesicles of a phospholipid 
bilayer surrounding the cytoplasmic material. The autophagosome merge with 
lysosomes to create the microenvironment necessary for the degradation and 
recycling of their content (Figure 4.2). 
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Figure 4.2. Autophagy induction and regulation mechanisms[23]. 
 
Once the membrane formation initiated, follows its extension, which requires 
two ubiquitin-like conjugation systems: ATG5-ATG12 and LC3-ATG8 
(microtubule-associated protein light chain 3). The LC3 system is present in 
two forms: the inactive, free cytosolic form (LC3-I) and the active form 
conjugated to phosphatidylethanolamine (LC3-II). The function of ATG5-
ATG-12 and LC3 systems is the complexation to autophagosome membrane 
extension, sustaining their growth until the formation of mature vesicle 
(autophagosome mature) and represents the specific signal, need to address the 
vesicle to the process of fusion with lysosomes and finally to the degradation 
of the cargo [24] (Figure 4.2).  
As mentioned above, the autophagic process is involved in the regulation of 
cellular homeostasis in response to environmental stimuli. However, new and 
more complex roles have been attributed to autophagy in pathological 
conditions, such as cancer. In fact, it should be underlined the dual and 
contrasting function of autophagic activation in oncogenesis: in early stage of 
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tumorigenesis, its activation can initially prevent tumor formation, protecting 
cells; however, in the late stages of carcinogenesis, autophagy may sustain 
cancer growth by inducing drug resistance. In particular, four functionally 
different forms of autophagy can be induced by drugs treatment, defined as 
protective, not protective, cytotoxic or cytostatic autophagy [25] (Table 4.4). 
The protective form of autophagy can be activated by chemotherapy and 
confers resistance to treatments, protecting cancer cells. To detect this form, 
pharmacological inhibitors of autophagy, such as chloroquine (Figure 4.2) 
(inhibition of the proton pump responsible for lysosomal acidification) are 
experimentally used. After inhibition of the protective autophagy, it is possible 
to observe an increase of the cytotoxic effects of treatment, generally resulting 
in apoptotic cell death. 
 
Table 4.4. Characteristics of the four functional forms of autophagy [25]. 
 
 
 
On the opposite, when the “not protective” form is blocked, the cell sensitivity 
to therapy is not altered, as in the previous case (Table 4.4). The cytostatic 
form is related to cell growth arrest, while the cytotoxic autophagy is 
associated with a reduction of cell viability (Table 4.4). 
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4.2 Aims of the Chapter 
The aim of this section of the thesis is the evaluation of the potential biological 
effects of a carotenoid extract obtained from Cucurbita moschata in cancer 
cell lines. The specific objectives are as follows:  
-To develop a cellular delivery method (nanoemulsion) to vehicle the 
carotenoid extract; 
-To evaluate the biological effect of carotenoid extract on different malignant 
cell lines, chosen for their different resistance to anticancer therapies (drugs 
and radiations); 
-To study the mechanism of action triggered by carotenoids extract by the 
evaluation of: 1. the cellular phenotype; 2. the biochemical regulation of cell 
process involved in these in vitro models. 
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4.3  Materials and Methods 
 
4.3.1 Chemicals 
Phosphate buffer saline (PBS) tablets (Life Technologies); Dulbecco's 
Modified Eagle Medium (DMEM) (Life Technologies); Fetal bovine serum 
(FBS) (HyClone); Glutamine (Life Technologies); Penicillin/streptomycin 
solution (Life Technologies); Not-essential amino acids (EuroClone, Milan, 
Italy); Tetrahydrofuran (THF); Butylated hydroxytoluene (BHT); Tween 80; 
Hexane; Ethanol; Trypan Blue (Sigma-Aldrich); Chloroquine (Enzo Life 
Sciences); CyQuant Detection Kit (Life Technologies); Cell-ID Autophagy 
Detection Kit (Enzo Life Sciences); Hoechst; DMEM without phenol red (Life 
Technologies,); -carotene (Sigma-Aldrich); Quercetin (Sigma-Aldrich); 
ATRA (all-trans retinoic acid); MES (2-(N-morpholino)ethanesulfonic acid); 
Anti-LC3 I/II (Cell Signalling); Anti-pAMPK (Thr
172
) (Cell Signalling); Anti-
α-tubulin (Sigma-Aldrich); Horseradish peroxidase-linked secondary antibody 
(GE Healthcare). All other chemicals used were of research highest purity 
grade. 
 
4.3.2 Sample preparation 
Neapolitan pumpkin, Cucurbita moschata, was provided from Farris 
Company, located in Foggia, Italy. The rind was removed and the peeled flesh 
was chopped into small pieces and dehydrated to constant weight at 60 °C in 
the vacuum-drying oven. Simultaneously, seeds were recovered and 
dehydrated in the vacuum-drying oven. After grinding, aliquots (25 g each) of 
flesh matrix, milled seeds (co-matrix) or of a blend of oven-dried matrix plus 
co-matrix (1:1, w/w) were extracted by SC-CO2, carried out at ISPA-CNR 
(Istituto di Scienze delle Produzioni Alimentari, Consiglio Nazionale delle 
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Ricerche), Lecce (Italy) as reported by [26]. The oils extracted by S-CO2 from 
the pumpkin flesh (matrix), milled seeds (co-matrix) and matrix/co-matrix 
(1:1, w/w) blend were analyzed by HPLC method at ISPA-CNR as reported 
[26]. Briefly, each oil sample (0.1 g) was dissolved in 1 ml of ethyl acetate, 
filtered through a 0.45 m syringe filter and immediately analyzed by HPLC 
without extraction and saponification. Quali-quantitative analyses of tocols 
and carotenoids were carried out using an Agilent 1100 Series HPLC system 
and were separated using a reverse-phase C30 column (5 m, 250 x 4.6 mm) 
with mobile phases consisting of methanol (A), 0.2% ammoniumacetate 
aqueous solution/methanol (20/80, v/v) (B) and methyl-t-butyl ether (C). The 
isocratic elution was as follows: 0 min, 95% A and 5% B; 0–12 min, 80% A, 
5% B and 15% C; 12–42 min, 30% A, 5% B and 65% C; 42–60 min, 30% A, 
5% B and 65% C; 60–62 min, 95% A, and 5% B. The column was re-
equilibrated for 10 min between runs. The flow rate was 1.0 ml/min and the 
column temperature was maintained at 25 °C. The injection volume was 10 l. 
Absorbance was measured by diode array at wavelengths of 475 nm for 
carotenoids and 290 nm for vitamin E. 
 
4.3.3 Preparation and analysis of nanoemulsions  from the carotenoid 
extract 
Oil-in-water (O/W) nanoemulsions containing carotenoid extract (CEN, 
carotenoid extract nanoemulsion) were prepared using a high-energy 
emulsification-evaporation technique, according to [27]. Briefly, the 
carotenoid extract was mixed in a 1:3 ratio (v/v) with tetrahydrofuran (THF) 
containing 0.0025% (v/w) butylated hydroxytoluene (BHT) and was added to 
an aqueous solution containing 0.3% Tween 80. Organic/aqueous phase 
volume ratio was 1:9. Similar procedure was followed for a standard 
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preparation of -carotene nanoemulsions (CN) (2% w/v in THF/BHT). The 
emulsions were homogenized using an Ultra-Turrax homogenizer (T8, Ika-
Werke, Germany) performing three cycles at 10000xg for 2 min. To reduce 
particle size, samples were subjected to sonication (Sonicator, ultrasonic 
processor XL, Misonic), according to [28], performing three cycles of 30 sec 
each. The solvent was removed from nanoemulsion under nitrogen vapors. 
Afterwards, samples were sterilized throughout a 0.2 m membrane. Emulsion 
control (CTRL) was prepared replacing carotenoid extract with the same 
quantity of THF in the aqueous solution.  
The preparations were characterized by: 
 Granulometric analysis  
Particle size (expressed as “derived diameter”) distributions were measured by 
LALLS (Low Angle Laser Light Scattering Technique). A MasterSizer Model 
S equipped with Malvern Application Software (Malvern Instruments, 
Malvern, UK) and fitted with a Small Volume Presentation Unit (MS1) was 
employed. The refractive index of samples and dispersants was measured 
using an Optech model RM Abbe refractometer at a temperature of 20 °C and 
white light [29]. 
 -Carotene concentration 
The concentration of carotenoids incorporated into nanoemulsion was 
determined by extracting 0.5 ml of nanoemulsion with 6 ml of hexane and 
absolute ethanol (2:1 v/v) according to Yuan et al. [30]. Samples were 
vortexed for 1 min, centrifuged at 1200xg and the hexane phase containing 
carotenoids was collected. The extraction was repeated three times. An aliquot 
was lyophilized for the quantitative determination.  
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4.3.4 Cell culture  
Two different malignant cell lines, Caco-2 and SAOs, derived from human 
colorectal adenocarcinoma and osteosarcoma, respectively, were employed. 
For the proliferation assays, the cells were maintained at low confluence in 
polystyrene Petri plates (Corning, Milan) treated to ensure an optimal 
adhesion. The culture medium used was DMEM enriched to 10% FBS, 1% L-
glutamine, 1% not-essential amino acids, and 1% solution 
penicillin/streptomycin. The cells were maintained at a density of 1x10
6
/ml, at 
a temperature of 37 °C, with a percentage of 100% humidity and 5% CO2. The 
culture medium and the stimulation with CTRL and CEN were renewed every 
48 h to ensure a constant supply of nutrients. Cell count was performed using 
Trypan blue, a dye able to selectively stain the dead cells permeating through 
the damaged cytoplasmic membranes. Caco-2 and SAOs cells were incubated 
at different times (96, 120, 144, 168 h and 48, 72, 120, 168 h, respectively) 
with CEN, at a concentration of 400 g/ml and 200 g/ml (w/v) of carotenoid 
extract, respectively, and with their respective CTRL. At the end of 
incubation, cell suspension was stained with Trypan Blue solution (0.04% 
v/v), diluted in the culture medium (1:1). The cell count was performed using 
EVE Automatic cell counter (NanoEnTek) and expressed as cell number/ml. 
Furthermore, a software (EveTM PC Software, NanoEnTek) provided the 
number of living and dead cells also considering the presence of aggregates or 
cellular debris. 
 
4.3.5 CyQuant viability assay 
CyQuant viability assay was performed to quantify the number of living cells 
using a nuclear dye that selectively binds to nucleic acids, emitting 
fluorescence. Cells, Caco-2 and SAOs, were treated for 168 h with CEN, at a 
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concentration of 400 g/ml and 200 g/ml (w/v), respectively, and with their 
respective CTRL. In particular, to discriminate between protective or not 
protective autophagy, cells were added with 20 M chloroquine in the last 48 
h of incubation. At the end of incubation, CyQuant mixture, containing the 
nuclear dye (CyQuant nuclear stain) and the suppressor of basal fluorescence 
(Background suppressor) were added to the culture medium and incubated for 
1 h at 37 °C. Fluorescence was measured at the excitation wavelength of 485 
nm and 530 nm emission and the results were expressed as percentage of 
fluorescence of the untreated control using a microplate reader (Synergy HT- 
BioTek, Milan).  
 
4.3.6 CytoID Autophagy assay  
Autophagy was monitored by using the Cell-ID Autophagy Detection Kit 
which includes a dye used as a selective marker of pre-autophagosomes, 
autophagosomes and autolysosomes. Caco-2 and SAOs cells were incubated 
for 168 h with CEN, at a concentration of 400 g/ml and 200 g/ml (w/v), 
respectively, and with their CTRL in the presence of 20 M chloroquine, as 
positive control. After incubation, cells were washed with assay buffer and 
incubated with the autophagy detection marker and the nuclear dye, Hoechst, 
diluted 1:500 in DMEM without phenol red, supplemented with 5% FBS for 
30 min. Cells were rinsed with assay buffer to eliminate the excess of dye and 
the fluorescence was determined by a double reading: the fluorophore of 
autophagosomes was detected at the wavelengths of 495 nm (excitation) and 
519 nm (emission), as for FITC (fluorescein isothiocyanate); the Hoechst 
fluorochrome (which stains nuclei) was detected at the wavelengths of 
358/461 nm, such as for DAPI (4',6-diamidin-2-phenylindole). To quantify the 
autophagic vacuoles, we calculated the ratio of FITC/DAPI fluorescence using 
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a microplate reader (Synergy HT- BioTek). The autophagic vesicles were 
observed and photographed using a fluorescence microscopy (Zeiss Axiovert 
200, Milan, Italy) and by confocal microscopy (Leica SP8), using the filters 
for FITC and DAPI. 
 
4.3.7 SDS-PAGE and immunoblotting 
Caco-2 and SAOs cells were incubated with CEN, at a concentration of 400 
g/ml and 200 g/ml (w/v), respectively, and with their respective CTRL, in 
the presence of 2 M ATRA, as positive control. At the end of incubation, 
cells were lysed using a lysis buffer containing protease and phosphatase 
inhibitors, as reported by [31]. After the measurement of protein concentration 
[32], the total protein lysates were loaded on a 4%–12% pre-cast gel (Novex 
Bis-Tris pre-cast gel 4%–12%; Life Technologies, Milan) using MES (2-(N-
morpholino) ethanesulfonic acid) buffer and immunoblots were performed 
following standard procedures. To detect the presence of LC3-II, a specific 
antibody was used to recognize the two isoforms present (LC3-I/II), 
characterized by different electrophoretic mobility. To detect activated kinase 
AMPK, a primary antibody against pAMPK (Thr172) was used. To normalize 
and quantitate the expression levels of these proteins, an anti-α-tubulin 
antibody was employed. PVDF membranes were finally incubated with 
horseradish peroxidase-linked secondary antibody raised against mouse or 
rabbit and immunoblots developed using the ECL Plus Western Blotting 
Detection System Kit (GE Healthcare). Band intensities were quantified 
measuring optical density on a Gel Doc 2000 Apparatus (Bio-Rad 
Laboratories, Milan, Italy) and Multi-Analyst Software (Bio-Rad 
Laboratories,). 
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4.3.8 Chemiluminescence assay 
ATP measurement was performed using ATP detention kit (Lonza, Italy) 
according to [33], by a chemiluminescence assay. In presence of ATP, the 
luciferase converts the luciferin into the oxidised form, oxyluciferin, emitting 
a chemiluminescence light, linearly dependent on ATP concentration:   
ATP + D-luciferin + O2 -> oxyluciferin + AMP + PPi + LIGHT 
Caco-2 and SAOs cells were incubated for 48 h and 24 h, respectively, with 
CEN, at a concentration of 400 g/ml and 200 g/ml (w/v), respectively, and 
with their respective CTRL. As positive controls, 50 M quercetin and 2 M 
ATRA were used for Caco-2 and SAOs, respectively. At the end of 
incubation, cells were treated with ATP detection kit and chemiluminescence 
was measured after 10 min of incubation using a microplate reader (Synergy 
HT- BioTek).  
 
4.3.9 Statistical analysis 
Data are presented as mean values±standard deviation (SD) and the 
significance was measured by the use of Student’s test of at least five 
determinations. 
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4.4 Results and Discussion 
4.4.1 Pumpkin S-CO2 extract composition 
The oils extracted by S-CO2 from the oven-dried pumpkin flesh (matrix), 
milled pumpkin seeds (co-matrix) and matrix/co-matrix (1:1, w/w) blend, were 
assayed for their total vitamin E and total carotenoid contents, including the 
vitamin E homologues (i.e., tocopherol and tocotrienol forms) and carotenoid 
distribution profiles. The results obtained from ISPA-CNR showed that the oil 
extracted from the matrix/co-matrix mixture had a biochemical profile in-
between the seed and flesh oils (Table 4.5).  
 
Table 4.5. Vitamin E forms composition and carotenoid profile of oils 
extracted by SC-CO2 [26]. 
 
Data, expressed on a percentage basis and as mg/100 g oil, are the mean  
± SD  of three independent replicates (n = 3). 
nd, not detectable. 
Vitamin E form abbreviations are as follows: -T3, -tocotrienol; -T3, 
-tocotrienol;  -T,  -tocopherol;  -T,  -tocopherol. 
 
 
In fact, the extracts obtained from the matrix/co-matrix mix were enriched in 
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-T3 and -T3 beside tocopherols, compared to that obtained from the matrix 
alone, while -tocotrienol (-T3) was the constituent mostly contributing 
(>82%) to total vitamin E content of pumpkin seed oil extracted (Table 4.5). 
As expected, total carotenoid amount in the seed oil was extremely low (13.6 
mg/100 g). -Carotene represented the main carotenoid of pumpkin flesh oil, 
followed by  -carotene  -cryptoxanthin according to Seo et al. [34]. 
 
4.4.2 Nanoemulsions preparation and characherization 
To study the biological effect of carotenoid extract, an appropriate cellular 
delivery method was developed in order to increase the cellular uptake due to 
poor solubility of the lipophilic extract in the aqueous media. For this reason, 
we employed different protocols, including the incorporation in serum bovine 
serum, the preparation of lipid micelles and finally the use of oil-in-water 
(o/w) nanoemulsions. Considering the high sensitivity to light, oxygen and 
heat of the extract, we employed a formulation strategy that allowed to reduce 
the manipulations during the preparation steps and a better preservation over 
time. The incorporation of carotenoids in lipid micelles highlighted some 
critical points, relating to reproducibility and stability of the preparations (data 
not shown). On the other hand, the preparation of nanoemulsions improved 
carotenoids dispersion in aqueous media and facilitated their cellular uptake. 
For the production of o/w nanoemulsions, we used an emulsifier (Figure 4.3), 
able to reduce the interfacial tension between the oil and water phase, 
employing several protocols involving the use of various emulsifiers, which 
provided different results relating to the particle size. In particular, Tweens 80 
allowed the most stable preparation and the lowest particle size respect to 
other emulsifier used, such as Tween 20, carbomer and lecithin. The 
distribution of the particle size diameter of emulsions was determined by Laser 
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Light Scattering Technique. We obtained a greater reduction of particle size, 
by the use of ultrasonic technique in addition to the standard protocol of high-
energy homogenization method (Figure 4.3).  
 
 
Figure 4.3. Preparation of oil-in-water (o/w) nanoemulsions. 
 
As shown in Figure 4.4, the particle diameter of CTRL, CN (A) and CEN 
(B) was in the nanometer range. To verify the carotenoid retention in 
nanoemulsions, we extracted carotenoids from the nanoemulsion to measure 
the yield, which was of about 12 mg/ml (w/v) in each preparation, showing the 
high reproducibility of this methods. Furthermore, during the nanoemulsion 
preparation, we tested several formulations, changing specific parameters 
(e.g., amounts of carotenoids or emulsifier, the ratio carotenoids/emulsifier). 
We obtained an optimal incorporation of carotenoids in nanoparticles 
employing a concentration of 2% -carotene (w/v in THF/BHT) and 0.3% 
Tween 80.  
To our knowledge, this method of delivery of carotenoids extract is a novelty 
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in the studies of biological effect of these class of molecules employing cell 
culture models. 
 
 
Figure 4.4. Volume distribution % in graphical form of -carotene 
nanoemulsion (A) and carotenoid extract nanoemulsion (B). Particle size, 
expressed as “derived diameter” distributions, was measured by LALLS (Low 
Angle Laser Light Scattering Technique) as described in “Materials and 
Methods”. The refractive index of samples and dispersants was measured 
using an Optech model RM Abbe refractometer at a temperature of 20 °C and 
white light. 
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4.4.3 Antiproliferative effect of CEN on Caco-2 and SAOs cell lines 
We evaluated the effects of the three oils extracted and we decided to employ 
for our study the preparation from pulp/seed (1:1, w/w) blend, which showed 
the higher biological activity (data not shown).  
We firstly tested CEN biological activity on several malignant cell lines, 
chosen for their different sensitivity to anticancer drugs (BH-3 mimetics, death 
ligands) [35, 36] or radiations [13]. In a preliminary screening, we tested the 
effect of CEN on the proliferation of cell lines derived from solid tumors of 
epithelial (Caco-2) [37], or mesenchymal origin (SAOs, U2Os, HepG2) [38], 
or derived from chronic lymphocytic leukemia cell line (HG3). However, 
since HG3 and HepG2 did not produce reproducible results, probably due to 
their sensitivity to nanoemulsions reagents, we employed Caco-2 and SAOs 
cell lines as a suitable model since their low toxicity to CTRL nanoemulsions 
preparation. In particular, Caco-2, derived from a human colorectal 
adenocarcinoma is able to simulate the carotenoids path in vivo after oral 
absorption. In fact, in vivo, after oral ingestion, carotenoids are solubilized in 
mixed micelles, formed by lipids emulsified with pancreatic juice. Dietary 
carotenoids solubilized in mixed micelles are taken up into the intestinal 
epithelia for the incorporation into chylomicrons. The transfer of carotenoids 
to intestinal cells are mediated by simple diffusion dependent on the 
concentration gradient across the cellular membrane and/or facilitated 
diffusion through scavenger receptors. Previous work indicated that when 
carotenoids solubilized in mixed micelles were incubated with human 
intestinal Caco-2 cells, the absorption is simulated and a positive relationship 
was found between carotenoids hydrophobicity and the amount taken up by 
the cells [39]. In addition, Caco-2 cells represent an ideal cellular model for 
their ability to spontaneously differentiate in vitro upon reaching the 
confluence or following the exposure with differentiating agents derived from 
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diet such as butyric acid and carotenoids [37]. Similarly, SAOs cell line, 
derived from a human osteosarcoma, is able to differentiate in vitro following 
treatment with ATRA, the physiologic derivative of -carotene [38]. SAOs 
also show high resistance to apoptotic stimuli and -radiation [13, 35, 36]. 
To evaluate the effect of carotenoid extract on cellular proliferation, we firstly 
performed a dose-response experiment to determine and select the ideal 
concentration of CEN, which corresponds to the lower toxic effect of the 
vehicle (CTRL). Therefore, Caco-2 and SAOs cells were incubated at different 
times with CEN, employing the minimum active concentration of 400 g/ml 
and 200 g/ml of carotenoid extract (w/v), respectively. Nanoemulsions 
without carotenoids (CTRL) were employed as a control, using the same 
volumes applied for CEN. The effect on cell viability (Trypan blue method) is 
reported in Figure 4.5 and shows how incubation of Caco-2 with CEN 
significantly slowed cell proliferation at 96, 120, 144, 168 h of incubation, 
compared to control experimental points (untreated and CTRL) (Figure 4.5, 
A). Similarly effect was measured at 120 and 168 h for SAOs cells after CEN 
treatment compared to controls, as reported in Figure 4.5, B. It is interesting 
to note that the antiproliferative effect of CEN cannot be attribute solely to the 
presence of β-carotene, since when we assayed this compound at the same 
concentration present in CEN, we did not measure any significant effect on 
cell growth; it behaved as CTRL (data not shown). 
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Figure 4.5. Cell growth of Caco-2 and SAOs cell lines. (A) Caco-2 cells were 
mantained at 37 °C at a density of 3x10
4
/ml of DMEM and treated with CTRL 
and CEN (400 g/ml, w/v) every 48 h. Cell count was performed at all times 
indicated. (B) SAOs cells were mantained at 37 °C at a density of 6.7x10
4
/ml 
of DMEM and treated with CTRL and CEN (200 g/ml, w/v) every 48 h. Cell 
count was performed at the indicated times. Cell viability was evaluated using 
Trypan blue method as described in “Materials and Methods”. The bars in the 
graphs indicate SD; symbols indicate signiﬁcance: *p<0.05 and **p<0.01 
respect to CTRL (nanoemulsions prepared in the absence of carotenoid 
extract). 
 
The decreased rate of cell growth was also confirmed by CyQuant viability 
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assay, a methoth which uses a nuclear stain that selectively binds to nucleic 
acids, especially to DNA, emitting fluorescence directly proportional to the 
cell number. The representative micrographs of the cell nuclei performed by 
fluorescence microscopy, after CyQuant assay, report the slowdown of Caco-2 
(Figure 4.6, C) and SAOs (Figure 4.6, F) cell proliferation at 168 h from 
treatment with CEN, compared to CTRL (Figure 4.6, B and E) and untreated 
points (Figure 4.6, A and D). 
 
  
Figure 4.6. Micrographs of cell nuclei of Caco-2 (A, B, C) and SAOs (D, E, 
F) after the indicated treatments (optical microscope Axiovert 200 Zeiss; 
FITC 200X magnification). Representative images of untreated Caco-2 cells 
(A), treated with CTRL (B) and CEN (C). Representative images of untreated 
SAOs cells (D), treated with CTRL (E) and CEN (F). 
 
The quantitative measurement of this effect is reported in Figure 4.7, 
confirming that the treatment with CEN significantly reduced the cell 
proliferation, expressed as percentage of fluorescence, in Caco-2 (Figure 4.7, 
A) and SAOs (Figure 4.7, B). 
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Figure 4.7. Cell viability of Caco-2 (A) and SAOs (B) cell lines treated with 
CTRL and CEN. Cells were mantained at 37 °C at a density of 2.5x10
3
/ml of 
DMEM and treated with CTRL and CEN (400 g/ml for Caco-2 and 200 
g/ml for SAOs) every 48 h. The CyQuant viability assay was performed after 
168 h of treatment, as described in “Materials and Methods”. The bars in the 
graphs indicate SD; symbols indicate signiﬁcance: *p<0.05 and **p<0.01 
respect to CTRL (nanoemulsions prepared in the absence of carotenoid 
extract). 
 
4.4.4 Activation of autophagy by carotenoid extract 
We hypothesized that the reduced cell proliferation in the absence of any clear 
sign of cell death induced by CEN could be related to the activation of an 
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autophagic process. This hypothesis also emerged from the microscopical 
observation of CEN-treated cells which evidenced the presence of intracellular 
vacuoles. To verify this hypothesis, we used multiple assays to detect 
autophagy and to avoid false-positive results. 
The autophagosome were specifically stained with Cyto-ID Green autophagy 
dye, a fluorescent reagent, after Caco-2 and SAOs cell treatment with CEN, at 
a concentration of 400 g/ml and 200 g/ml (w/v), respectively, and with their 
respective CTRL. As positive control, we employed chloroquine, a reagent 
well known due for its ability to block autophagic flux and cause an increase 
in autophagosome accumulation in the cytoplasm [40]. As reported in Figure 
4.8, an increse of autophagosomes after treatment with CEN was clearly 
visible with fluorescence microscopy (green fluorecence), in Caco-2 (Figure 
4.8, C panel 1; 4.8, A panel 2) and SAOs cell lines (Figure 4.8, G panel 1; 
4.8, B panel 2) respect to untreated (Figure 4.8, A and E, respectively) and 
CTRL (Figure 4.8, B and F, respectively). The chloroquine treated Caco-2 
and SAOs cells are reported in Figure 4.8, D and H, respectively. 
 
1) 
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2) 
 
Figure 4.8. Micrographs of autophagic vacuoles in Caco-2 and SAOs. The 
photographs were taken with a fluorescence invertoscope (Axiovert 200 Zeiss) 
and a confocal microscope (LEICA SP8) with a total magnification of 200X 
(panel 1) and 400X (panel 2) to highlight the autophagic vacuoles (green) and 
cell nuclei (blue). Representative images of cells Caco-2 (A), treated with 
CTRL (B) and CEN (C panel 1; A panel 2) and chloroquine (D). 
Representative images of cells SAOs (E), treated with CTRL (F) and CEN (G 
panel 1; B panel 2) and chloroquine (H). 
 
The result of the CytoID autophagy assay was quantified as described in 
Methods section by measuring the fluorescence of autophagosomes (FITC) 
and by normalizing it respect to the fluorescence emitted by cell nuclei 
(DAPI). Data in Figure 4.9 report the activation of autophagy by CEN, 
through a significant increase of autophagic vacuoles, expressed as ratio 
FITC/DAPI, in Caco-2 (Figure 4.9, A) and SAOs (Figure 4.9, B), respect to 
controls.  
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Figure 4.9. Autopahgosome quantification with Cyto-ID in Caco-2 (A) and 
SAOs (B). The cells were mantained at 37 °C at a density of 2.5x10
3
/ml of 
DMEM and treated with CTRL and CEN (400 g/ml for Caco-2 and 200 
g/ml for SAOs) every 48 h. Cyto ID authophagy assay was performed as 
reported in “Materials and Methods”. The bars in the graphs indicate SD; 
symbols indicate signiﬁcance: **p<0.01 respect to CTRL (nanoemulsions 
prepared in the absence of carotenoid extract), +p<0.05 and ++p<0.01 
respect to untreated-cells. 
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To further confirm the activation of autophagy after treatment with CEN, we 
used the molecular marker LC3-II, the lipidated isoform of LC3 protein, 
essential in the autophagosome membrane formation. The immunoblots and 
the corresponding densitometric analysis (numbers on the bottom of the 
panels) are reported in Figure 4.10, which shows increased expression of 
LC3-II band at 168 h of incubation with CEN on Caco-2 (1.25 fold) (Figure 
4.10, A) and in SAOs (4 fold) (Figure 4.10, B). The increase of LC3-II was 
also detectable in both cell lines at earlier times (96-120 h; data not shown). 
 
 
Figure 4.10. Immunoblots of LC3-I, LC3-II expression in Caco-2 (A) and 
SAOs (B) cells treated for 168 h with CTRL and CEN (400 g/ml for Caco-2 
and 200 g/ml for SAOs) as reported in “Materials and Methods”. The 
numbers, below the bands indicate the densitometric analysis values, resulted 
by the ratio of the lipidated isoform LC3-II and α-tubulin. 
 
4.4.5 CEN activates “not protective” autophagy 
Data obtained from CytoID assays and immunoblotting confirmed the 
involvement of autophagy in reducing cell proliferation after CEN treatment. 
Therefore, we further investigated this phenomenon trying to classify the 
effect of CEN on autophagic induction in one of the four forms of autophagy 
described above (Table 4.4), which are differently associated with cancer cell 
 
 
 
Chapter IV: Antiproliferative effect of carotenoids from Cucurbita moschata 
152 
 
growth in response to stress induced by chemotherapy. In the present study, 
we can easily exclude cytotoxic autophagy, characterized by cell death, as well 
as cytostatic autophagy where a classical cell cycle arrest can be detected. 
Therefore, we tried to discriminate between the protective or not-protective 
forms of autophagy, using chloroquine as one of the most used 
pharmacological inhibitor of autophagic flux [41]. The rational of the 
experiment has been the following: in the presence of “protective” autophagy, 
we expect that the inhibition of the autophagic flux caused by chloroquine 
should result in an increased cytotoxicity of the treatment under investigation 
(in our case, CEN+chloroquine treated cells compared to CEN mono-
treatment) generally associated to apoptotic cell death; alternatively, in the 
presence of a “not protective” autophagy, following chloroquine inhibition, we 
should not detect any significant changes in the cytotoxic effect of 
CEN+chloroquine versus CEN alone. As shown in Figure 4.11, the co-
treatment chloroquine+CEN did not reduce significantly cell viability 
compared to chloroquine or CEN mono-treatments. Therefore, we concluded 
that the activation of autophagy in Caco-2 and SAOs cells did not protect cells 
from the effect of CEN on cellular viability, inducing a not protective 
autophagic phenotype. 
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Figure 4.11. Activaction of a not protective autophagy by CEN in Caco-2 (A) 
and SAOs (B). The cells were mantained at 37 °C at a density of 2.5x10
3
/ml of 
DMEM and treated with CTRL and CEN (400 g/ml for Caco-2 and 200 
g/ml for SAOs) every 48 h and 20 M chloroquine was added in the last 48 h 
of incubation. The CyQuant viability assay was performed after 144 h of 
incubation as described in “Materials and Methods”. The bars in the graphs 
indicate SD; symbols indicate signiﬁcance: *p<0.05 and **p<0.01 respect to 
CTRL (nanoemulsions prepared in the absence of carotenoid extract); no 
significant differences between CEN+Chloroquine vs CEN. 
 
The paradoxical role of autophagy is revealed especially in studies of tumor 
biology and its complex function is strongly dependent on the cellular context. 
As reported above, the autophagy has two primary and opposing functions in 
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tumor cells in response to stress induced by chemotherapy or radiation [25]. 
Initially, the induction of a “protective” autophagy by chemotherapy in tumor 
cells was considered to be a positive response from scientists. Therefore, it has 
been examined that the modulation of this process could provided for new era 
in the enhancement of antitumor drug and radiation effectiveness. In fact, 
since the protective autophagy may protect cancer cells from environmental 
insults and confers resistance to chemotherapy, several clinical trials have 
focused on improving the response to treatment, combining chloroquine or 
hydroxychloroquine with various conventional treatment modalities [25]. 
Even if in positive outcomes of clinical trials could potentially represent a 
revolution in cancer therapy based on the inhibition of autophagy, the data on 
preclinical animal models are still insufficient [25]. Furthermore, from a 
pharmacokinetic point of view, it is not known whether chloroquine or 
hydroxychloroquine may achieve such concentrations to effectively inhibit 
autophagy in normal clinical regimens [25].  
For these reasons, it has been discussed that the possibility of 
chemotherapeutic drugs and radiation to promote a “not protective” form of 
autophagy could be a positive phenomenon, especially if it is related to the cell 
cycle block (cytostatic autophagy) and/or the activation of cellular 
differentiation. In the past years it was introduced the concept of 
“differentiation therapy” in tumor biology by inducing the cancer cells to 
differentiate, in order to inhibit their proliferation and reduce their invasivity. 
As reported above, one of the greatest achievements in this field was reached 
by the discovery that ATRA was able to induce, in most cases, the complete 
remission of the disease in patients with APL, by inducing a process of 
cellular differentiation [12].  
It has also been showed that the activation of the differentiation in 
osteosarcoma cell lines by ATRA involves the activation of the autophagic 
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process [13], presumably for his key role in the recycling of macromolecules 
and cell organelles essential to osteoid formation in mature osteoblasts [42]. 
In support of this view, it should be considered the role of autophagy in 
osteoblasts function, involved in mineralization and bone homeostasis [42]. In 
fact, it has been demonstrated the involvement of autophagy as important 
mediator of bone cell function in normal physiology and in pathology [43]. In 
particular, the relevance of the autophagy, related to the differentiation 
process, is also reported by Vessoni et al. [44] in some stem cell populations. 
Moreover, it has been showed that genetic or pharmacological autophagy 
inhibition suppresses mesenchymal stem cell differentiation to osteoblasts 
[45].  
The role of not protective autophagy in cellular differentitation is 
demonstrated also in several intestinal cell lines (Caco-2, HT-29) [46]. In 
particular, it has been reported that a cytoplasmic heterotrimeric Gi3 protein 
regulates autophagy in these human colon cancer cell lines and their state of 
differentiation [46]. Since the interpretation of our data suggest a slow down 
effect on cell proliferation, it is reasonable to assume that not protective 
autophagy induced by CEN could be related to cellular differentiation in SAOs 
and Caco-2 cell lines. For these reasons, further studies are needed to evaluate 
an induction of differentiated phenotype associated with retarded proliferation 
after incubation of Caco-2 and SAOs cells with CEN, using biochemical and 
morphological markers such as alkaline phosphatase, particularly expressed in 
these two experimental models [47]. 
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4.4.6 Biochemical regulation of autophagy by carotenoid extract 
Energetic depletion is an important modulator of autophagy. Therefore, we 
investigated whether autophagy induced by CEN was related to an initial 
alteration of energetic metabolism. To this aim, intracellular ATP was 
measured as an index of functional integrity of metabolically active cells. As 
illustrated in Figure 4.12, the ATP intracellular levels, expressed as 
chemiluminescence value, were significantly reduced after 48 h and 24 h of 
incubation with CEN in Caco-2 cells (Figure 4.12, A) and SAOs (Figure 
4.12, B), respectively. 
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Figure 4.12. ATP levels of Caco-2 (A) and SAOs (B) after treatment with 
CEN. The cells were mantained at 37 °C at a density of 2.5x10
3
/ml of DMEM 
and treated with CTRL and CEN (400 g/ml for Caco-2 and 200 g/ml for 
SAOs). After 24-48h h, ATP intracellular levels were measured as reported in 
“Materials and Methods”. The bars in the graphs indicate SD; symbols 
indicate signiﬁcance:*p<0.05 and  ** p<0.01 respect to CTRL 
(nanoemulsions prepared in the absence of carotenoid extract). and 
+p<0.05and ++p<0.01 respect to untreated-cells. 
 
Starting from data showed in Figure 4.12, we verified if the decrease of ATP 
could activate kinase AMPK, a metabolic modulator of glucose and lipid 
metabolism in response to the alterations of nutrients and intracellular ATP 
levels. AMPK is an  heterotrimer with the threonine-172 phosphorylation 
on the catalytic -subunit essential for its fully activation [22]. In particular, 
the -subunit includes the four domains of allosteric regulation by AMP/ATP, 
which act as an allosteric activators and inhibitors, respectively, by binding at 
exchangeable sites CBS1 and CBS3, two pairs of motifs in tandem related to 
cystathionine-b-synthase sequences (Figure 4.13). Therefore, the activation of 
AMPK is induced by changes in the AMP/ADP/ATP binding on the CBS 
domains of -subunits. In details, an energetic imbalance induces the 
formation of ATP and AMP from the adenylate kinase by the reaction 2ADP -
> ATP + AMP. Considering that a 10% variation of ATP levels results in a 
more than 8-fold change in AMP concentrations, AMP replaces ATP in the -
subunit. This allosteric change triggers a myristoyl switch, freeing Thr172 
which becomes available for phosphorylation by upstream kinases. 
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Figure 4.13. AMPK allosteric regulation by AMP, ADP and ATP [22]. 
 
AMPK is required for the autophagy induction and is involved in the initial 
stage of autophagosomes nucleation. We hypothesized that autophagy could 
be activated by a reduction of ATP induced by CEN, through the involvement 
of AMPK. To confirm this possibility, we evaluated the expression levels of 
the phosphorylated and active form of protein, pAMPK (Thr
172
), which 
increased twice after CEN treatment compared to controls, as resulted by 
densitometric analysis in Figure 4.14.  
 
 
Figure 4.14. Immunoblots of pAMPK in SAOs cells treated for 24 h with 
CTRL and CEN (200 g/ml of carotenoid extract) as reported in “Materials 
and Methods”. 2 M ATRA was used as positive control. The numbers, below 
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the bands indicate the densitometric analysis values, resulted by the ratio of 
pAMPK and α-tubulin. 
 
Therefore, to support our hypothesis that autophagy induced by CEN could be 
linked to cellular differentiation, it was shown by [48] that AMPK is activated 
during osteoblast differentiation. In particular, it has been suggested that early 
catabolic changes are important to provide the energy source for osteoblasts 
and the activation of AMPK and autophagy is a significant event to induce 
osteoblasts to progress to the final stages of differentiation [48]. In this study 
the authors demonstrate that the induction of autophagy is required at the 
beginning of the differentiation and IGF-I/insulin-like growth factor binding 
protein 2 (IGFBP-2) activate important components for autophagosome 
formation. As reported in Figure 4.15, IGF-I and IGFBP-2 stimulate AMPK 
activation, resulting in activation of autophagy, which is required for optimal 
osteoblast differentiation [48].  
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Figure 4.15. Regulation of AMPK and autophagy required for osteoblast 
differentiation [48]. 
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4.5 Conclusions 
In the present study, we investigated the biological effect of a carotenoid 
extract from Cucurbita moschata on different transformed human cell lines. 
The first important novelty here reported is the potential impact of the 
nanoemulsion technology employed as a promising system to improve 
solubility of the carotenoids extracts, enhancing their stability and preventing 
their degradation. Further studies are in progress to improve this technique. 
The results show that CEN slowdowns cancer cell growth and this effect could 
be related to an alteration in energy metabolism and induction of not 
protective form of autophagy through the activation of kinase AMPK. To our 
knowledge, the data reported in this Chapter represent one of the very few 
example present in the Literature where a carotenoid-derived preparation 
interfered with the autophagic process in malignant cell lines. This preliminary 
pre-clinical study represents an important indication that carotenoid extract 
from Cucurbita moschata can be tested as therapeutic adjuvant in association 
with chemotherapeutic or radiation treatments. Data from our group on 
ATRA reinforces this hypothesis [13]. In this context, the next pre-clinical 
step should be the recurrence to a suitable animal models to test the 
chemopreventive and/or chemotherapeutic efficacy of our carotenoid 
nonoemulsions. 
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5.1 Conclusions  
The present thesis reports data on the biological properties of bioactive 
extracts prepared from Italian cultivars/products and assayed on different in 
vitro models to test their ability to ameliorate conditions of cellular oxidative 
stress often associated with the occurrence of degenerative pathologies, such 
as cancer and neurodegenerative diseases. The two classes of biomolecules 
investigated, polyphenols and carotenoids, are largely present in the three 
different foods and beverage considered: red wine, elderberries and pumpkin. 
Although the strategy to test vegetable extracts enriched with a specific class 
of biological compounds in preclinical cellular models is not novel and many 
examples are abundantly present in the literature, we selected this approach for 
two main reasons. Firstly, the measure of the biological response of an extract 
potentially includes possible additive/synergistic effects of more than a single 
compound and may result in enhanced functional outcomes. This possibility 
can reflect the observation that many bioactive molecules are present in the 
extract at relatively low concentrations, not enough to generate, per se, any 
measurable effect, but, when associated with others, can contribute to improve 
a given pathological or pre-pathological condition. The rationale of this 
hypothesis resides in the observation that, generally, biological extracts, like 
those tested in the present project, contain compounds which are structurally 
and functionally similar. To express this concept with a figurative example, a 
single, strongly active compound, added at high (pharmacological) 
concentrations to a sick cell/tissue may represent a “gun bullet”, compared to 
the “hundreds pellets” of a hunting rifle cartridge which mimic the mixture of 
molecules in a bioactive extract, each of them present at very low 
concentrations. 
The second reason that brought us to focus the present work on the use of 
polyphenolic and carotenoid extracts is related to the possibility to design and 
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develop prototypes of functional foods enriched with these bioactive 
components, an outcome partially obtained, as discussed in the following 
paragraphs, although not included in the main frame of this thesis since the 
results are still preliminary. Work is in progress to complete these tasks which 
represent the expected continuation of the present project. 
As stated above, the evaluation of the biological activity of the selected 
extracts using different pre-clinical experimental models highlights the 
potential applicative interest of the present work both in the nutraceutical and 
pharmaceutical sectors. To this regard, we would like to stress the rationale 
behind the cellular models employed in the present thesis, as summarized in 
the cartoon below (Figure 5.1).  
 
Figure 5.1. Scheme summarizing the employed experimental models. 
 
We used human erythrocytes as a “physiological” model of cellular structures 
where oxidative damage occurring during the life cycle, especially in ageing, 
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may be ameliorated by grape polyphenols present in red wines. The same class 
of bioactive compounds can protect against neuronal injury caused by ROS in 
IMR32 cells, resembling the neurodegenerative damage occurring in elderly.  
Finally, a different class of antioxidant compounds, carotenoids from 
pumpkin, showed a very peculiar way to protect cells from cancer, another 
degenerative disease whose occurrence is highly related to lifestyle (including 
diet) and ageing. 
In details, our data indicate the existence of novel mechanisms triggered by 
red wine polyphenols and resulting in the protection of RBCs by plasma 
oxidizing species. These compounds, in fact, are able to increase RBCs 
antioxidant defences by activating PMRS. The importance of this system is 
closely related to the increased oxidative stress in plasma, that occurs during 
aging. For this reason, the strengthening of RBCs antioxidant systems, 
including GSH and GSH-dependent enzymes, exerted by red wine-derived 
polyphenols, provides a mechanism to counteract the oxidative injuries, that 
constantly damage RBCs due to their biological role of oxygen transporters. 
Moreover, we hypothesized that red wine polyphenols trigger a slight, but 
significant increase of intracellular ROS, which induces a cellular adaptive 
response, resulting in increasing RBCs antioxidant defences. The corollary of 
our conclusion is that red wine polyphenols must act as weak pro-oxidants and 
undergo autoxidation induced by the ferryl myoglobin. This is not totally new, 
in fact, when polyphenols lose an electron or act as a reducing agents, become 
radicals and their oxidized intermediates can also behave as pro-oxidants. 
Interaction between polyphenols and transition metal ions can result in pro-
oxidants formation, oxidized intermediates or oxidation products, such as 
semiquinones and quinones [1]. These species are extremely reactive and lead 
to ROS production, such as O2
.-
 and H2O2 inside the cell (Figure 5.2) [1]. 
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Figure 5.2. Formation of semiquinone and quinone by polyphenols [1]. 
 
The presence of ROS at low concentrations seems to be involved in normal 
cellular function, as well as disease prevention [2]. These circumstantial 
evidence are in favour of our hypothesis that red wine polyphenols generate 
low concentration of H2O2, which induce the cellular adaptation to oxidative 
stress. This aspect highlights the preventive role of polyphenols, which, 
through this mechanism of cellular adaptation against oxidative stress, can 
prevent the onset of degenerative and age-depending diseases related to 
oxidative damage, including neurodegeneration. In fact, we also described, in 
an in vitro neurodegenerative model, the protective role of a polyphenolic 
extract from S. nigra berries against oxidative damage induced by neurotoxic 
agents. Also in this case, we produced experimental evidence that polyphenols 
exert their neuroprotective effect by slightly increasing ROS levels, which, in 
turns, induced a cellular adaptive response. The data obtained provide an 
initial indication for future clinical trials addressed to prove the preventive role 
of this natural extract against neurodegenerative disease. However, we cannot 
ignore the large body of data which limit the clinical relevance of polyphenols 
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due to their difficulty to cross the BBB, which is required to explicate the 
potential neuroprotective effects. Moreover, oral administration of 
polyphenols implies their biotransformation and metabolism which largely 
influences their bioavailability. As reported in the “Introduction” of Chapter I, 
phenolic compounds are metabolized after intestinal uptake before being 
delivered to different tissues or organs by blood circulation to exert their 
biological effects. Once absorbed, polyphenols are conjugated to glucuronide, 
sulphate and methyl groups in the gut mucosa and inner tissues [3]. Future 
studies are needed to evaluate the biological activities of the conjugated 
derivatives and microbial metabolites of polyphenols, or to explore the 
possibility that these derivatives, after their cellular uptake, are converted back 
to the original aglycone, a possibility verified in several experimental 
conditions [4]. If proven, this achievement could contribute to the 
development of a dietary strategy to maximize the health benefits of phenolic 
compounds and their metabolites. 
To this respect, considering the protective role of polyphenols against 
oxidative damage, we and other colleagues hypothesized that the intake of 
grape polyphenols could exert a beneficial effect in the plasma of healthy 
subjects. Therefore, in collaboration with Dr. Giacco of the Institute of Food 
Science, National Research Council in Avellino, we are participating to a 
clinical trial, approved by the Ethics Committee, within the frame of a PRIN 
(Research Projects of National Interest) project and aimed to evaluate the 
protective role of a juice enriched with grape polyphenols on healthy subjects 
(data in preparation). In particular, we measure the activity of antioxidant 
enzymes, such as CAT and SOD, and PMRS activity in blood samples drawn 
from the experimental versus the control group (subjects who drank juice 
without polyphenols) within 24 h after the intake. We detect that an increase 
of intracellular GSH concentration and the activitation of antioxidant enzymes, 
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such as SOD, after 360 min of juice assumption compared to the control group 
(work in progress).  
As depicted in Figure 5.1, a specific workpackage of this project (Chapter IV) 
investigated the potentiality of a carotenoid-enriched extract from pumpkin to 
find applicative outcomes in the biomedical area. This possibility is supported 
by the large body of scientific evidence, widely cited in Chapter 1 and in the 
Introduction of Chapter 4, that fruits and vegetable contains dietary 
chemopreventive agents, including vitamin A derivatives. To support this 
view, we evaluated the functional effects of a pumpkin carotenoid extract on 
the proliferation of malignant cell lines, studying the molecular targets 
affected by carotenoids. We ended up with the observation that pumpkin 
carotenoids do not directly kill cancer cells, but slow down their proliferation. 
In two different cell lines, Caco-2 and SAOs, derived from human epithelial 
colorectal adenocarcinoma and osteosarcoma, respectively, the carotenoid-
enriched extract induced an alteration of the energetic metabolism which 
resulted in a decreases intracellular concentration of ATP and the activation of 
an autophagic process. Probably, the “not-protective” autophagy detected in 
our experiments directly or indirectly induces cellular differentiation in 
malignant cells, a possibility that deserves further investigations. 
A novelty of the present work, verified for both wine-derived polyphenols and 
pumpkin carotenoids is the observation that single compounds present in these 
extracts, and well-known in the literature for their broad biological activities 
are not responsible for the observed phenomena. In fact, in Figure 2.14 of 
Chapter II, we reported that few of the most representative phenolic 
compounds tested on erythrocytes at the concentrations usually present in red 
wines were not as effective as when assayed in the whole extract, suggesting 
the possible existence of a synergistic mechanisms. Similarly, -carotene from 
pumpkin, assayed as individual compound did not show any effects on cell 
proliferation at the concentration present in the extract, suggesting, also in this 
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case, a synergism among different components, or the presence of not yet 
identified bioactive molecules. 
Considering the potential therapeutic applications of carotenoids in cancer 
cure and prevention, we cannot ignore the failure or null effects of several 
clinical trials mentioned in the above chapters which highlight the need to 
clarify important aspects of their molecular mechanism of action. We hope 
that our study may contribute to improve the knowledge on how this class of 
compounds, poorly studied at molecular level because of their low solubility 
can be effective against cancer and suggest  pharmaceutical applications. 
Despite the large rumour present on the media about the potential health 
effects of functional food and/or nutraceutical containing bioactive extracts, it 
is important to make a clear distinction between commercial interests and 
robust scientific data to support conclusions on the disease preventive efficacy 
of these molecules. Key issues, as metabolism and bioavailability, may 
strongly influence the positive cause-effect relation between intake of 
carotenoids-enriched food and disease prevention. For this reason, 
technological processing of carotenoids is crucial to ensure their applicative 
outcomes on an industrial scale, through the design of formulations, which 
allow to preserve their physical and chemical stability and effectiveness. The 
difficulty in developing an ideal formulation concerns the limits in 
manipulation of these molecules, which are sensitive to light, high 
temperature, oxygen, all conditions resulting in reduced stability, formation of 
degradation products and loss of biological activity [5]. For example, during 
preparation, processing, and storage of nutraceutical products, for the presence 
of double bonds in their structure, carotenoids are susceptible to different 
degradation reactions. The more frequent reactions that may occur are 
oxidation and isomerization. Oxidation may occur either by a spontaneous 
autoxidation in presence of oxygen, or by photoxidation, which involves 
singlet oxygen, while isomerization includes trans-isomers, more common and 
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stable in foods, and cis-isomers, usually formed during food processing. This 
chemical transformations influence the phenotypic aspects of product, but also 
reduce the functional activity of carotenoids. As reported in the 
“Introduction”, Chapter I, low bioavailability of carotenoids limits their 
efficacy since the amount that reaches the bloodstream is very poor. 
Considering the lipophilic nature of these compounds, the formulation 
strategies are related to the use of a delivery vehicle able to increase their 
solubility in the aqueous fluids. Therefore, several advanced technologies are 
considerably expanding. Among these techniques, the formation of micelles 
and liposomes, microscopic spherical lipid vesicles, allows the incorporation 
of the lipophilic molecules in an internal core surrounded by a phospholipid 
mono- or bilayer, respectively [6]. Furthermore, microencapsulation is valid 
technique, that enhances the stability of carotenoids by physical isolation 
through packaging wall compounds, also called shell or coating. The 
formation of wall with appropriate polymers can protect bioactive molecules 
from oxygen and chemical and enzymatic degradations and increase the 
solubility/dissolution rate in water [7]. These materials are often biodegradable 
polymers, which protect core material and modify the rate of release of 
carotenoids in a specific target of the body [7]. Among this, spray-drying is a 
microencapsulation technique particularly indicated for heat sensitive 
components such as carotenoids, and widely used by pharmaceutical and food 
industry. Therefore, we suppose that the transformation in a stable dry 
powders form by spray-drying is a convenient way to increase the shelf-life 
and improve the physical chemical behaviour of carotenoid extract through the 
use of an appropriate polymers [8]. For this reason, during the last part of this 
project, we performed preliminary experiments aimed to develop a protocol 
for spray-drying process employing the carotenoid extract (work in progress) 
hoping to obtain a stable and high bioavailable formulations to be included in 
prototypes of functional foods, a challenge already explored in the course of 
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the present project. To this aim, we already designed and produced prototypes 
of bakery products (breads, cookies, Figure 5.3) made with flour rich in 
carotenoids obtained from the pumpkin. In the continuation of this work, these 
prototypes will be the subject of a study approved by the Ethics Committee, 
aimed to demonstrate the effects of bread enriched-carotenoids on blood 
glucose/insulin/lipid metabolism, markers of oxidative stress and subclinical 
inflammation in overweight subjects after 3-weeks of assumption (work in 
progress). 
 
 
Figure 5.3. Flour (A) obtained from the long pumpkin of Naples and derived 
prototypes of bakery products: bread (B) and cookies (C and D). 
 
The data reported in this thesis have been published [9] [10] or presented as 
posters or communications at national and international conferences [11] [12] 
[13] [14] [15]. 
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